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Dry powder inhalers (DPIs) and pressurised metered dose inhalers (pMDIs) are 
devices used to deliver therapeutic agents to the lungs. Typically, inhaled active 
pharmaceutical ingredients (APIs) are electrically resistive materials and are prone to 
accumulating electrostatic charge. The build-up of charge on inhaled therapeutics has 
traditionally been viewed as a nuisance as it may result in problems such as weighing 
errors, agglomeration, adhesion to surfaces and poor flow. Energetic processing steps 
such as micronisation, blending, blister/capsule filling as well as fluidisation of the dose 
will result in a large number of particulate collisions which can result in charge transfer. 
Charge present on aerosol particles may also affect the in vivo performance by altering 
the inhaler delivery efficiency and promoting electrostatic precipitation within the lung. 
 
This study aimed to develop and assess repeatable and reliable methods of performing 
electrostatic measurements of particles for inhalation and to understand the 
relationship of charge with environmental relative humidity. 
 
A powder ladle was constructed to perform net charge measurements of inhalation 
grades of lactose and used to assess the extent of triboelectrification during low shear 
turbula blending. Results demonstrated the importance of the method of addition used 
to transfer a sample to a net charge measurement device. 
 
The electrical properties of DPI formulations were investigated using a Charge Decay 
Time Analyser. It was determined that both API concentration and relative humidity 
play an essential role in governing the extent to which a DPI formulation can become 
electrostatically charged and the subsequent rate of charge decay. 
 
Finally, the bipolar Next Generation Impactor (bp-NGI) was developed and assessed 
as a tool to measure the bipolar charge to mass ratios of therapeutic aerosol particles 
in order to address the unmet need of combining a bipolar charge measurement 
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the bp-NGI at 35% RH (n=3, mean ± SD) 
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Table 6.5 Masses and percentages of lactose particles deposited within the 
bp-NGI at 35% RH (n=3, mean ± SD) 
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the bp-NGI at 55% RH (n=3, mean ± SD) 
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bp-NGI at 55% RH (n=3, mean ± SD) 
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Chapter 1    Introduction 
 
1.1 Respiratory drug delivery 
 
1.1.1 Respiratory tract physiology 
 
The respiratory system is the means by which aerobic respiration is performed by all 
mammals. In human physiology it begins with the pharynx and larynx, which lead to the 
oropharynx, followed by the trachea and finally the lungs. The purpose of the lung is to 
absorb gaseous oxygen into the circulatory system and release carbon dioxide back 
out into the external environment (Griffith et al. 2009). A schematic representation of 
human lung physiology is shown in Figure 1.1 (Griesenbach et al. 2004). The trachea 
bifurcates into the left and right main bronchi of each lung. The bronchi in turn bifurcate 
into shorter and smaller diameter bronchi and with successive narrowing and 




Figure 1.1 Diagram of human respiratory tract (adapted from Griesenbach et al., 
2004) 
 
The bronchioles in turn bifurcate many times leading to alveolar sacs consisting of 
many alveoli at the periphery of the lung. In all there are approximately 23 bifurcations 
from the trachea to the alveoli (Prokopovich 2013). The alveoli are supplied with an 
abundant blood supply which facilitates efficient gaseous transfer. The respiratory 
volume of a pair of typical adult lungs is approximately 4 litres, however, the successive 
bifurcation of the airways and spherical shape of the alveoli result in an extremely large 
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internal surface area of the lungs in the order of 50 m2 (Hasleton 1972). The internal 
surfaces of the entire respiratory tract are covered in epithelial cells which can perform 
a number of functions including the removal of airborne particles via mucociliary 
clearance where the cells produce a layer of mucus which works together with upward 
beating cilia hairs to expel foreign particulates (Knowles and Boucher 2002).  
 
 
1.1.2 Common respiratory diseases and their treatments 
 
1.1.2.1 Asthma 
Asthma is the most prevalent respiratory illness with an estimated 235 million sufferers 
worldwide (WHO 2011). When an asthma sufferer is exposed to a substance which 
irritates the airways, known as an asthma trigger, an inflammatory response is 
produced which causes constriction of the airway smooth muscles, inflammation as 
well as mucus secretion (Knox et al. 2000). A prolonged reaction can lead to an 
asthma attack where the sufferer has greatly restricted breathing capacity which may 
result in hospitalisation and in severe cases, death (Sidebotham and Roche 2003). The 
root causes have yet to be definitively proven, however, genetic predisposition, diet, 
hygiene, pollution, chemicals and smoking have all been suggested as possibilities 
(Gern et al. 1999). Worryingly, the prevalence of asthma worldwide is increasing, not 
just in western cultures, but also in developing countries (Beasley et al. 2000) and so 
treatments for asthma remain an important area of pharmaceutical research. 
Therapeutic agents for asthma include corticosteroids such as budesonide and 
fluticasone propionate which reduce and control inflammation (Kimura et al. 2009) and 
beta-adrenoceptor agonists (beta agonists) which are bronchodilators used to open the 
airways (Matera et al. 2008). Beta agonists may be short acting but provide a rapid 
onset of action such as in the case of salbutamol sulphate and are useful to alleviate 
asthma attacks (Cullum et al. 1969). Other beta agonists are long acting including 
formoterol fumarate, salmeterol xinafoate and ultra-long acting such as indacaterol 
maleate, which are used as maintenance therapies and may be taken once or twice 
daily as a preventative treatment (Brookman et al. 2007, Dahl et al. 2010). It is 
common for corticosteroids and beta agonists to be provided to asthma patients in a 
combined dose and many combinations are currently available on the market (Chung 




1.1.2.2 Chronic obstructive pulmonary disease 
Chronic obstructive pulmonary disease (COPD) is currently the fourth leading cause of 
chronic morbidity and mortality in the United States and by 2020 is projected to reach 
the top five on the list in terms of burden of worldwide diseases (Rabe et al. 2007). 
COPD is primarily caused by smoking and pollution resulting in chronic inflammation 
that leads to alveolar wall destruction known as emphysema.  This results in increased 
numbers of alveolar macrophages, neutrophils and cytotoxic T-lymphocytes, and the 
release of multiple inflammatory mediators including lipids, chemokines, cytokines and 
growth factors (Barnes et al. 2003). Other symptoms include tightening and constriction 
of the lung air passages, mucus secretion, wheezing and cough (Abbas et al. 2014). 
The most effect treatment for COPD is smoking cessation, however, as in the case of 
asthma, combination treatments of corticosteroids and long acting beta agonists are 
commonly used to alleviate the symptoms (Miller-Larsson and Selroos 2006). 
Anticholinergics, also known as muscarinic antagonists, such as ipratropium and 
tiotropium, which act as bronchodilators by reducing smooth muscle contraction, may 
also be prescribed (Disse 2001). 
 
1.1.3 Drug particle deposition within the lung 
 
1.1.3.1 Inertial impaction 
Inertial impaction is one of the dominant mechanisms of particle deposition in the lung 
and occurs mainly in the bronchi and bronchioles (Sbirlea-Apiou et al. 2007). As the 
patient inhales therapeutic aerosol particles, the airstream changes direction multiple 
times as it passes through the repeating bifurcations of the internal lung structure. At 
each bifurcation particles above a certain mass will possess too much momentum to be 
able to change direction with the airflow and so will impact on the respiratory surface. 
The probability that a particle impact will occur is calculated by the Stokes number 






 Equation 1.1 
Where ρp is the density of the particle, d is the diameter of the particle, V is the velocity 
of the air, η is the viscosity of the air and r is the radius of the airway. The greater the 
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value of the Stokes number, the greater the chance that the particle will impact onto the 
airway surface (Kiao et al. 2010). For Stokes’ law to be valid, the airflow through the 
lung must be laminar. Therefore the value for the Reynold’s number, given by Equation 




 Equation 1.2 
If the Reynold’s number falls outside this range, particle deposition will occur not only 
as a result of inertial impaction, but also as a result of turbulence. However, given 
average geometries and inspiratory flow rates, laminar flow is typical within the human 
lung with the possible exception of the trachea (Carvalho et al. 2011). 
 
1.1.3.2 Sedimentation 
Sedimentation is the process by which particles are suspended in the respiratory tract 
due to the effect of gravity as a function of time. If the breath hold time is increased 
more time is allowed for particles to sediment which can increase lung deposition 
(Zeng et al. 2001). Assuming that the relative velocity of the surface of the particle and 
the airstream is zero, Stokes’ Law can be used to predict the terminal settling velocity 
(vts) during sedimentation for spherical particles with diameters in the range 1-40 μm 





 Equation 1.3 
Where ρa is the density of air and g is the gravitational acceleration (Gonda 2004). For 
particles smaller than 10 μm a slip correction factor (Cc) should be applied to Stokes’ 
law as shown in Equation 1.4. 
𝐶𝑐 = 1 + 𝐾𝑛 [𝐴1 + 𝐴2 𝑒𝑥𝑝 − (
𝐴3
𝐾𝑛
)] Equation 1.4 
Where Kn is the Knudsen number and A1, A2 and A3 are experimentally determined 
constants. The size dependence is related to the downward gravitational force of the 





Diffusion occurs when particles are small enough to be able to be displaced by 
molecular gas bombardment which is described by Brownian motion (Yu and Hu 1983). 
The ability of a particle to be displaced is determined by its diffusion coefficient, Dif, 




 Equation 1.5 
Where k is the Boltzman constant and T is the absolute temperature. In reality only 
sub-micron diameter particles are expected to be influenced by Brownian motion during 




Interception may occur for non-spherical, irregularly shaped aerosol particles which do 
not possess a central centre of mass. In this case the distal end of the particle may 
encounter the airway surface earlier than would be predicted using the inertial 
impaction, sedimentation or diffusion theories (Zhang et al. 1996). This can lead to the 
particle being deposited higher in the respiratory tract than may be predicted. In reality, 
as the airway diameter is much larger than the typical API aerodynamic diameter, 
interception is not thought to be an important factor in regional lung deposition. 
 
1.1.3.5 Electrostatic Precipitation 
Electrostatic precipitation may cause particle deposition by three main methods. Firstly, 
as an aerosol cloud of particles charged with the same polarity is generated, the like 
charges will repel which will cause the particles to move apart from one another. In a 
confined space such as the bronchi this will lead to an increase in the deposition 
(Mayya and Sapra 2002). Secondly, as a charged particle approaches an uncharged 
surface within the respiratory system, an “image charge” of opposite polarity may be 
induced onto said surface which will enhance the attraction between the two, and 
hence increase the probability of deposition by electrostatic precipitation (Soltani and 
Ahmadi 1999). Finally, negative charges occur naturally on the surfaces of cell 
membranes and so if a positively charged aerosol particle approaches, the electrostatic 
attraction will thus increase the amount of deposition (Patton et al. 2004). A summary 
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of previously published literature discussing the clinical relevance of aerosol charge 
can be found in section 1.3.5. 
 
1.1.4 Pharmaceutical devices for delivering aerosols to the lung 
 
1.1.4.1 Nebulisers 
Nebulisers use compressed gas or ultrasound to convert aqueous solutions or 
suspensions of respiratory drug products into a fine aerosol mist which is inhaled by 
the patient, either directly from the mouthpiece of the device or using a facemask (Lass 
et al. 2006). The operation of a nebuliser is neither patient driven nor requires 
coordinated breathing which can help to increase patient adherence (Latchford et al. 
2009). In addition nebulisers may be used for prolonged periods of time compared with 
pMDIs and DPIs which can increase the maximum dose delivered (Everard et al. 
1992). Due to limitations such as cost, noise, a lack of portability and the need for 
hygienic conditions, nebulisers are often restricted to hospital environments (Demir and 
Saryal 2003). However, recent developments such as personalised miniature 
nebulisers may start to overcome these limitations (Knoch and Keller 2005). 
 
1.1.4.2 Electrosprays 
Electrosprays are created with the use of a cone-jet which operates by passing a liquid 
slowly through an electrified capillary needle, creating charged droplets which is known 
as spray atomization. The droplets possess a narrow particle size distribution and tight 
control is achievable making electrosprays suitable for inhaled therapeutics (Gomez 
2002).  The scaling law of the spray current, I, emitted from an electrified liquid 
meniscus of a highly conducting liquid is described by Equation 1.6. 





 Equation 1.6 
Where ψ is the flow rate, γ is the surface tension, σ is the electrical conductivity and β 
is the liquid-vacuum permittivity ratio. f  is a dimensionless function dependent on the 
liquid used which may be experimentally determined (Gañán-Calvo et al. 1997). In 
order to prevent image forces from causing deposition in the upper regions of the 
respiratory tract Noakes et al. devised an electrospray system which incorporates a 
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corona discharge of opposite polarity to neutralise the charge present on the droplets 
(Noakes et al. 1990). Studies have indicated that the efficiency of electrosprays at 
delivering drug particles to the lung may be significantly improved with respect to 
current approaches and research has been conducted to commercialise the technology 
as a portable liquid dose inhaler (Placke and Zimlich 2002). 
 
1.1.4.3 Pressurised metered dose inhalers (pMDIs) 
The first pMDI was developed by Riker laboratories in 1956 for use with epinephrine 
and isoproterenol, the idea coming from comparing a can of hairspray to a nebuliser 
(Anderson 2005). The design consists of a pressurised canister containing a propellant, 
surfactant and a suspension or solution of the therapeutic agent (Rubin and Fink 2005). 
Originally chlorofluorocarbons (CFCs) were used as the propellant, but due to the 
harmful effect they have been shown to have on the environment, modern pMDIs use 
hydrofluorocarbons such as hydrofluoroalkane (HFA) 134a instead (Noakes 2002). A 
known volume of the pMDI suspension fills a metering chamber which is surrounded by 
a plastic actuator and mouthpiece. In order to release the dose, the pMDI is depressed 
or actuated which produces a fine atomised spray over approximately 100-200 
milliseconds (Dunbar 1998). The greatest limitations of pMDIs are that often 
inconsistent dosing occurs as a result of poor patient breath coordination, excessive 
inspiratory flow velocity and the cold Freon effect which can result in inefficient delivery 
of the API and poor patient compliance (Grossman 1994). 
 
1.1.4.4 Dry Powder Inhalers (DPIs) 
Over the past forty years, DPIs have become increasingly used due to the limitations of 
pMDIs (Grossman 1994). DPIs are routinely employed to deliver bronchodilators and 
corticosteroids used in the maintenance of asthma and chronic obstructive pulmonary 
disease (COPD) (Newman 2004). A dry powder inhaler formulation usually consists of 
micronised drug particles blended with larger coarse lactose carrier particles that 
promote flow properties, reduce aggregation and help in dispersion (Alagusundaram et 
al. 2010). They have the added advantage of being actuated by the patient’s own 
inspiratory flow improving the delivery efficiency as compared with pMDIs, where 
ensuring correct patient inhaler technique is a constant challenge. 
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Many different designs of DPI inhalers have been produced such as capsule, blister 
and powder reservoir devices. In a capsule based device such as the Aerolizer® 
device (Novartis, Switzerland), a capsule, usually manufactured from HPMC or gelatin 
containing the DPI formulation, is pierced by the user within the device. Blister devices 
such as the Diskus™ device (Glaxo Smithkline, UK) operate by a similar principle 
except that the doses are contained within a blister strip located inside the inhaler. 
Powder reservoir devices such as the NEXThaler™ (Chiesi, Italy) contain a bulk 
reservoir of the DPI formulation which is metered by a dosing mechanism inside the 
device. Blister and reservoir devices, although more expensive to manufacture, provide 
the benefit of complete containment of the DPI formulation as well as the capability of 
including a dose counter. 
 
1.1.5 Characteristics of particle interactions 
 
1.1.5.1 Van der Waals forces 
Van der Waals forces are experienced by atoms, molecules and surfaces and can be 
attractive or repulsive in air. They are relatively weak compared to covalent bonds and 
ionic interactions but fundamentally contribute to the forces of cohesion and adhesion 
between macroscopic objects. They are anisotropic in nature meaning they are 
dependent on the particular orientation with which the two bodies approach each other. 
The van der Waals forces are classified into dipole-dipole, dipole-induced dipole and 
induced dipole-induced dipole, with dipole-dipole interactions being the strongest in 
nature. The van der Waals force (Fvw) between two spherical objects of radii r1 and r2 is 




 Equation 1.7 
 
Where AH is the Hamaker constant (~10
-19 – 10-20 J) and d is the distance between the 
two objects (Overbeek and Sparnaay 1954). The van der Waals force between two 
species is proportional to the inverse of the square of the distance between them. As 
such they will be much more significant in bulk powders where there is intimate contact 
between particle surfaces as compared with gases where the constituent species are 
relatively far apart. In reality, particulate systems rarely consist of perfect spheres and 
the van der Waals forces will be more considerable as the surface contact area 
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between particles will be greater and the distance between the species reduced (Visser 
1989). 
 
1.1.5.2 Capillary forces 
Capillary forces between particles caused by the condensation of water from a humid 
atmosphere may lead to a significant increase in the cohesive strength of a bulk 
powder which may in turn affect its flowability and deagglomeration characteristics 
(Stevens et al. 2009). The presence of condensed water in between two particles may 
lead to the formation of a pendular bridge which will act to hold the particles together 
via a meniscus or capillary force. The shape of the particles and the type of interparticle 
contact will affect the strength of the bridge and hence the magnitude of the force 
(Tselishchev and Val'tsifer 2003). The capillary force, Fc, between two identical 
spherical objects of radius, r1, is given by Equation 1.8. 
 
𝐹𝑐 = 2𝜋𝑟1𝛾 Equation 1.8 
 
Where γ is the surface tension of the aqueous bridge. Studies have shown that non 
surface specific capillary forces play a significant role in the adhesion between drug 
particle and carrier particle in DPI formulations. The behaviour is heavily dependent on 
the ambient relative humidity as this will determine the amount of water adhered to the 
particle surface (Price et al. 2002, Young et al. 2004). 
 
1.1.5.3 Electrostatic interactions 
Electrostatic interactions are considered as the third main force which governs particle 








1.2 Fundamental Theory of Electrostatic Charge 
 
1.2.1 Definition and fundamental principles 
 
According to Aristotle, the first person attributed with recording the phenomenon of 
electrostatic charge was the Greek scientist Thales of Miletus (c. 600 B.C.), who 
observed the ability of the material amber to attract light materials such as paper or 
feathers (Sheean 1930). Charge is a fundamental property of two atomic particles – the 
proton and the electron. Protons in the nucleus of an atom are positively charged and 
the orbiting electrons are negatively charged. Like charges repel and opposite charges 
attract and this electrostatic attraction holds electrons in their orbits around the nuclei of 
atoms.  
 
1.2.1.1 Coulombic forces 
The force of attraction or repulsion experienced by two charged bodies is described by 





 Equation 1.9 
 
Where F is the force of attraction or repulsion between the two charged bodies, Q1 is 
the magnitude of charge on body 1, Q2 is the charge on body 2 and r is the distance 





 Equation 1.10 
 
Where ε0 is the relative permittivity of free space and εr is the relative permittivity of the 
environment in which the two charges are contained. 
Charge is measured in Coulombs, C, where one Coulomb is one ampere.second (A.s). 
The charge of an electron (e = -1.602 x 10-19 C), was first measured by Millikan and 
Fletcher in 1909 in what became famously known as Millikan’s oil drop experiment, 
which used an electric field to counter gravitational and drag effects and suspend small 
ionised droplets of oil in mid-air (Millikan 1911). 
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1.2.1.2 Field Strength and Voltage 
All charged bodies will possess an electric field associated with the charge present. 
The electric field strength, E, at a distance from a body, r, with charge, Q, is described 




 Equation 1.11 
 
The electric field generated by a charged spherical object may be visualised by 
imagining field lines emanating from the body as shown in Figure 1.2. 
 
Figure 1.2 Electric field lines emanating from a charged sphere 
Voltage, also described as potential difference, is measured in Joules per Coulomb 
(J.C-1) and is defined as the integral of the field strength between two points in an 
electric field as described by Equation 1.12. 
𝑉(𝐴) − 𝑉(𝐵) = ∫ 𝐸𝑑𝑎
𝐵
𝐴
 Equation 1.12 
Where V(A) – V(B) is the voltage, or potential difference between two points A and B in 
an electric field at a distance of a apart. Voltage may also be described as the 







The potential difference, V, of a body with charge, q, with respect to ground is 
proportional to the charge on the body as determined by its capacitance, Ca, as 
described by Equation 1.13. 
𝐶𝑎 =
𝑞
𝑉⁄  Equation 1.13 
Capacitance is measured in Farads, F, and a Farad capacitor with a charge of 1 
Coulomb has a potential difference of 1 Volt between the charged body and ground. 
Capacitors are utilised to store electric charge and electrometers used for the 
measurement of charge contain capacitors in to which the charge will flow. 
 
1.2.1.4 Current 
Current, I, measured in Amperes or Amps, is defined as the flow of electric charge as 
function of time, t, as described by Equation 1.14. 
𝐼 =
𝑞
𝑡⁄  Equation 1.14 
One Amp is equal to one Coulomb of charge per second. In electronics currents 
normally consist of a flow of electrons moving through a conductive metallic wire and 
are also used to transfer electrical signals and energy. 
 
1.2.1.5 Resistance and conductance 
Resistance, R, measured in Ohms, is defined by Ohm’s law as described by Equation 
1.15 and is a measure of the degree to which a material will resist a current flowing 
through it or across its surface. 
𝑅 = 𝑉 𝐼⁄  Equation 1.15 
Electrical resistivity, ρe, described by Equation 1.16 is governed by the relationship of a 
material’s length, l, and cross sectional area, A and provides a way of predicting the 







 Equation 1.16 
If the electrical resistivity is low then electrons may freely flow through the body to earth 
or to other materials and the charge decay time will be rapid. If the body is more 
electrically resistive, also known as insulating, then charge decay times will be much 
longer as electrons may not easily flow through the body’s structure. Materials such as 
metals will have low electrical resistivity as electrons are easily able to move through 
the structure. Conductivity, σ, is simply the inverse of resistivity and describes the ease 
with which a current may pass through a material. 
 
1.2.2 Electron transfer via triboelectrification 
 
When two different materials with differing electrostatic properties come into physical 
contact with each other and subsequently separated, an exchange of charged species, 
normally electrons may occur. After the exchange each material will be left with an 
unequal net charge of opposite sign, an example of the contact between to insulators 
resulting in electron transfer is shown in Figure 1.3.  
 
Figure 1.3 Two insulators becoming electrostatically charged via triboelectrification 
In Figure 1.3 A two different, uncharged insulators move towards each other, in Figure 
1.3 B the insulators come into surface contact with each other, in Figure 1.3 C, a 
transfer of electrons occurs from Insulator 1 to Insulator 2, resulting in Insulator 1 
39 
 
becoming positively charged and Insulator 2 becoming negatively charged. In Figure 
1.3 D, after the insulators have become charged they become separated. 
This phenomenon is known as contact-electrification or triboelectrification, and the 
process of rubbing or colliding two materials together to deliberately cause this 
phenomenon is known as tribocharging or triboelectric charging (Kwetkus 1998). Many 
common materials are susceptible to this phenomenon and may be placed on a 
triboelectric series an example of which is shown in Figure 1.4. 
 
Figure 1.4 Triboelectric series of a selection of common materials 
 
Each material is placed on the scale according to its charging propensity when rubbed 
against another material on the scale. For example, if a piece of polyester is rubbed 
with wool, the polyester will become negatively charged, and the wool positively 
charged. Powders, which have small particle sizes and large surface area to mass 
ratios are susceptible to extensive tribocharging during energetic processes such as in 
the case of volcanic eruptions and the movement of dust and sand by the wind (Kok 
and Lacks 2009). In extreme cases, a large build-up of electrostatic charge has even 
been responsible for dust explosions where either a corona, brush or spark discharge 
is of an energy greater than the Minimum Ignition Energy (MIE) of the dust cloud 
(Manjunath 2011). Applications have been developed to exploit this phenomena where 
the motion of charged particles is controlled such as in electrostatic precipitation for 
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example in photocopiers, printing, electrophotography (Hoshino et al. 2010) and the 
manufacture of sandpaper (Schlacht 1941).  
 
1.2.2.1 Work function 
The amount of charge transferred during triboelectrification of two conductive materials 
will depend on the work functions of the each material, which is a measure of how 
much energy is required to remove an electron from the Fermi level of the material to 
its vacuum energy level. Charge transfer ceases when the Fermi levels of the two 
materials become equal, minimising the difference in energy (Matsusaka et al. 2010). 
Figure 1.5, shows an approximation of the change in energy of two dissimilar 
conductive materials (e.g. metals) pre and post a triboelectrification event where a 
single electron is transferred from one conductor to the other. 
 
 
Figure 1.5 Electron transfer between two metals upon triboelectrification (adapted from 
Matsusaka et al. 2010) 
 
Assuming the contact between the materials results in thermodynamic equilibrium, the 





 Equation 1.17 
Where ф1 is the work function of material 1, ф2 is the work function of material 2 and e 
is the elementary charge. The amount of charge transferred between the two materials 




𝛥𝑄 = 𝐶𝑎0𝑉𝐶 Equation 1.18 
Where Ca0 is the capacitance between the bodies at a separation distance where 
charge is no longer transferred between them. The theory agrees fairly well with 
experimental data generated (Harper 1967), and any discrepancies may be due to, for 
example, surface contaminants, environmental effects and surface roughness of the 
materials tested. 
 
1.2.2.2 Effective work function 
For insulator - conductor contacts, as there is an absence of labile electrons in the 
insulator, the idea of an effective work function for the insulator may be used to 
estimate the amount of charge transferred (Davies 1969). The contact potential 






 Equation 1.19 
Where фins is the effective work function of the insulative material and фcon is the work 
function of the conductive material. After the charge is transferred the energy levels of 
the two materials are assumed to be equalised. Some agreement is found with 
experimental data (Davies 1969) however, the theory does not always hold for 
insulator-insulator contacts. 
 
1.2.2.3 Surface state model 
The work function and effective work function theories generally hold experimentally 
when one of the components is a conductive material. However, for insulator-insulator 
contacts the theory may not always apply due to the lack of the presence of labile 
electrons which are easily transferred from one material to the other. The surface state 
model assumes that the movement of electrons is more restricted and the available 
energy level is referred to as the surface state (Lowell and Rose-Innes 1980). When 
two materials come into contact, the electrons from the filled surface state of one 
material transfer to the empty surface state of the other in order to equalise the energy 




Figure 1.6 Surface state model for an insulator-insulator contact (adapted from 
Matsusaka et al. 2010). 
 
After insulators come into contact the charge transfer causes the Fermi level of 
insulator 1 to change by Δ1 and the Fermi level of insulator 2 to change by Δ2. The 
difference between the charge of the two materials also produces a potential 
difference, 𝑒𝐸𝑓𝑧0. Therefore the expression for the energy level is given by Equation 
1.20 (Lowell and Truscott 1986a).  
 
𝛷1 + 𝛥1 +  𝑒𝐸𝑓𝑧0  = 𝛷2 − 𝛥2 Equation 1.20 
  
This theory has been shown to be accurate for the charging of toner particles during 
electrophotography (Cotler et al. 1995). 
 
1.2.2.4 Electron Affinity 
Electron affinity, measured in kJ/mol, is defined as the amount of energy released 
when an electron is added to a neutral atom or molecule in the gaseous state to form a 
negatively charged ion. If the process is energetically favourable, the enthalpy will be 
negative and energy will be released. If a material has a high electron affinity an atom 
or molecule in its surface will easily pick up electrons and if the material has a low 
electron affinity the reverse will be the case. Electron affinity tends to follow the eight 
electron rule whereby atoms will seek to either lose or gain electrons so that a full outer 
shell of eight electrons is achieved. For example, a sodium atom loses an electron to 
become an Na+ ion or a chlorine atom gains an electron to become a Cl- ion. 
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1.2.2.5 Ion transfer 
Surface impurities which may be ionic in nature have been suggested to play a role in 
the tribocharging of insulators. Ion transfer during the contact between two dissimilar 
materials has been described previously (Robins et al. 1975, Mizes et al. 1990, 
Williams 2011) and ions may exist on the surface of both conductors and insulators, 
held in place either by weak van der Waals forces or solvated in a thin layer of surface 
moisture. However, the presence of water on the surface of a material will increase its 
conductivity and lower the electrical breakdown strength of air, resulting in a decrease 
in the charge present by increasing the charge decay rate (Lee 1994). Without 
determining precisely which ions are present on the surface of materials pre and post 
triboelectrification events, and the extent of adsorbed moisture present it cannot be 
concluded for certain whether ion transfer plays a dominant role in the transfer of 
charge from one species to another. However, artificially doping surfaces with ions has 
been exploited, for example with the use of charge control agents in the 
electrophotographic industry (Anderson 1996). 
 
1.2.2.6 Material Transfer 
When two materials come into contact it is possible that rather than electrons or ions 
being transferred, material such as solid particles may be transferred from the surface 
of one material to the other. If the material which is transferred carries electrostatic 
charge, charge will be transferred from one material to the other (Lowell and Rose-
Innes 1980). Charge transfer during insulator-insulator or metal-insulator contact may 
not be influenced by previous identical contacts. It has been demonstrated that material 
transfer occurs to a large extent on the first contact and to a much smaller extent on 
subsequent contacts and therefore it may be concluded that material transfer is not the 
primary mechanism of contact electrification (Lowell 1977b). However, common 
manufacturing techniques for DPI formulations include coating coarse lactose carrier 
particles with micronized API particles. If the API particles carry charge then the 







1.2.3 Bipolar charge 
 
Many of the theoretical models developed to describe charge transfer and 
triboelectrification assume that charged species are only transferred from one material 
to another resulting in a unipolar charge distribution for each material present during 
the contact (Saini et al. 2007). During the manufacture of respiratory drug products, 
respiratory particles will undergo collisions with many different types of materials such 
as stainless steel, used to construct equipment for micronizing and blending, gelatin or 
hydroxypropylmethyl cellulose (HPMC) used for capsules and the plastic and metal 
components of the inhaler. Excipient-excipient, excipient-API and API-API collisions will 
also lead to charge transfer (Castle and Schein 1995). In this case the overall net 
charge of the powder will remain constant but due to the different types of collisions 
involved some particles will become positively charged and some will become 
negatively charged, resulting in a bipolar charge distribution within the powder where 
the particles will be both positively and negatively charged at the same time. This may 
be difficult to assess accurately using conventional methods of measuring net charge 
as net charge only provides a sum of the positive and negative charges present (Lowell 
and Truscott 1986b). A graphical representation explaining this phenomenon is shown 






Figure 1.7 Representation of a group of bipolarly charged particles. 
 
In this example it is assumed that each positively charged particle has lost one unit of 
elementary charge causing the total overall positive charge in the system to be +5. 
Each negatively charged particle has gained one unit of elementary charge and the 
overall negative charge in the system is -5. If the particles are collected together then 
the overall net charge recorded for the system will be zero as the positive and negative 



















5 x particles with +1 charge 
5 x particles with -1 charge 
Total net charge = 0 
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1.2.4 Static charge decay 
 
Once a material becomes electrostatically charged, the charge will decay over time and 
the material will return to its original, neutral state. For conductive materials this may be 
due to a flow of electrons to or from the conductor to another material, or to earth. 
Electrons will flow relatively quickly through conductors and this will result in short 
charge decay times in the order of seconds to minutes. For insulators, where the 
movement of electrons is much slower, the static charge decay rates can be much 
slower, taking many minutes, hours or even days. In this situation, oppositely charged 
carriers, electrons or ions will be attracted by the electric field created by the charged 
body. As they come into proximity of the body their electric field superimposes the 
electric field of the charged body making the total field decrease (Jonassen 2002). 
Charge decay may occur in three different ways:  
 Charge decay of a capacitive system: an insulated conductor characterised by 
its capacitance, Ca and resistance to ground, R. 
 Charge decay of a non-conducting system: the charge is located on a 
semiconducting material with a given resistivity, ρ, and permittivity, ε, where 
charge decay occurs through the material or along its surface. 
 Charge decay through the air, facilitated by the presence of moisture as the 
water layer acts as a conductor 
The general relationship which provides the rate of charge decay of a charged material 
is given by Equation 1.21 
 
𝑄 = 𝑄0 𝑒
−1
𝜏  Equation 1.21 
Where Q is the charge at a given time, Q0 is the initial charge and τ is the time constant, 
given by Equation 1.22, which indicates the time taken for the charge to decay to 1/e of 
its initial value = 36.8%.  
𝜏 = 𝑅𝐶𝑎 Equation 1.22 
Where R is the material’s resistance and Ca is its capacitance. For an electrically 
insulating material, it is assumed that the charge is not uniformly distributed throughout 
the material, but instead resides at the surface where a charging event, such as 
triboelectrification has occurred. In this case the concept of surface charge density may 
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instead be used to calculate the charge decay rate which is governed by the same 
mathematical relationship. As suggested by Coelho et al. charge decay of resistive 
materials follows an exponential route (Coelho et al. 1989) and this has been 
demonstrated for both polymers and active pharmaceutical ingredients (Carter et al. 
1998). 
 
1.2.5 Effect of relative humidity 
 
Variations in particle morphology will affect the surface area and roughness and hence 
the degree of surface water condensation (Young et al. 2007). In addition the chemical 
structure of the functional groups at the surface will determine the extent of surface 
water coverage - polar functional groups will attract polar water molecules through van 
der Waals forces, whereas non-polar functional groups will not bind water as strongly. 
As mentioned in section 1.2.4, relative humidity can increase the static charge decay 
rate of charged materials. The presence of water will act to reduce the surface 
resistivity by increasing the dielectric permittivity (Lutz and Kindersberger 2009) and at 
high humidity absorbed moisture may increase the material’s overall conductivity 
(Kwok and Chan 2008a) and even change the surface chemistry (Young et al. 2007). 
The amount of bound surface water increases with increasing humidity until a sorption-
desorption equilibrium is reached (Lutz and Kindersberger 2009). It is essential that 
during electrostatic measurements the sample being tested is equilibrated for sufficient 
time at the specified humidity in order to allow the equilibrium to be established and 
that the humidity is kept constant throughout the course of the experiment.  
 
1.3  Processes resulting in electrostatic charge build up on DPI particles 
 
1.3.1 Formulation and processing 
 
Electrostatic charge build-up on DPI formulation particles will mainly occur during 
formulation preparation, where the active pharmaceutical ingredient is blended with 
course carrier lactose, and processing, where the formulation is placed in storage, 
dispensed into capsules or blister strips or transferred to a powder reservoir device. 
During these processes as particles are disturbed and agitated they undergo collisions 
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with themselves and the surfaces with which they come in contact with. During such 
collisions particles will become charged via the mechanism of triboelectrification which 
may result in a bipolar charge distribution. This may affect the physical structure of the 
blend and result in processing problems such as weighing errors, agglomeration, poor 
flow, adhesion to container surfaces, reduced API recovery, loss of content uniformity 
and manual handling difficulties. The presence of charge on a DPI formulation, which 
does not decay quickly with time, may result in variable formulation performance.  
 
1.3.1.1 Micronisation 
Although electrostatic charge build up on an API during micronisation is not commonly 
reported in the literature, it is a well-known issue observed in industrial manufacturing 
sites. Micronisation is a highly energetic process where course API crystals are 
entrained in an airflow and jet milled so that they are impacted into the metallic 
surfaces of the mill at very high velocities. This results in the crystals breaking apart 
into smaller fragments and the goal is to achieve a particle size diameter of less than 
5µm so that the particles will be therapeutically available when aerosolised as part of a 
DPI formulation. The impact of the API crystals with the mill and subsequent transfer to 
a storage container results in a high level of static charge build up on the API particles, 
making them difficult to handle and process. Recent developments in the field of 
supercritical fluids have produced processes where particles of suitably small diameter 
for inhaled drug delivery may be prepared (Chen et al. 2002). Shekunov et al. utilised 
supercritical CO2 to produce salmeterol xinafoate particles of suitable particle diameter 
for respiratory drug delivery. Post processing, the particles were characterised for a 
range of physico-chemical properties including surface energy using inverse gas 
chromatography and electrostatic charge using a Faraday pail. The supercritical 
salmeterol particles were compared with salmeterol particles which had been prepared 
using a conventional micronisation process. Results demonstrated that both the 
surface energies and electrostatic charge values were lower for the supercritical 
particles indicating that supercritical fluid technology may be preferential to 
micronisation as the amount of charge build up on the particles is reduced (Shekunov 






Blending of DPI formulations may be low shear or high in nature and involves agitating 
a mixture of the API and the course carrier lactose in order to produce a homogeneous 
blend with suitable content uniformity. As particles experience movement within the 
vessel, they experience collisions with each other and with the walls of the vessel 
resulting in triboelectrification of the particle surfaces. The quantity of charge build up 
will depend on a number of factors including the blending vessel material (Elajnaf et al. 
2006), the humidity of the environment and electrostatic properties of the particle 
surfaces (Nemeth et al. 2003), the presence of contamination (Eilbeck et al. 2000), the 
extent of amorphous content (Murtomaa et al. 2002) and the speed and length of time 
that the formulation is blended for (Pingali et al. 2009). Local temperature fluctuations 
during turbulent flow may also affect the extent of triboelectrification (Grant et al. 1968). 
Once the blending process has been completed, residual charge may remain on the 
formulation and this may adversely affect the flow, handling characteristics and ability 
to dispense the formulation into capsules or blisters. Charge measurements of DPI 
formulations post blending typically rely on pouring the sample out of the blending 
vessel and into a Faraday pail. This may result in additional triboelectrification of the 
powder as it slides over the surface of the vessel walls which may create variability in 
the results generated.  
 
1.3.1.3 Further processing 
In addition to micronisation and blending further processing steps may result in the 
triboelectrification of powders. The British Standards Institute lists typical charge values 















10-3  -  10-6 
10-1 -  10-3 
1  -  10-2 
102  -  10-1 
103  -  10-1 
 
Table 1.1 Typical charge to mass ratios experienced by a medium resistivity powder 
during powder handling processes 
 
If these processes are not tightly controlled, charge build up may be variable which 
may lead to difficulty in processing DPI blends and lead to the problems described 
previously. As such, many companies seek to mitigate charge build up using methods 
such as active static eliminators (Revel et al. 2003). 
 
 
1.3.2 Dynamic charge generation upon inspiratory flow 
 
Not only will DPI formulations experience charge build up during manufacturing and 
processing but they will also undergo triboelectrification upon aerosolisation within an 
inhaler. The process of aerosolisation requires the patient to inspire through the device, 
drawing air through it at high velocity. This will cause the particles to deagglomerate 
from each other, fluidise and enter the air stream. Typically the particles do not exit the 
inhaler immediately, but circulate within the internal cavity of the inhaler for some time 
where they may undergo numerous interparticulate collisions and collisions with the 
device material. Shur et al. demonstrated using computational fluid dynamics that the 
velocity of the air travelling through a modified cyclohaler will influence the particle 
impact velocities and frequency (Shur et al. 2012) and these impacts will govern the 
extent of triboelectrification. The extent of charge build up will also depend on a 
number of other factors including the deaggregation mechanism of the device, the 
device material, the physico-chemical and electrical properties of the particles (Wong et 
al. 2014), the flow rate and humidity of the air (Rowley and Mackin 2003), and the 
capsule material in the case of capsule based devices. Due to the multicomponent 
nature of the formulation and the different materials used to construct the device the 
particles will experience many different types of collisions which can lead to the 
generation of a bipolar charge distribution. The resultant Coulombic interactions 
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between the particles may affect the extent of deaggregation of the API from the 
lactose carrier which in turn will affect the formulation performance. In addition the 
presence of electrostatic charge may affect the in vivo deposition of the aerosol 
particles as described in section 1.3.3. 
 
1.3.3 Clinical relevance of aerosol particle charge 
 
As described in sections 1.3.1 and 1.3.2, numerous processes may result in the 
generation of electrostatic charge on respiratory aerosol particles. After manufacturing 
is complete and the dosage form is packaged and labelled, a delay ranging from weeks 
to months may occur before the medication may reach the patient. It is assumed that 
during this time that any electrostatic charge present will have dissipated. However, the 
API and carrier particles may become electrostatically charged upon the highly 
energetic process of aerosolisation, which occurs as the patient takes the medication 
and so a large proportion of the inspired dose will be statically charged. A bipolar 
charge distribution may result, with charged particles of opposite signs attracting each 
other and charged particles of the same sign repelling each other. Regardless of the 
polarity, as a charged particle approaches the wall of an airway it can induce an image 
charge on its surface which will enhance its attraction and subsequent deposition 
(Bailey 1997).  
Several studies have been performed to determine the effect of particle charge on the 
extent of in vivo deposition. Fraser measured the in vivo deposition of dust particles in 
a rabbit model and found that deposition increased with increasing charge magnitude 
(Fraser 1966). Ali et al. observed an increase in deposition with increasing particle 
charge and mass in a replica cast of a human oral pharyngeal laryngeal airway (Ali et 
al. 2009b). Chan and Yu observed a significant increase in deposition in the bronchial 
airways of a hollow human lung cast for particles of 2-5μm with 360-1100 electrons of 
charge per particle (Chan and Yu 1982).  Melandri et al. measured the deposition of 
inhaled charged carnauba wax particles with particle diameters of 0.3, 0.6 and 1.1μm in 
human volunteers at a range of inspiratory flow rates and showed increasing particle 
deposition with increasing particle charge (Melandri et al. 1983). Bailey et al. developed 
a mathematical model of the lung using computational tools and modelled the 
deposition of 0.5 and 5μm diameter particles at 0, 50 and 200 electrons of charge per 
particle. Results demonstrated that charged particles deposited more efficiently in the 
bronchioles and alveolar regions due to their confined space and that deposition was 
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enhanced with increasing particle charge and duration of patient breathing pause 
(Bailey et al. 1998). Newhouse et al. conducted a study of inhaled tobramycin in 
healthy volunteers where the API was absorbed over several hours, this has been 
attributed to positive charge on the API molecule binding to the naturally occurring 
negative charges on the surfaces of cell membranes (Newhouse et al. 2003, Patton et 
al. 2004). Thus from previously published work it may be concluded that the presence 
of electrostatic charge on respirable aerosol particles is an important factor in 
determining the extent of in vivo deposition and hence the efficacy of the therapy.  
 
 
1.4 Techniques for the measurement of bulk powder and aerosol 
particle charge 
 
1.4.1 Static measurements 
 
1.4.1.1 Faraday pail 
The first commonly used piece of equipment employed to measure the net electrostatic 
charge of materials was the Faraday pail. It is based on an experiment conducted by 
Michael Faraday in 1843, who demonstrated the effect of placing a statically charged 
object within a conductive chamber. In Faraday’s experiment a metal ice pail was 
connected to a gold leaf electroscope. As he lowered a charged metal sphere into the 
pail, without touching it, the charge of the sphere induced an equal and opposite 
charge on the inner surface of the pail. This in turn, caused an electrical current to flow 
to the electroscope which indicated the presence of the charge by the gold leaf moving 
position. As the sphere was then removed from the pail, the electroscope reading then 
returned to zero, indicating that the charge on the pail was induced by the sphere. If the 
sphere was placed in the pail and then touched the internal surface, the electroscope 
would record the same value for the charge, but then as the sphere was removed, the 
electroscope reading would remain constant. This indicated that the charge on the 
sphere had been transferred to the pail through surface contact. By charging the 
sphere in a repeatable way Faraday proved that the measurement of the induced 
charge is the same as the measurement of the charge through physical contact 
(Faraday 1844). Modern Faraday pails use an electrometer rather than a gold leaf 
oscilloscope to measure the charge of objects placed within them. Rather than moving 
a gold leaf, the flow of charge is stored within a capacitor in the electrometer from 
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which the charge value is recorded (Gross 1950). A diagram of a typical Faraday pail is 
shown in Figure 1.8 and shows the inner well where samples are placed, and the 
connection to the electrometer. The diagram also shows an electrically grounded outer 
well which surrounds and is electrically isolated from the inner well by PTFE insulation. 
The purpose of the outer well is to shield the inner well from external electric fields and 




Figure 1.8 Diagram of Faraday pail and electrometer 
 
The Faraday pail has been used extensively for performing measurements of the net 
charge of pharmaceutical grade powders. Murtomaa et al. measured the effect of the 
triboelectric charging of various lactose grades by sliding powder samples through a 
polypropylene tube and found that the extent of triboelectrification increased with 
increasing amorphous content (Murtomaa et al. 2002). Rowley used a Faraday pail to 
determine the extent of triboelectrification of salbutamol sulphate DPI formulations 
during cyclone charging and found an increase in the air flow velocity correlated with 
an increase charge build up (Rowley 2001). Supuk et al. constructed an oscillating 
shaker to tribocharge powder samples in a repeatable way and measured the net 
charge build-up of a variety of pharmaceutical excipients and APIs by pouring samples 
directly from the shaker and into the Faraday pail (Supuk et al. 2009). 
Measurements recorded by the Faraday pail return values in multiples of the 
elementary unit of charge, Coulombs, and measurements are normalised by dividing 
the charge of the sample by its mass in order to provide a measurement of charge 
density. They are limited by the fact that they are unable to record the bipolar charge 




1.4.1.2 Multiple Faraday pail system 
A system developed by Sharmene Ali et al. comprises of nine Faraday pails laid out in 
a cross formation as shown in Figure 1.9. The system was used to characterise the 
electrostatic charge of three different polymer powders used for electrostatic powder 
coating (Sharmene Ali et al. 1998).  
 
Figure 1.9 Nine Faraday pails arranged in a cross formation (adapted from Sharmene et 
al., 1998) 
The authors imparted electrostatic charge to the polymer powders by means of a fluid 
bed drier with PVC walls and then dropped the powder into the Faraday pails using a 
powder scoop from a predetermined height. The results demonstrated that each of the 
powders exhibited a bipolar charge distribution with different polarity charges being 
recorded as a function of the radial distance from the central pail. In addition the 
authors developed a mathematical model to describe the trajectories of the bipolarly 
charged particles taking into account the range of electrical, gravitational and drag 
forces on each particle (Sharmene Ali et al. 1998). Although this application allows 
bipolar charge of particles to be measured using Faraday pails, the charge 
measurements generated by each pail cannot be proven to be real bipolar charge as 
there is no way to discern whether complete charge separation of the particles had 
occurred during their time of flights. The system is also unsuitable for correlating 
bipolar charge with pharmaceutical aerosol particle performance. 
 
1.4.1.3 Atomic Force Microscopy (AFM) 
Atomic force microscopy (AFM) has become a commonly used technique to measure 
adhesive and cohesive forces during particle interactions of DPIs (Begat et al. 2004). 
AFM studies have also been used to characterise the electrostatic charge present on 
model spheres (Gady et al. 1996) and electrophotographic materials (Zhou et al. 2003). 
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Bunker et al. mounted single lactose particles onto AFM cantilever tips at a relative 
humidity of 0.1%. The long range electrostatic forces of the charged lactose particles 
were subsequently characterised by generating force-distance curves. Single contact 
electrification and tribocharging were simulated by varying the lactose-glass contact 
time. Results demonstrated that increasing lactose-glass contact time increased the 
electrostatic charge present. Also by increasing the humidity from 0.1% to 5% resulted 
in the dissipation of the charge generated on the lactose particle.  
 
1.4.2 Dynamic measurements 
 
1.4.2.1 Electrical Single Particle Aerodynamic Relaxation Time Analyser (ESPART) 
The electrical single particle aerodynamic relaxation time (ESPART) particle analyser 
uses laser-Doppler velocimetry to simultaneously determine aerodynamic diameter and 
electrostatic charge of single particles with diameters of less than 70µm (Mazumder et 
al. 1983). Particles are introduced to the system and fall vertically in between two laser 
beams where they are either simultaneously subjected a DC electric field and an 
oscillating acoustic field or to an AC electric field on its own. In the DC application, the 
acoustic field causes the particles to oscillate and their motions are tracked by the 
lasers. Due to the particle’s mass, a phase lag will be discerned and this is proportional 
to the particle’s aerodynamic diameter. The DC electric field will bend the particle’s 
trajectory and the amount of bend will be dependent on the polarity of the charge 
carried and the charge to mass ratio. Thus by performing both measurements 
simultaneously the quantity and polarity of the charge may be calculated. In AC mode, 
the polarity of the electric field switches from positive to negative at a frequency of 50 
Hz and this causes the particle to oscillate backwards and forwards in direction 
creating a phase lag detected by the lasers. The magnitude of the phase lag allows the 
particle diameter (proportional to the mass) to be calculated and the amplitude of the 
particle oscillations (equivalent to the distance moved by the particle) allowing the 
quantity of charge to be calculated. Software developed for use with the ESPART 
counts the particles detected by the laser and assigns each particle into a diameter 
range (Mazumder et al. 1983). 
Although the ESPART can perform highly accurate measurements it is limited by the 
speed at which the lasers can track particles falling through the detectors. Also it is only 
capable of measuring a single particle at a time and thus cannot measure all of the 
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1.4.2.2 Aerosol electrometer apparatus 
 
The aerosol electrometer apparatus as shown in Figure 1.10 is a dynamic charge 
measurement technique suitable for the measurement of the net charge of the fine 
particle fraction of pharmaceutical aerosols (Byron et al. 1997). An inhaler is attached 
to a metal throat which in turn is connected to an impaction stage identical to the 
Marple Miller Cascade Impactor 5µm cut off stage which removes course carrier 
particles if a DPI formulation is analysed. The entire fine particle fraction of the emitted 
dose is collected in an aerosol filter, housed in a Faraday pail which shields the filter 
from external electric fields and stray charges. As charged particles impact onto the 
filter the current generated is recorded by an electrometer as a function of time. 
Equation 1.23 describes the relationship between charge, Q, current, I and time, t. 
 
𝑄 = 𝐼𝑡 Equation 1.23 
Integration of Equation 1.23 with respect to time yields Equation 1.24. 
𝑄 = ∫ 𝐼
𝑡𝑓
𝑡𝑖
𝑑𝑡 Equation 1.24 
Where ti is the initial time that the current is recorded and tf is the time at which the 
current returns to the baseline. Therefore by plotting the current vs time profiles 
generated and calculating the area under the curve, the total net charge of particles 





Figure 1.10 Aerosol electrometer apparatus (adapted from Byron et al., 1997). 
The apparatus was used to characterise the net charge of the fine particle fractions of 
DPI formulations emitted from the Turbuhaler® and Dryhaler® devices with a range of 
different active pharmaceutical ingredients. Results demonstrated that the net charge 
values were influenced by the device design and therefore aerosol deaggregation 
mechanism, shot number through the device and the particle physico-chemical 
properties.  
 
1.4.2.3 Electrical Low Pressure Impactor (ELPI) 
The ELPI, as shown in Figure 1.11, was originally designed to perform particle size 
distribution measurements of charged airborne particles (Keskinen et al. 1992). The 
instrument consists of a diode type corona charger coupled to a 13 stage Berner type 
multijet low pressure impactor which can be used to classify aerosol particles in the 
size range of 0.3-10µm. Initially the corona voltage was set to ±5 kV with the aim of 
producing an electric field which would induce a known, particle size dependent 
quantity of charge to particles entering the impactor stages. As particles impact onto 
the stages of the ELPI, the currents induced by the charges present on the particles 
are recorded using the electrometers. As for the aerosol electrometer apparatus, by 
integrating the current with respect to time, the net charge of the particles deposited 
may be calculated. 
Originally the ELPI was used for industrial applications such as the measurement of 
particles emitted by combustion engines (Ahlvik et al. 1998) but it has also been used 
for measuring pMDI (Crampton et al. 2004) and DPI particles (Kwok and Chan 2008a). 
This was achieved by modifying the ELPI such that a USP throat was connected to the 
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inlet and the corona charger was switched off to ensure that charge readings recorded 
were an inherent property of the formulation aerosolisation process and not artificially 
created. Glover & Chan found no significant difference in the charge of pMDI particles 
with the corona switched off compared to when it was switched on (Glover and Chan 
2004b). Although the ELPI is not a pharmacopeia impactor it is a useful tool for 
recording the net charge of aerosols deposited, however, it is unable to accurately 
record bipolar charge. The ELPI stages may be washed down and the diluent analysed 
via HPLC to determine the mass of the particles present on each stage allowing for the 
net charge to mass ratios of the particles to be determined. 
 
 






1.4.2.4 Electrostatic twin stage impinger 
A device developed by Zhu et al. incorporated electrostatic measurements with a 
modified pharmacopoeia twin stage impinger with the aim of classifying the net charge 
of the entire aerosol dose, rather than just particles in the range of 0.3-10µm as may be 
achieved with the ELPI (Zhu et al. 2008). The apparatus allows for measurements of 
the currents generated as charged aerosol particles are collected in the upper and 
lower impinger stages. As for the aerosol electrometer apparatus and ELPI, by 
integrating the current with respect to time, the net charge of the particles deposited 
may be calculated. A formulation containing Inhalac 230®, with an median particle 
diameter of 80.2µm and micronised salbutamol sulphate, with an median diameter of 
4.3µm was aerosolised with a Rotahaler® and analysed using the apparatus. It was 
found that the Inhalac 230®, collected in the upper stage was found to carry a net 
positive charge and that salbutamol sulphate, collected in the lower stage was found to 
carry a net negative charge which was in line with measurements recorded using a 
conventional Faraday pail (Zhu et al. 2008). However, charge balance between the two 
formulation components was not observed. Although the electrostatic twin stage 
impinger is useful for determining the net charge of the coarse carrier lactose in DPI 
formulations, the mass of the lactose was not recorded. In addition a detailed 
aerodynamic particle size and charge classification of the fine particles is not able to be 
calculated and the equipment would not be able to provide accurate charge to mass 
ratio measurements of a DPI formulation containing a milled grade of lactose 
containing fine particles.  
 
1.4.2.5 Electrostatic Next Generation Impactor (eNGI) 
The Next Generation Impactor, is a pharmacopoeia tool used to classify the 
aerodynamic particle size distributions (APSDs) of pharmaceutical inhalation products 
and a detailed description of the operation may be found in Chapter 2, section 2.3. The 
electrical Next Generation Impactor (eNGI) as shown in Figure 1.12 was first 
developed by Hoe at al. at the University of Sydney in 2009. The authors took the idea 
of the ELPI and combined it with the NGI in order to perform net charge measurements 




Figure 1.12 The electrical Next Generation Impactor (adapted from Hoe et al., 2009) 
 
The collection cups of the NGI are covered with an acrylic latex coating, which 
electrically isolates the cup from the impactor body which has the effect of turning each 
cup into a Faraday pail. Each cup is connected via a BNC connector and coaxial cable 
to a scanner card and electrometer which measures the current transferred from the 
aerosol particles deposited. As for the aerosol electrometer apparatus, by integrating 
the current with respect to time, the net charge of the particles deposited may be 
calculated. After the net charge measurements are recorded the NGI cups are washed 
and the API deposited is quantified using HPLC allowing for the net charge to mass 
ratios to be determined. The NGI as a whole is contained within an earthed metal cage 
in order to shield the cups from external electric fields and stray charges. The authors 
used the equipment to characterise Flixotide® pMDI and demonstrated equivalence 
with net charge measurements determined by the ELPI and that the eNGI generated 
identical measurements to the NGI in terms of aerodynamic particle size classification 
(Hoe et al. 2009c). A further study looked at the effect of flow rate on the net charge to 
mass ratios of the pMDIs Flixotide™, Seretide™ and Serevent™. They found that as 
the flow rate increased, the fine particle fraction increased, as did the net charge to 
mass ratio values (Hoe et al. 2009a). The authors also used the eNGI to perform net 
charge measurements of Pulmicort® and Bricanyl® DPIs and found comparable 
readings to those generated with the ELPI. In the same study the authors found that 
the net charge to mass ratio values generated increased as a function of flow rate with 
a concomitant increase in fine particle fraction (Hoe et al. 2009b). 
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Whilst the eNGI is undoubtedly a useful tool for characterising both the aerodynamic 
particle size distributions and net charge to mass ratios and makes use of an accepted 
pharmacopoeia impactor, like the ELPI it does not allow for the bipolar charge to mass 
ratios of aerosol particles to be calculated. 
 
1.4.2.6 Bipolar Charge Measurement System (BCMS) 
In order to address the unmet need for measuring the bipolar charge present on 
pharmaceutical aerosol particles Balachandran’s group at the University of Brunel 
devised a bipolar charge measurement system (BCMS) as shown in Figure 1.13 (Kulon 
et al. 2001). The system consists of a metal tube, 39mm in diameter, 300mm in length 
split in half via a central block into two D shape passages. Three wires, 1mm in 
diameter, run along the length of each passage, with one set of wires having a positive 
voltage of 5kV applied and the other with a negative voltage of 5kV applied. Using a 
vacuum pump, suction is created to cause air to flow the tube at a known flow rate, with 
half of the air flow entering each section. In the positive section, the electric field 
generated by the high voltage on the wires repels the positively charged particles onto 
electrically isolated sections of the outer tube and the charge of the particles on each 
section is recorded using an electrometer. The same occurs for the negative section 
with the charge of the negative particles recorded. Whilst particles with the same 
polarity of charge are repelled onto the surface of the tube, oppositely charged particles 
are attracted to the wires. Thus this system allows for the simultaneous measurement 
of both the negative and positive charges present on the aerosol particles entering it. 
Knowing the flow rate of the air, the electrical mobilities of the particles, that is, the 
ability of a charged particle to move within an electric, field may also be calculated. 
However, the quantities of aerosol particles deposited on each section were not 






Figure 1.13 Schematic of the bipolar charge mobility analyser, charged particles 
deposited on HV wires not shown for clarity (adapted from Kulon et al., 2001). 
 
 
1.4.2.7 The Dekati Ltd. BOLAR™ 
The BOLAR™ is a bipolar charge measurement system which has recently been 
developed by Dekati Ltd. in collaboration with GlaxoSmithKline, Tampere University 
and the Finnish Meteorological institute  (Yli-Ojanpera et al. 2014). Working under the 
same theoretical principals as the BCMS, the system is able to separate bipolarly 
charged aerosol particles into their respective positively and negatively charged 
components using electrostatic precipitation. The charge measurement system is 
incorporated with an aerosol impactor and the instrument is controlled by Bipolar 
Electrical Collection Units (BECUs). A schematic of the experimental set up operating 





Figure 1.14 Schematic of the Dekati Ltd. Bolar™ (adapted from Yli-Ojanpera et al. 2014) 
 
An inhaler is connected to the equipment via a USP induction port which in turn is 
connected to a six port flow divider. Five BECUs are connected to ports on the flow 
divider as well as an additional sampling port. Each BECU consists of an impactor 
stage and an electrostatic precipitator which is composed of two concentric metal 
tubes, the inner connected to a +1 kV high voltage source and the outer connected to a 
-1 kV high voltage source. This facilitates the precipitation of charged particles with 
sufficient electrical mobility to be deflected by the electric fields and onto the tube walls. 
Once the particles are precipitated their charge is recorded using the same 
methodology as for the ELPI and the eNGI. Each BECU has a specific particle cut off 
diameter e.g. for BECU 4, only particles of 4.2 µm and below are permitted to enter the 
electrostatic precipitator. The sequence of events involves selection of the aerosol 
particle diameter size range using the appropriate impactor, separation of the positive, 
negative and neutral particles, charge measurement of each class of particles, mass 
measurements of each class of particles and finally calculation of the charge to mass 
ratios. By subtracting the charge and mass values generated from one BECU by 
another the bipolar charge to mass ratios of a specific particle diameter range may be 
determined. For example by subtracting the values generated by BECU 4 from the 
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values generated by BECU the bipolar charge to mass ratios of a particle diameter 
range of 7.3 µm to 11.6 µm may be calculated (Yli-Ojanpera et al. 2014). 
Although the BOLAR™ is undoubtedly a big step forward in accurately quantifying the 
bipolar charge to mass ratios of aerosol particles it is not capable to incorporate the 
equipment with an approved pharmacopoeia impactor. 
 
1.5 Aims of the study, hypotheses and thesis structure 
Despite a large amount of research that has been conducted in recent years in the 
area of aerosol electrostatics, the precise mechanisms governing the electrostatic 
properties of particles for inhalation remain under contention, without a clear answer as 
to which theories explaining the mechanisms of charge transfer are truly accurate and 
which play a dominant role in determining the extent of triboelectrification during 
pharmaceutical processing and respiratory drug delivery. The generation of 
electrostatic charge during manufacturing and processing on the microstructure of a 
DPI blend and its relationship with fine particle performance is still relatively poorly 
understood. The in vitro and in vivo performance of a DPI is directly related to the 
physical properties of the blend and the presence of electrostatic charge is suspected 
as a cause of increased powder cohesion, reduction in deaggregation and therefore 
reduction in performance.  
Moreover, although methods for measuring charge build up on pharmaceutical 
powders are available, they are prone to operator error and are notoriously difficult to 
repeat. Static measurement systems such as the Faraday pail are commonly applied, 
however, they are only capable of measuring the net charge of samples and do not 
take into account the bipolar charge distribution which may be present in a powder 
sample. Dynamic systems for measuring the net charge of aerosol particles upon 
aerosolisation have been developed, however they suffer from the same insensitivity. 
Bipolar charge measurement systems have been developed, however these are not 
compatible with standard pharmacopeia testing equipment. 
This project aims to achieve the following goals:  
 Validate novel methodologies for determining electrostatic charge build up on 
DPI formulations during processing. 
 Determine the effect of API concentration on the susceptibility of DPI blends to 
become electrostatically charged. 
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 Determine the influence of environmental relative humidity on the static charge 
build-up of DPI formulations and subsequent charge decay rate. 
 Develop a novel aerosol impactor for the measurement of bipolar charge to 
mass ratios of aerosol particles compatible with an approved pharmacopoeia 
aerosol impaction method. 
 Perform dynamic charge measurements of capsules and devices during DPI 
formulation aerosolisation and simultaneously measure the aerosol particle 
charge. 
 
This project aims to investigate the following hypotheses:  
 DPI formulations will become negatively charged when the particles come into 
contact with stainless steel surfaces during processes such as pouring, sieving 
and blending. 
 The contribution to the electrostatic properties of a DPI formulation will be far 
greater from the API, which is normally electrically resistive, than the lactose 
carrier, which is electrically conductive. 
 Relative humidity will reduce the ability of a DPI formulation to become 
electrostatically charged and will increase the subsequent rate of charge decay. 
 Aerosolised pMDI and DPI formulations will possess a bipolar charge 
distribution, the magnitude of which will be dependent on the electrostatic and 
physico-chemical properties of the formulation and the inhaler, the 
aerosolisation mechanism and the environmental conditions. 
 
In order to achieve these goals, the structure of this thesis is set out as follows: 
 
Chapter 1 – Introduction 
Chapter 2 – General methods 
Chapter 3 – Net charge measurements of inhalation grade lactose 
Chapter 4 – The effect of relative humidity on the static charge decay rate of DPI 
formulations 
Chapter 5 – Measuring the bipolar charge distributions of commercial pMDI 
suspensions using the bipolar Next Generation Impactor  
Chapter 6 – The effect of relative humidity on the electrostatic properties of a 
budesonide DPI formulation  
Chapter 7 – General conclusions and further work 
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Chapter 2    General Methods 
 
2.1 General physico-chemical characterisation 
 




Scanning electron microscopy (SEM) is commonly used to provide qualitative visual 
representations of the morphology and particle size of APIs and lactose carrier 
particles for inhalation. In addition, information can be gained on the structure of a DPI 
blend including the extent of agglomeration of the API and the extent of lactose carrier 
particle surface coverage. Typically, a conductive sample is irradiated with a highly 
focussed electron beam which results in both penetration backscattering and 
secondary electron scattering from the surface of the sample. Backscattering occurs as 
the result of electrons from the beam interacting with the surface of the sample and 
secondary electron scattering occurs from low energy electrons from the sample itself 
(Wells 1974). Typically the images created achieve very high resolution in the order of 
nanometers and high quality 3D images are produced of sample surfaces. 
 
A simplified schematic of a scanning electron microscope is shown in Figure 2.1. An 
electron beam in the order of 40 keV is passed through condenser lenses in order to 
narrow the beam produce a beam of suitable diameter, known as the spot size. The 
deflectors, which consist of two pairs of electromagnetic coils, are used to move and 
split the beam and allow for the magnification of the sample surface to be controlled. 
The beam is passed through the objective lens which allows for stigmatism reduction 
and the image to be focussed. The back scattering electron detectors and secondary 
electron detector collect electrons emitted from the sample surface of the sample. The 
collected electrons are then accelerated, the signal amplified and then sent to the 
display which generates a visual representation of the sample surface. The system is 
kept under constant high vacuum which prevents air molecules from interfering with the 







Figure 2.1 Simplified schematic of a scanning electron microscope 
 
 
2.1.1.2 Measurement methodology 
Scanning electron microscopy (SEM) images of the lactose samples was performed on 
a JEOL JSM-6480LV (JEOL, Tokyo, Japan). SEM imaging of non-conductive materials 
is not possible due to an absence of low energy electrons in the sample surface and so 
samples were mounted on sticky carbon tabs and coated with a thin layer of gold using 
an Edwards sputter coater S150B (Edwards, Israel) for 5 minutes prior to analysis. An 
acceleration voltage of 10 kilovolts was used for the imaging. 
 
 
2.1.2 Particle size 
2.1.2.1 Theory 
 
The particle size of aerosol particles for inhalation is a significant factor which affects 
the performance of the formulation. In order to reach the deep lung and be 
therapeutically effective at typical values of human inspiratory flow rate, API particles 
must normally have a diameter of less than 5 μm to pass through the mouth, throat and 
upper airways of the patient. In addition, the diameter of the coarse carrier particles of 
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the formulation will also affect its performance (Shur et al. 2008). In addition, particle 
size measurements are routinely performed during DPI formulation development and 
the data generated is included in regulatory submissions as part of the specification of 
the drug product.  
 
The most commonly used technique employed to measure the particle size 
distributions of particles for inhalation is laser diffraction. When a beam of 
monochromatic light is focussed through a dispersion of particles which have a 
dielectric constant different from unity, the light will be either absorbed or diffracted (Xu 
2002). Diffraction results in a scattering of the light and typically interactions with 
smaller particles result in larger scattering angles as well as lower intensities (Newton 
1982). The scattering pattern generated is integrated and used to calculate a weighted 
distribution of the volume equivalent diameters of the particles by applying a suitable 
mathematical model (Shekunov et al. 2007). 
 
Two different mathematical models are commonly employed for interpolating data from 
laser diffraction measurements which are Mie and Fraunhofer theories (Schwarz et al. 
2001). Mie theory is generally considered to be more accurate and makes the 
assumption that the particles are smooth and spherical and that scattering is caused by 
the difference between the refractive index of the particles and their surrounding 
medium (Mie 1908). However, Mie theory is difficult to employ as it requires a large 
amount of computing power and the particles are not spherical, have rough surfaces 
and are of unknown refractive index. Fraunhofer theory is more suitable to employ as it 
assumes that the particles are much larger than the wavelength of the light and that no 




2.1.2.2 Measurement Methodology 
 
Lactose samples were dispersed dry at a pressure of 2 bars using a RodosT4 
disperser and a Vibri feeder (Sympatec GmbH, Germany). API samples were 
measured in a wet cell with a small quantity of the particles being redispersed in a 
solution of 0.1% w/v of lecithin (BDH Ltd., Poole, UK) in cyclohexane by sonicating for 
5 minutes. The resultant suspension was then diluted down to 50 ml in the cuvette to 
produce an optical concentration of not more than 15%. Particle size measurements 
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were performed using a HELOS laser diffraction sensor with an R4 lens and analysis 
was performed using WINDOX 4.0 software (Sympatec GmbH, Germany). Five repeat 
measurements were taken for each sample and the values recorded for the d10, d50 and 
d90 were averaged as well as the percentage of particles less than 5 μm.  
 
2.1.3 API and lactose assay by HPLC 
2.1.3.1 Theory 
 
High performance liquid chromatography (HPLC) is commonly used in the 
pharmaceutical industry to assess the assay, content uniformity and in vitro 
performance of DPIs (Erni 1990). The technique involves dissolving the sample to be 
measured in a solvent of a known volume. A small quantity of this solution is then 
placed into a vial and a known volume is then injected into a flow of a solvent mobile 
phase which is pumped through an HPLC system. The mobile phase passes through a 
stationary phase which is normally attached to the surface of small silica particles, with 
preselected diameters, which are tightly packed within a stainless steel column (Unger 
et al. 2008). As the mobile phase passes through the column, the analyte interacts with 
the functional groups of the stationary phase and thus travels more slowly through the 
column than the mobile phase. Various analytes may be separated due to differences 
in their distribution coefficients (D). The distribution coefficient is defined as the ratio of 
the affinity of the analyte to the stationary phase to the affinity of the analyte to the 
mobile phase. If multiple analytes are to be analysed, for example an API together with 
various degradation products, or two different APIs as part of a combination drug 
product, differences in the polarity, functional groups or chiral centres of the molecules 
will result in differing distribution coefficients and therefore retention times (Rt) as long 
as suitable chromatographic conditions are employed (Perera and Lough 2011). Once 
the analytes exit the column, a detector such as a UV photospectrometer, evaporative 
light scattering detector or mass spectrometer may be used to determine the 
concentration of the analyte which entered the column.  By comparing with a calibration 
curve created from samples of known concentrations, the amount of material originally 
dissolved into the solution may be determined. Factors which influence the retention 
time include the chemical structure of the analytes, the flow rate, pressure and 
composition of the mobile phase, the type of column stationary phase, the column 




2.1.3.2 Measurement methodology 
 
2.1.3.2.1       Active Pharmaceutical Ingredients 
 
The HPLC system consisted of a pump (Jasco PU-980, Jasco Corp., Japan) coupled to 
an autosampler (Jasco AS-950) and UV detector (Jasco UV-975) set at the required 
wavelength for the determination of the API. Separation was performed using a 
suitable column (either ODS or BDS stationary phase) maintained at the required 
temperature using a column oven (Jasco CO-965). The mobile phase selected was 
filtered through a 0.45μm nylon membrane (Whatman International Ltd., Maidstone, 
UK) and degassed. The retention time for the API was recorded, quantification was 
carried out by an external standard method and linearity was checked between 0.5 and 
50 μg/mL. Precise chromatographic conditions employed for each API are summarised 
in the methods sections in subsequent chapters. 
 
2.1.3.2.2       Lactose 
 
The same HPLC system was used to characterise lactose as for the APIs. An amine-
bonded silica gel column (APS-2 Hypersil, 100x3mm, Thermo Scientific, Waltham, MA, 
USA) was used for chromatographic separation of lactose as the amine groups on the 
stationary phase interact with the reducing groups of carbohydrates allowing for 
efficient separation (Wei and Ding 2000).  As lactose does not possess a UV active 
chromophore an evaporative light scattering detector (ELS 1000, Polymer Labs, 
Church Stretton, Shropshire, UK) was employed using previously developed 
methodology (Beilmann et al. 2006). The detector works by nebulising the eluent using 
a flow of pressurised nitrogen gas and then heating the resultant aerosol to drive off the 
solvent as shown in Figure 2.2. The resultant solid lactose particles then pass through 
a light detector which measures their optical concentration, producing a peak with the 
intensity corresponding to the concentration of lactose contained in the mobile phase. 
The mobile phase consisted of 75 : 25 acetonitrile to deionised water and the injection 
volume was 100 µl. The column was maintained at 30⁰C and the retention time for 





Figure 2.2 Schematic of an evaporative light scattering detector 
 
The nebuliser temperature of the ELS detector was set to 60⁰C and the evaporation 
temperature to 110⁰C. The flow rate was 1.0 mL/min and the gas flow rate was set to 
1.5. The retention time for lactose was recorded, quantification was carried out by an 
external standard method and linearity was checked between 0.5 and 50 μg/mL. The 
plot of peak area against concentration was found to follow a quadratic function as has 
been observed previously with similar evaporative light scattering experiments (Hewitt 
et al. 2008). 
 
2.2 Manufacture of DPI formulations 
 
2.2.1 Theory 
Doses of therapeutically active compounds to the lung are often relatively small, 
typically in the range 25-500 μg, which equates to a very low volume of solid powder. In 
order to reach the deep lung, API particles are usually micronised to produce particles 
which possess an aerodynamic diameter of less than five microns. This results in a 
powder with a large mass to surface area ratio with a high level of inter-particle 
cohesive forces, which cause poor deagglomeration and fluidisation characteristics. In 
the case of pMDIs the API particles are suspended in a liquid propellant which is 
aerosolised through a valve. However, in order to inhale the therapeutic dose, the 
patient must coordinate their breathing when the canister is depressed which can lead 
to compliance problems as a result of poor technique.  
 
To overcome the limitations of pMDIs, DPI formulations were developed in which APIs 
are mixed with inert carrier particles such as mannitol or, more commonly, lactose 
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monohydrate in order to provide formulations with suitable flow and handling 
properties, which allows for easier metering of doses into capsules or blisters (Prime et 
al. 1997). Homogeneous mixtures of API and carrier particles must be produced in 
order to ensure uniformity of the delivered dose which is typically achieved by blending 
using either low or high shear systems. The carrier particles are usually larger in 
diameter, in the order of hundreds of microns, than the API, which is normally 
micronised to produce particles in a sub five micron range. In order to produce robust, 
homogeneous DPI formulations, the API and lactose raw materials are sieved prior to 
blending in order to break up any large agglomerates. After sieving, the API and 
lactose are blended using optimised conditions to produce a homogenous mixture prior 
to encapsulation into gelatin or HPMC capsules or packaging into blisters. API and 
lactose particles are highly susceptible to triboelectrification during processing and 
handling, making manufacturing of drug only DPI formulations technically challenging 
due to the resultant poor flow characteristics (Pingali et al. 2009). 
 
 
2.2.2 Sieving and blending 
Unless otherwise stated, DPI formulations containing lactose and an API were 
prepared using a small scale laboratory process. 10% of the lactose required was 
passed through an 850μm mesh sieve, followed by the total amount of the API, 
followed by a further 10% of the total lactose required in order to make a lactose-API 
sandwich. This sandwich was then blended in a stainless steel vessel at 22 RPM for 10 
minutes using a type T2F Turbula blender (WAB, Nidderau-Heldenbergen, Germany) 
to create a preblend. Half of the remaining lactose was then passed through the sieve, 
followed by the preblend, followed by the remaining lactose, in order to make a second 
sandwich. This sandwich was then blended for a further 20 minutes at 22 RPM. 
Stainless steel vessels were selected so that approximately one half to two thirds of the 
blending vessel volume was empty to facilitate thorough mixing. Once the final 
blending step was completed, the blend was transferred to a polythene bag and was 
stored in a relative humidity chamber with a saturated salt solution of potassium 
carbonate at 43% RH (Fisher Bioreagents, NJ, USA) in an air conditioned room 







2.2.3 Assay and content uniformity 
 
Assay of the API and content uniformity measurements were performed using a 
suitable HPLC method for the API according to USP monograph <905> Uniformity of 
Dosage Units (USP 2011). 10 x 25mg samples were removed from the blend from 
random locations and dissolved with sonication in 100 mL of the appropriate mobile 
phase. The batch was passed if the mean assay was within 95-110% and the 
acceptance value, L1, was less than 15.0.  
 
 
2.2.4 Capsule Filling 
Size three HPMC capsules (Qualicaps, Madrid, Spain) were selected for the studies. 
Capsules were filled by hand using a five place analytical balance (Sartorius BP911D, 
Surrey, UK) to 25.0 ± 0.05 mg. Once filled, capsules were stored in a relative humidity 
chamber with a saturated salt solution of potassium carbonate at 43% RH (Fisher 




2.3 Conventional in vitro performance analysis with the Next 




In vitro experiments are crucial for determination of the performance of an inhaled drug 
product formulation. The most common techniques, as listed in the European and 
United States pharmacopoeias (PhEur 2008, USP 2011), are performed using 
impingers or cascade impactors which are collectively known as aerodynamic particle 
size classifiers. These instruments allow for determination of an API specific, 
aerodynamic particle size distribution classification. Early impactors were adapted from 
instruments developed for measurements of environmental aerosol particles (Mitchell 
and Pilcher 1959) and deposition of particles onto agar plates for cell cultures 
(Andersen 1958) and were not optimised for inhaler formulations. In order to 
standardise testing, a consortium of pharmaceutical companies compiled a list of key 
attributes required of an impactor which included: complete recovery of the dose 
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delivered, ease of use for the operator, the ability to operate over a range of flow rates 
and being automatable. This resulted in the development of the Next Generation 
Impactor (NGI), the design and calibration of which is summarised by Marple et al. 




The NGI operates by aerosolising the dose from an inhaler and drawing the resultant 
aerosol particles through a cascade impactor with a flow of laminar air. The impactor 
consists of seven impaction stages and a micro orifice collector (MOC). Each impaction 
stage consists of a number of jets which are directed towards a collection cup where 
aerosols of a specific aerodynamic diameter range are impacted. Stage 1 has the 
largest jet diameter followed by stage 2 and so on, until the air stream reaches the 




Figure 2.3 Diagram of an impaction stage, adapted from Marple et al. 2003b 
 
As air passes through the jets, entrained aerosol particles either collect on the 
impaction surface or are carried through to the next stage. The jets are designed so 
that at the flow rate range of the NGI, 15-100 Lmin-1, the air will travel in a laminar 
fashion, with a Reynold’s number, Re, in the range 500 < Re < 3000. The Reynold’s 




𝑅𝑒 = 𝜌𝑊𝑉0 / 𝜂 Equation 2.1 
Where ρ is the density, V0 is the velocity and μ is the viscosity of the air. The 
aerodynamic cut off diameter, d50, for a given stage is calculated by using Stokes Law 





√𝑆𝑡50 Equation 2.2 
Where η is the viscosity of air at 25°C, n is the number of jets of the given impaction 
stage, ρae is the unit density of the particle, 𝛹 is the total volumetric flow rate through 
the impactor stage and St50 is the Stokes number at 50% collection efficiency (Marple 
et al. 2003b). The Stokes number is determined from the ratio of the separation 
distance, S to the jet diameter, W. For round nozzles and in most impactors, √St50 = 
0.495. As the impaction stages decrease from Stage 1 to the MOC, the number of jets 
increases and the jet diameters and separation distances both decrease. This leads to 
the overall aerodynamic particle cut off diameter decreasing with each successive 
stage.  
 
The cut off diameter of particles, d50, for each NGI stage are given by Marple et al. for 
flow rates of 30 and 60 and 100 L/min (Marple et al. 2003a). Using Equation 2.3 as 
given in the United States Pharmacopoeia (USP) unknown particle cut off diameters, 
D50, at a flow rate, 𝛹, may be determined from the known particle cut off diameters 
D50,Qn, from a known flow rate, 𝛹n (USP 2011). 
 
𝐷50,𝑄 = 𝐷50,𝑄𝑛 (𝛹𝑛 𝛹⁄ )
1/2 Equation 2.3 
Substituting particle cut off diameter values from Marple et al. for a flow rate 60 L/min 
into Equation 2.3 produces values for particle cut off diameters at 90 L/min. The 
particle cut off diameters for the NGI for flow rates of 30, 60 and 90 L/min for each NGI 








Particle Cut off Diameter (D50) μm 
30 L/min 60 L/min 90 L/min 
1 11.7 8.06 6.48 
2 6.40 4.46 3.61 
3 3.99 2.82 2.30 
4 2.30 1.66 1.37 
5 1.36 0.94 0.76 
6 0.83 0.55 0.43 
7 0.54 0.34 0.26 
MOC 0.36 0.14 0.13 
 
Table 2.1 Calculated values for the particle cut off diameter for the NGI at 30, 60 and 90 
L/min 
 
2.3.3 Experimental Setup 
 




Figure 2.4 The Next Generation Impactor complete with USP induction port and 




The device is connected using a rubber mouthpiece to the USP throat which is used to 
mimic the throat and upper airway. Although crude in its design, the throat collects a 
large quantity of coarse carrier lactose particles due to it possessing a sharp 90° bend. 
However, research is currently underway in order to optimise the geometry of the USP 
throat to provide a more representative model of human physiology (Zhang et al. 2006, 
Mitchell et al. 2012). The throat is then connected to a preseparator which is also used 
to remove additional coarse carrier lactose particles. Owing to the large particle size of 
the carrier lactose, deposition within the preseparator is governed primarily by 
gravitational forces rather than impaction (Marple et al. 2003b). The preseparator is 
connected to the impactor body where the airflow passes through Stages 1-7 and the 
MOC. Each stage has a collection cup below it where aerosol particles of a given 
particle diameter range for the flow rate employed are impacted. 
 
2.3.4 Measurement Methodology 
 
The collection cups of the NGI were coated with a solution of 1% w/w silicone oil in 
hexane in order to prevent particle bounce. The solution was allowed to dry so that the 
hexane evaporated leaving a thin film of silicone oil in order to eliminate particle 
bounce. 
 
The preseparator was filled with 15mL of mobile phase, The NGI was then assembled 
and the lid closed. The flow rate of air through the NGI was produced using a vacuum 
pump connected to a TPK critical flow controller (Copley Scientific, Nottingham, UK). 
The flow rate was measured using a DFM2000 flow meter (Copley Scientific, 
Nottingham, UK) and adjusted using the TPK to a flow rate so that a 4 kPa pressure 
drop across the device was achieved for DPIs. As described by Mohammed et al, the 
ratio of the pressure downstream, P2, to upstream, P3, of the TPK valve was 
maintained at ≤ 0.5 to ensure critical flow through the DPI and laminar flow through the 
NGI (Mohammed et al. 2012). 
 
A capsule of the DPI formulation was then placed within the Aerolizer device, the 
capsule was pierced and then the closed device was placed within the rubber 
mouthpiece connected to the USP throat so that an air tight seal was formed. The 
timing of the TPK was adjusted so that a total of 4 litres of air was drawn through the 
system, for example at a flow rate of 90 L/min air was drawn through the system for 2.7 
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seconds. 4 litres was selected as a typical volume representative of patient lung 
capacity. 
 
Five shots were actuated through the system and once this was completed the 
individual components including the capsules, device, mouthpiece and throat, were 
washed using mobile phase into separate volumetric flasks to recover the API. 85mL of 
mobile phase was added to the preseparator, the cups for stages 1-5 of the NGI were 
washed with 20mL of mobile phase, cups for stages 6-7 were filled with 5mL of mobile 
phase and the cup for the MOC was filled with 10mL of mobile phase to recover the 
API. Samples from the washed components along with samples from the NGI 
collection cups were analysed using HPLC to calculate the API mass deposition profile. 
 
2.3.5 In vitro performance indicators 
 
The total amount of drug recovered for each NGI experiment was calculated from the 
HPLC results as a percentage of the theoretical delivered dose from the formulation. 
The mean mass aerodynamic diameter (MMAD), geometric standard deviation (GSD) 
and fine particle mass (FPM) of the API particles were calculated using the cumulative 
impactor stage by stage API deposition data according to standard regulatory guidance 
(EMEA 2006). The FPM indicates the mass of aerosol particles less than 5μm which 
are believed to be small enough to be therapeutically active. The MMAD is calculated 
from the plot of the cumulative percentage of mass less than the stated cut-off diameter 
versus the cut-off diameter by determination of the diameter at 50% and indicates the 
mean aerodynamic diameter of these respirable aerosol particles (EMEA 2006). The 
fine particle fraction of the emitted dose (FPFED) may also be quoted which is the FPM 










2.4 Electrostatic measurements of net charge 




The fundamental theory describing the Faraday Pail is described in Chapter 1, Section 
1.4.1. 
 
2.4.1.2 Measurement Methodology 
 
The electrometer used in conjunction with the Faraday pail was a Keithley Instruments 
6517B electrometer (Keithley Instruments, Cleveland, USA), which was connected to 
the Faraday pail via a coaxial cable with Bayonet Neill Concelman (BNC) connector. 
The electrometer was set to measure in charge mode (Q) with the appropriate range in 
Coulombs (C). Prior to introducing a sample to the pail, the electrometer capacitor was 
discharged using the ZCHK button and then the electrometer reading was zeroed using 
the REL button. During all measurements the operator wore a conductive wristband 
connected to earth to prevent additional charging of the measured sample. Once the 
charge of the sample was measured, the sample was transferred to a weighing boat 
and the mass measured using a five place analytical balance (Sartorius BP211D, 
Surrey, UK). Values were reported in terms of charge density (nC/g) by dividing the 
charge measured on the sample by its mass. Values of the net charge density were 
determined in triplicate unless otherwise stated. The temperature and humidity of the 
environment during each net charge measurement was also recorded for reference 
using a hygrometer (Rotronic Hygropalm, West Sussex, UK). For powder samples the 
inner cup of the Faraday pail was washed in between each set of sample 
measurements with water and methanol twice, dried in a Gallenkamp OV-440 oven at 
60⁰C (Gallenkamp, Loughborough, UK) and allowed to cool to room temperature. 
 




A flow through Faraday Pail (FTF) was designed in order to record dynamic net charge 
measurements of a DPI inhaler upon aerosolisation of a formulation. The FTF was 
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cylindrical in shape and may be thought of as a bottomless conventional Faraday Pail 




Figure 2.5 Flow through Faraday pail 
 
The design was based on equipment developed by Chow et al. who used a similar 
system to measure the dynamic charge generated upon aerosolisation of Inhalac® 230 
from a Rotahaler® device (GlaxoSmithkline, Ware, UK) at varying flow rate and 
humidity (Chow et al. 2008). This system was based on the air stream Faraday cages 
developed by Kulvanich and Stewart who measured net charge to mass ratios of a 
range of API-excipient aerosol particles (Kulvanich and Stewart 1987) and Peart et al. 
who measured the net charge generated during deagglomeration of lactose-salbutamol 
sulphate blends (Peart et al. 1996). The system works by measuring the charge build 
up on materials based on induction, as opposed to contact. 
 
2.4.2.2 Measurement Methodology 
 
The FTF was clamped horizontally and attached to a stand at the correct height to 
measure an inhaler based on the experimental set up required. Figure 2.6 shows the 
experimental setup utilising a dose uniformity sampling apparatus (DUSA, Copley 
Scientific, Nottingham, UK) but the FTF may also be used with an impactor or other 






Figure 2.6 Experimental set up with electrometer, FTF, Aerolizer® device, DUSA and TPK 
 
Prior to all experiments, capsules and devices used were allowed to equilibrate for a 
minimum of 24 hours in order to allow any charge present to dissipate. In order to 
perform a dynamic charge measurement, a capsule was pierced and placed within the 
device. The device was then placed inside the rubber mouthpiece at the same depth 
each time. The stand holding the DUSA (or other test equipment) was retained in the 
same position throughout the experiments. The stand holding the FTF was adjusted to 
the correct height, so that the FTF could be moved horizontally across ensuring that 
the device was positioned exactly the centre of the FTF at the same depth each time. 
The simple act of the operator opening and closing the device was expected to 
tribocharge the exterior surfaces of the device in an unrepeatable way and so once the 
FTF had been positioned over the device, the electrometer capacitor was discharged 
using the ZCHK button and then the electrometer reading was zeroed using the REL 
button. Once the display was zeroed, readings were taken of the charge value at 
intervals of 0.12 seconds and stored in the electrometer data buffer. Then a capsule 
was aerosolised within the inhaler, resulting in the dynamic charge of the inhaler, 
capsule and formulation during the aerosolisation process being recorded. A typical 
plot of the dynamic charge measurement plotted as a function of time for a placebo of 







Figure 2.7 Typical dynamic charge vs time plot generated with the flow through Faraday 
pail 
The first five values of net dynamic charge prior to the commencement of air flow were 
recorded to ensure that no drift in the dynamic charge values were observed and 
values were recorded for the duration which the airflow travelled through the device. 
Once the airflow started, a rapid increase in the net negative dynamic charge was 
observed up until an equilibration point indicated by the horizontal arrow in Figure 2.7 
Values of the net charge density were determined in triplicate unless otherwise stated. 
 
 
2.5 Design of the bipolar Next Generation Impactor (bp-NGI) for 
measurement of bipolar charge to mass ratios and in vitro 




Upon aerosolisation of either a pMDI or a DPI, both carrier and drug particles present 
in the formulation enter a high kinetic energetic state. This results in particles 
experiencing numerous collisions with each other and with the inhaler during which 
electron transfer may occur via the process of triboelectrification, causing the creation 
of highly charged species. The presence of static charge on therapeutic aerosol 
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particles may affect the in vivo performance of the formulation due to increased API 
deposition within the inhaler or capsule, increased adhesion between the API particle 
and carrier particle surfaces and increased deposition of aerosol particles within the 
throat and upper airway (Chan and Yu 1982). Electrostatic charges on aerosol particles 
are thought to enhance deposition by increasing attractive forces to airway surfaces. 
According to Coulomb’s law as described in Equation 2.4, the strength of the 
electrostatic field a charged particle will possess relative to an object is inversely 
proportional to the square of the distance of the object to the centre of the particle. 
Therefore electrostatic attraction is particularly relevant in the small airways and alveoli 





|𝑄| Equation 2.4 
 
Where |𝐸| is the magnitude of the electric field in Volts per metre, 𝜀0 is the permittivity 
of free space, 𝜀𝑟 is the permittivity of the medium the electric field is contained in, r is 
the distance of the charged particle from the object and |𝑄| is the magnitude of the 
charge on the particle. 
 
Electrostatic precipitation utilises the concept of electrical mobility which is the ability of 
a charged particle to move within an electric field. It is routinely employed in a wide 
range of applications such as the electrophotographic industry, where charged particles 
adhere to paper during photocopying (Adachi et al. 2005, Schein 2008, Hoshino et al. 
2010), the cleaning of exhaust gases released during combustion (Jaworek et al. 
2006), and electrostatic spraying for painting conductive materials (Schmitt and 
Lebienvenu 2003). Separation of bipolarly charged aerosol particles into their separate 
negative and positive population distributions may be achieved by employing negative 
or positive electric fields, in order to repel or attract the particles away from each other. 
Systems such as those developed by Kulon et al. and O’Leary et al. allow the ratio of 
negatively to positively charged particles - the bipolar charge ratio as well as the 
quantity of charge present on the particles to be measured, but were not suited for 
determinations of the mass of the particles precipitated (Kulon and Balachandran 2001, 
O'Leary et al. 2008). More recently, the Bolar™ (Dekati Ltd., Finland) was designed as 
a bespoke piece of equipment for measuring bipolar charge distributions of aerosol 
particles (Yli-Ojanpera et al. 2014). As such a novel apparatus for performing bipolar 
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charge measurements and quantifications of aerosol particles – the Bipolar Next 




A schematic representation of the bp-NGI for operation with a DPI device is shown in 
Figure 2.8. The apparatus employs two electrostatic precipitators which efficiently 
collect both negatively and positively charged aerosol particles. Aerosol particles travel 
through the particular NGI stage and the flow is bifurcated into the two precipitators 
with one electrode being held at a high negative voltage and the other at the same but 
opposite polarity voltage with high voltage sources (Spellman, CZE1000R, West 




Figure 2.8 Diagram of bp-NGI experimental set up 
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A summary of the deposition profile of bipolar charged particles is shown in Table 2.2. 
Negatively charged particles are repelled by the negative electrode and are deposited 
onto the negative precipitation tube and positive electrode. Positively charge particles 
are similarly deposited onto the negative electrode and are repelled by the positive 
electrode onto the positive precipitation tube. Aerosol particles with a very low electrical 
mobility, which are not precipitated onto either the electrodes or the precipitation tubes, 
are collected on 0.45μm filters (Whatman, Fisher Scientific, UK) housed at the base of 




Particles Positively Charged Particles 
Low Electrical Mobility 
Particles 
Negative Precipitation 
Tube Positive Precipitation Tube Negative Filter 
Positive Electrode Negative Electrode Positive Filter 
 
Table 2.2 Deposition profile of bipolar charged particles within the bp-NGI 
 
 
An example of the particle trajectories within the negative precipitation section of the 
bp-NGI is shown in Figure 2.9. The flow rate is controlled by a TPK (Copley Scientific, 
Nottingham, UK) attached to a vacuum pump and is set with the flow meter. The 
precipitation tubes are connected via BNC adapters and coaxial cables to a Keithley 
Instruments 6521 multi input scanner card which is connected to the electrometer for 
charge measurements (Keithley Instruments, Reading, UK). The system is modular in 
nature so that each part may be separately washed down for drug quantification via 
RP-HPLC. The operator is connected to earth at all times via a wrist band and the 
outer tubes surrounding the precipitation tubes are also connected to earth to create a 
Faraday shield from external electric fields and stray charges to further ensure the 






Figure 2.9 Particle trajectories within the negative precipitation section of the bp-NGI 
 
2.5.3 Calculation of the electrical mobilities of aerosol particles 
 
The bp-NGI is designed using the concept of the electrical mobility which is the ability 
of a charged particle to move within an electric field. The electrical mobility of a 





 Equation 2.5 
Where n is the number of elementary charges on the particle, e is the elementary 
charge, 1.602 x 10-19 Coulombs, ηair is the viscosity of air at 25°C, and rp is the radius 
of the particle. The density of the particles is assumed to be 1g/cm3. The electrostatic 
precipitation sections of the bp-NGI may be connected to any of stages 1-8 of the 
conventional NGI. Values for rp were calculated from known particle cut off diameters 
for the conventional NGI. By dividing the particle cut off diameters by two in order to 
calculate Rp and substituting a value of 1.81 x 10
-5 Pa.S for the viscosity of air, ηair, the 
electrical mobilities of aerosol particles with 100, 200 and 300 electrons of charge per 




2.5.4 Calculation of the theoretical collection efficiency of the bp-NGI 
 
In order to maximise the collection efficiency of charged aerosol particles entering the 
electrostatic precipitation of the bp-NGI it was necessary to optimise the dimensions of 
the system by taking into account the electrical mobilities of the aerosol particles and 
choosing suitable dimensions for the components of the electrostatic precipitators. A 
plan view diagram of the cross section of one of the electrostatic precipitators is shown 
in Figure 2.10. 
 
Figure 2.10 Plan view of an electrostatic precipitator 
 
For a charged particle entering a cylindrical electrostatic precipitator under conditions 
of laminar flow, the theoretical collection efficiency, Kprecip ,as given by Kulon et al. is 
given by Equation 2.6 (Kulon et al. 2001). 
 





𝑣𝑜 𝑙𝑛(𝑟2 𝑟1⁄ )
 × 100 Equation 2.6 
 
Where r1 is radius of the electrode, r2 is outer tube radius, V is voltage across the 
electrode, l is the length of the electrode, v0 is the speed of air past the electrode and Zp 
is the electrical mobility of the particle (Kulon et al. 2001). By converting flow rates, 𝛹, 
87 
 
of 15, 30 and 45 Lmin-1 into cm3/s, the speed of the air through the tube, 𝑣0 , is 
calculated using Equation 2.7. 
 
𝑣0 =  4𝛹 πd
2⁄  Equation 2.7 
Where d is the diameter of the tube in question.  
 
The theoretical collection efficiencies of aerosol particles entering the electrostatic 
precipitation system, with 100, 200 and 300 units of elementary charge per particle 
were calculated at flow rates of 15, 30 and 45 L/min to take into account the bifurcation 
of the air flow to the negative and positive precipitation sections respectively as shown 












Figure 2.11 Theoretical collection efficiency of the bp-NGI at A, 15, B, 30 and C, 45 Lmin
-1
 
for each NGI impaction stage for 100, 200 and 300 electrons per particle 
 
Optimal values of V, l, r1 and r2 were selected to ensure maximum collection efficiency 
of the system was obtained, whilst at the same time ensuring the equipment was of 
practical dimensions for laboratory use. The length of the precipitation tubes was 
capped at 60 cm to allow the quantification of API particles within to be accurately 
determined and to prevent the bp-NGI from becoming too large in size. Under 
conditions of turbulent air flow, accurate deposition of charged particles within the 
electrostatic precipitation tubes would not be guaranteed and therefore a value for the 
radius of the precipitation tune, r2, which ensured laminar flow of air at the maximum 
value of air flow rate through the system was selected.  
 
 
2.5.5 Determination of laminar flow through the electrostatic precipitators 
 
An indication of whether air flow will be laminar through a tube may be determined from 
the Reynold’s number, Re, which is a dimensionless value used in fluid dynamics. For 
500 < Re < 3000 the flow will be laminar (Marple et al. 2003b) and values outside this 
range will indicate transient or turbulent flow. The Reynold’s number for dynamic air 
flow through a circular tube is given by Equation 2.8. 
 





Where ρ is the density of air, 1.18 kg/m3 at 25°C, v is the speed of the air through the 
tube, d is the diameter of the tube and η is the dynamic viscosity of air, 18.6 μPa.s = 
1.86 x 10-5 kg/(m.s). The Reynold’s numbers for the bp-NGI operating at 30, 60 and 90 
Lmin-1 were calculated as 848, 1695 and 2543 respectively, falling within the range in 
which laminar flow will occur. 
 
 
2.5.6 Consideration of the breakdown voltage required to create a corona discharge 
 
One potential concern when the design of the bp-NGI was being developed was the 
potential of corona discharges, in the form of sparks to arc between the high voltage 
electrodes and the precipitation tubes. This may occur when the voltage is large 
enough to overcome the electrical resistance of the air between two conductive 
materials (Ward 1965). The breakdown voltage, V, required to form a corona discharge 
between the electrode and the tube was calculated using a Paschen curve for air, 
described by Equation 2.9.  
 
𝑉 =  
𝑎𝑝𝑑
ln(𝑝𝑑) +  𝑏
 Equation 2.9 
 
Where a is a constant (4.36 x 107 V/(atm.m) for air at standard atmospheric pressure), 
b is also constant (12.8), p is the air pressure and d is the distance between the 
electrode and the precipitation tube. Using d = 0.00195, equivalent to subtracting the 
radius of the electrode from the radius of the precipitation tube, a value for the 
breakdown voltage, V, was calculated at 95.93 kV. This is in large excess of the 3 kV 
used for the experiments and so the equipment was deemed to be safe in this aspect.   
 
2.5.7 CAD diagrams of the bp-NGI 
Having decided on the design of the bp-NGI and finalising the preferred dimensions, a 
description was converted into CAD diagrams in the department of mechanical 
engineering at the University of Bath in order to aid in the construction. Figure 2.12 
shows the complete electrostatic precipitation section of the bp-NGI drawn to scale 




Figure 2.12 Scale diagram of the electrostatic precipitation section of the bp-NGI 
A more detailed diagram of an electrostatic precipitator is shown in Figure 2.13. It 
includes scale representations of the inlet, electrode, electrode holder, aluminium 




Figure 2.13 Scale diagram of an electrostatic precipitation section 
 
As the electrostatic precipitation section of the bp-NGI was designed to attach directly 
to the bottom of a conventional NGI, a specially designed frame was constructed. This 
was designed to support the weight of the system and was required because the NGI 
could no longer sit directly on top of a laboratory bench due to the electrostatic 
precipitators beneath. The frame was designed which would provide structural rigidity 
and run from the top of the system, where the NGI is located, to the bottom at the exits 
from the electrostatic precipitators. The bottom section of the frame is shown in Figure 
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2.14 and shows the negative and positive electrostatic precipitation sections side by 
side. The diagram also shows the outlets for the air flow for each precipitator which are 
connected by rubber tubes (not shown) to a central manifold. This manifold was in turn 
connected to a TPK (Copley Scientific) and vacuum pumps, in order to control the flow 
rate and duration of air flow through the system. The bottom of the frame was equipped 




Figure 2.14 Bottom section of the bp-NGI and frame 
 
In order to connect the electrostatic precipitation section to the bp-NGI, a specially 
designed NGI cup, plan view shown in Figure 2.15 A was manufactured with the 
inclusion of a screw thread which would allow a connector to be screwed into the 







                   
Figure 2.15 Plan view of A, modified NGI cup, and B, connection of NGI to electrostatic 
precipitation section 
 
A diagram of the top section of the frame is shown in Figure 2.16 and shows a specially 
designed metal plate attached to the NGI via custom made screws. The NGI sits on top 
of the frame guided by locator pins connected to the frame, lined up with holes drilled 
into the metal plate. 
 
 




2.5.8 Charge measurement methodology 
 
Measurements were performed using a 6517B electrometer, 6521 scanner card and 
KUSB-488B USB connector (Keithley Instruments Inc., Berkshire, UK) connected to a 
PC with Testpoint Version 6 software for data acquisition. During all measurements the 
operator wore a conductive wristband connected to earth to minimise external electric 
fields. The frame of the bp-NGI and the outer tubes of the precipitation sections were 
also connected to earth. To perform charge measurements the negative and positive 
precipitation tubes were connected to channels 1 and 2 of the scanner card 
respectively via coaxial cables with BNC connectors and the electrometer capacitor 
was discharged using the ZCHK button and then the electrometer reading was zeroed 
using the REL button. Static measurements of charge on the precipitation tubes were 
performed using charge mode, Q, when only minimal current could be recorded by the 
electrometer. Dynamic measurements were performed using current mode, I. A 
background measurement was performed for each tube by activating the TPK to pull 
air only through the system for the required length of time and at the required flow rate. 
Subsequently, five successive shots of aerosol were delivered to the bp-NGI with the 
current and time readings for each precipitation tube recorded in the electrometer 
buffer and then transferred to Microsoft Excel for data analysis. A typical plot of the 
current vs time profiles generated for A, the negative precipitation tube, and B, the 









Figure 2.17 Typical current vs time plots for A, the negative precipitation tube, and B, the 
positive precipitation tube 
 
Equation 2.10 shows the relationship between, current, I, charge, Q and time, t, namely 
that the current is equal to the rate of charge transfer over a given time. 
 
𝐼 = 𝑑𝑄 / 𝑑𝑡 Equation 2.10 
By integrating both sides of Equation 2.10, the total charge transferred from the aerosol 
particles is given by Equation 2.11.  
 
𝑄 =  ∫ 𝐼 𝑑𝑡
𝑡𝑓
𝑡𝑖
 Equation 2.11 
Where tinitial is the time at which the current begins to rise and tfinal is the point at which 
the current returns to the baseline. This value for Q is equal to the area under the curve 
between ti and tf. Therefore, the areas under the curve were calculated for each current 









2.5.9 Background measurements of the charge on the precipitation tubes 
 
Background measurements of the charge values for each tube were recorded both with 
the high voltage switched off and on, in order to check that that the precipitation tubes 
were successfully electrically isolated from the rest of the system. At zero volts, the 
charge values for both tubes were shown to remain constant and at zero as a function 
of time indicating efficient electrical isolation of the tubes via the PTFE holders. Figure 
2.18 shows the drift in the charge measurement of A, the negative precipitation tube 
and B, the positive precipitation tube upon applying a voltage of -3.0kV and +3.0kV to 





Figure 2.18 Drift in charge measurements of precipitation tubes as a function of time 





The values for the rate of change of charge as a function of time were determined to be 
0.0047nC/s and 0.0061 nC/s which were considered to be too small to affect the 
overall value of the charge measurements recorded. However, the background current 
created by this induced charge was subtracted from all measurements in order to 
normalise the data. 
 
2.5.10 Computational Fluid Dynamic Modelling 
 
Computational fluid dynamic (CFD) modelling is a useful tool for performing theoretical 
predictions of the flow of liquids and gases over surfaces and through pipes and tubes. 
It has many practical applications and is commonly used in areas such as meteorology 
(Yin et al. 2010), oceanography (Blazek 2001), astrophysics (Trac and Pen 2003), the 
oil and gas industries (Lakehal 2013), the automotive (Falcitelli et al. 2002), aircraft 
(Zhang et al. 2013), food industries (Scott and Richardson 1997)  and ship design (Peri 
et al. 2001) .  
 
In order for charged particles to be efficiently collected by the bp-NGI it is essential that 
laminar flow be maintained through the electrostatic precipitation sections. Any 
turbulence present would prevent particles from being subject to the principals of 
inertial impaction and would result in random deposition throughout the system. This 
would lead to innacurate determinations of the formulation performance. The 
theoretical Reynold’s numbers (Re) for flow rates of 30, 60 and 90 L/min, equivalent to 
15, 30 and 45 L/min through each precipitation section were calculated and fell 
between the range 300≤Re≤3000, indicating that laminar flow through the precipitation 
sections should be ensured. In order to determine the validity of the calculations the 
design of the system was characterised using CFD to check whether laminar flow 
would be maintained given the dimensions of the system 
 
A numerical model of the bp-NGI experimental apparatus was generated and solved 
using ANSYS ® 14.5 academic software at the Department of Civil Engineering at the 
University of Bath. The process included 3D CAD generation of the equipment, 
meshing design and refinement, selection of suitable numerics, solution of the case 
using the Bath University HPC (High Performance Computer) and post-processing of 






The geometry of the bp-NGI was drawn in 3D at 1:1 scale using ANSYS Workbench 
software via conversion of a 2D CAD diagram provided by the Department of 
Mechanical Engineering at the University of Bath. Some minor alterations to the exact 
experimental geometry were included to reduce the computational complexity of the 
model. This included the assumption that all pipe joints were ideal (smooth), and the 
route of the pipework at the outflow was simplified. Images of the completed model are 
shown in Figure 2.19. 
 
 
Figure 2.19 3D CAD images of bp-NGI geometry. A, the full rig; B, the connection from 









Discretisation was obtained using a hybrid method on ANSYS Mesh software. All pipe 
inner surfaces were meshed using layered body conforming hexahedral elements, with 
the remaining space filled with unstructured tetrahedral elements. The cell size was 









The numerical model was developed and solved using an implicit Reynolds-Averaged 
Navier-Stokes (RANS) method with ANSYS CFX 14.5 software.  Details of the key 
numerical environment parameters are summarised in Table 2.3. To mimic the 
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experimental procedure, the transient model consisted of an initial condition of still air, 
followed by 2.7 seconds of suction at the outlet equal to 90 l/min, followed by a further 
8 seconds with the outlet closed. The timestep control used an adaptive method, 
enabling the target residuals for mass and momentum to be met with high 
computational efficiency. The case was solved using 4 parallel central processing unit 
(CPU) cores taking approximately 52.4 hours. Post-processing was completed using 
ANSYS CFD-Post software. 
 
Discipline Parameter Value 
Fluid Properties 






Temperature 296.15 K 
Heat Transfer Isothermal 
Timestep control Coeffcient Loops Minimum 2, Maximum 5 
Solution Control Equation Residual Target Maximum 1e
-05 
rms 
Turbulence Equation Model Shear Stress Transport 
Boundary 
Conditions 
Inlet Opening (relative pressure = 0) 
Internal Surfaces No – slip walls 
Outlet (during suction) 0.0005925 kg/s (equiv. 30 l/min) 
Mesh Properties 
Total Elements 6,981,628 
Total Nodes 1,804,269 
 




Predicted airflow through the electrostatic precipitation sections at 45 L/min was 
visualised using a streamline representation as shown in Figure 2.21. 
 
 
Figure 2.21 Streamline representation of air flow through the electrostatic precipitation 
sections of the bp-NGI at 45 L/min 
 
 
Predicted airflow through the electrostatic precipitation sections at 45 L/min was 





Figure 2.22 Velocity contour representation of air flow through the electrostatic 
precipitation sections of the bp-NGI at 45 L/min 
 
The figures show that some turbulence is predicted at the exit of the nozzles of stage 2 
where the air rapidly changes speed as the flow exits from the narrow diameter jets 
and into the larger diameter precipitation section. Further turbulence is also predicted 
at the T-piece where the airflow bifurcates into the two precipitation sections. However, 
by the time the airflow reaches the electrostatic precipitation sections it is predicted to 
be laminar, with minimal turbulence created as the air meets the tips of the two 
electrodes. Therefore confidence was gained that turbulence would not affect the 
precipitation efficiency of the system. Future CFD investigations suggested involve 










DPI formulations consist of an active pharmaceutical ingredient (API) mixed together 
with a coarse carrier particle, which is lactose monohydrate (Pitchayajittipong et al. 
2010). The manufacture of DPI formulations consists of various processing steps such 
as sieving, blending, pneumatic conveying and dosing into capsules. During each 
processing step, lactose monohydrate particles may become statically charged via the 
mechanism of triboelectrification.  Differences in the work function (the ability to remove 
an electron from the vacuum energy level) will result in electron transfer between the 
DPI formulation particles and the various surfaces they may encounter (Matsusaka and 
Masuda 2003). This may cause handling issues and influence the formulation blend 
structure. Simple transport of lactose by pouring will result in tribocharging of the 
particles, the mechanisms for which have been outlined in detail (Ireland 2010b). A 
study conducted by Murtomaa and Laine showed the extent of triboelectrification with 
lactose, glucose and mixtures of the two experienced upon passing through a glass 
pipe into a Faraday pail (Murtomaa and Laine 2000). Sieving is a useful process for 
breaking up any large agglomerates of powder, which have formed either upon storage 
or as a result of small quantities of moisture being present in the sample. Sieving also 
ensures that adequate mixing is facilitated during blending to produce a homogenous 
formulation (Steckel et al. 2006). When particles of lactose are passed through a sieve 
it might be hypothesised that negative charge will be transferred to the particles due to 
a frictional triboelectrification mechanism, with labile electrons easily removed from the 
surface of the metal and transferred to the sieved material. To the author’s knowledge, 
investigations into the extent of the triboelectrification of inhalation grade lactose during 
sieving have not previously been reported. 
 
Once sieving has been completed, A DPI formulation is normally blended to produce a 
homogenous mixture to ensure uniformity of the delivered dose of API (de Boer et al. 
2012). It is well know that electrostatic charge will build up on the DPI formulation as a 
result of frictional triboelectrification resulting from lactose and API particles colliding 
with the internal surface of the blending vessel (Kwok and Chan 2009). Charge build up 
in DPI formulations during blending may produce agglomeration and flow problems 
resulting in handling issues (Noakes 2004) as well as material transfer from the bulk 
powder bed to the blending vessel walls (Lowell 1977a). Eilbeck et al. showed that 
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when lactose was tribocharged in a stainless steel vessel using an air cyclone, the 
particles became tribocharged and adhered to the stainless steel surface (Eilbeck et al. 
2000). When successive runs were performed without cleaning in between, the extent 
of coating of the stainless steel surface increased and so the extent of charge build up 
on the non-adhered particles decreased. Conversely, the presence of electrostatic 
charge during blending may be beneficial. Staniforth and Rees used an air cyclone to 
purposefully induce electrostatic charge onto various sugar based pharmaceutical 
excipients, including lactose monohydrate, in order to produce ordered homogenous 
mixtures (Staniforth and Rees 1981). Similarly, Pu et al. performed low shear blending 
experiments with lactose and caffeine and showed that reducing electrostatic charge 
during the blending process resulted in poorer blend homogeneity. They also showed 
that by charging the excipient and API with a corona discharge blend homogeneity was 
improved (Pu et al. 2009). Elajnaf et. al performed a detailed study looking at the effect 
of blending vessel material and relative humidity on the extent of triboelectrification 
during low shear Turbula blending of DPI formulations containing salbutamol sulphate 
and ipratropium bromide (Elajnaf et al. 2006). Their findings showed that the type of 
blending vessel material used altered the charge values and that as the relative 
humidity increased, the extent of charge built up decreased. However, their results 
were achieved by pouring directly from the blending vessel into the Faraday pail post 
blending and this may have resulted in additional tribocharging of the sample resulting 
in some of the large standard deviations observed. A further study conducted by 
Engers et. al investigated the extent of triboelectrification of dicalcium phosphate 
dihydrate, microcrystalline cellulose and lactose monohydrate during low shear 
blending in a stainless steel vessel (Engers et al. 2006). The results showed very little 
difference in the net charge values recorded between the control experiment (pouring 
the material from the vessel into a Faraday pail without blending) and having blended 
the sample for either twenty and forty rotations. This indicated that the charge value 
recorded was chiefly as a result of the pouring of the sample, rather than the blending. 
 
A further consideration is whether lactose monohydrate particles being used in the 
manufacture of DPI formulations carry any inherent charge prior to use. A literature 
search did not reveal any previous attempt to measure the net charge on unprocessed 
pharmaceutical grade lactose monohydrate. No doubt this is with good reason as in 
order to transfer the powder to the Faraday pail it has previously been very difficult to 
do so without either pouring it from its container or by transferring it using a spatula or 
similar instrument. Both methods would result firstly in disturbing particles from the 
powder bed and secondly tribocharging these particles by sliding them over a surface. 
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The aim of this study is to produce a method to record accurate, repeatable and 
reliable net charge measurements of pharmaceutical inhalation grades of lactose 
monohydrate, as received and after the critical processing steps of sieving and 
blending. Murtomaa et al. showed that particle morphology and amorphous content 
may have an effect on the tribocharging characteristics of particles (Murtomaa et al. 
2002, Murtomaa et al. 2004) and therefore a cohesive grade of lactose monohydrate, 




3.2 Materials and methods 
3.2.1 Materials 
 
Respitose® ML001 and Respitose® SV003 grades of lactose monohydrate obtained 
from DFE Pharma (Veghel, The Netherlands) were used for the study. The samples 
were stored in a sealed humidity cabinet with a saturated salt solution of potassium 
carbonate (Fisher Bioreagents, NJ, USA) at 43% relative humidity in an air conditioned 




3.2.2.1 Particle size measurements 
 
Particle size measurements of the lactose monohydrate samples were measured 
dispersed dry at a pressure of 2 bars using a Sympatec Helos laser diffraction system 
with an R4 lens in conjunction with a RodosT4 disperser and a Vibri feeder controlled 
by WINDOX software (Sympatec GmbH, Germany). Five repeat measurements were 
taken for each sample and the values recorded for the d10, d50 and d90 were averaged 







3.2.2.2 Scanning electron microscopy 
 
Scanning electron microscopy (SEM) images of the lactose monohydrate samples was 
performed on a JEOL JSM-6480LV (JEOL, Tokyo, Japan). Samples were mounted on 
sticky carbon tabs and coated with an Edwards sputter coater S150B (Edwards, Israel) 
for 5 minutes prior to analysis. An acceleration voltage of 10 kilovolts was used for the 
imaging. 
 
3.2.2.3 Characterisation of rheological properties 
 
The rheological properties of the lactose monohydrate samples were characterised 
using an FT4 Powder Rheometer (Freeman Technology, Welland, UK) following the 
recommended operating procedures for analysing pharmaceutical powders (Freeman 
2007). Samples of powder were analysed in a 20 mL split vessel. Prior to determination 
of the values samples measured were preconditioned using a 23.5 mm blade, which 
was moved down a helical path through the sample with a helix angle of 5 degrees at 
60 mm/s. The two lactose monohydrate samples were exposed to increasing airflow 
velocities and the powder fluidisation energy (FE) with no aeration and the aeration 
energy (AE) at 8 m/s was recorded. The dynamic flow index (DFI) was also determined 
along with the conditioned bulk density (CBD) of each sample. 
 
3.2.2.4 Net charge measurements 
 
The net charge of the lactose monohydrate samples was determined using a custom 
made Faraday pail connected to a Keithley 6517B electrometer (Keithley Instruments, 
Cleveland, USA). A description of the principals behind the operation may be found in 
Chaper 2, section 2.8. Different methodologies were developed to introduce powder 
samples into the Faraday pail to determine the net charge of the sample prior to 
processing. These methodologies are described in the results and discussion section 









A range of different sieves were employed with differing mesh sizes all manufactured 
from stainless steel (Endecotts Ltd., London, England). A sieve was placed directly 
over the top of the Faraday pail connected to the electrometer with the zero check 
function enabled. A small quantity of powder was poured onto the top of the sieve so 
that it sat on the mesh without passing through. A stainless steel scraper (grade 316) 
was then used to pass the powder through the mesh. Once sufficient powder had 
passed through the sieve, the net charge of the sieved sample was determined by 
reading the value from the display on the electrometer. The mass of the powder 
measured was then determined by using the analytical balance.  
 
3.2.2.6 Low shear blending 
 
Prior to all low shear blending experiments, the powder samples were passed through 
a 250 μm sieve in order to break up any large agglomerates. Once sieved, powder was 
poured directly from the sieve pan into the blender vessel and the powder was allowed 
to stand for 1 hour under ambient conditions to allow any charge to dissipate prior to 
blending. Samples were blended using a WAB type T2F Turbula blender (WAB, 
Nidderau-Heldenbergen, Germany) at 22 RPM for a predetermined length of time. Net 
charge density of the powder was determined both pre and post blending by pouring 
the powder directly from the vessel into the Faraday pail, as well as being measured 
post blending with the fourth generation powder ladle as described in the results and 
discussion section. For comparisons of different container materials, 500 cm3 vessels 
were used made of stainless steel (grade 316), glass and polypropylene with 80 grams 
of Respitose® ML001 or Respitose® SV003 used for comparison. For comparisons of 
low shear vs high shear blending a 1000 cm3 vessel made of stainless steel (grade 
316) was used with 150 grams of Respitose® ML001 or Respitose® SV003.  
 
3.2.2.7 High shear blending 
 
Prior to all high shear blending experiments, the powder samples were passed through 
a 250 μm sieve in order to break up any large agglomerates. High sheer blending 
experiments were conducted using a Niro Microgral high shear blender (GEA, 
Maryland, USA). Once sieved, powder was directly poured from the sieve pan into the 
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glass vessel of the blender and the powder was allowed to stand for 1 hour under 
ambient conditions to allow any charge to dissipate prior to blending. The rotational 
speed of the impeller was set to 500 RPM and the blending time was set to the desired 
length using the operating software.  
 
3.3 Results and discussion 
 
3.3.1 Particle sizing of the two lactose monohydrate grades 
 
The particle size distributions of the two grades of lactose monohdrate selected for the 
study, ML001 and SV003, are displayed in Table 3.1. The average (n=5) of the 10% 
undersize (d10), 50% undersize (d50) and 90% undersize (d90) values were recorded as 
well as the percentage of particles with diameter less than 5 μm. The d10 and d50 values 
for ML001 were smaller than for SV003 and the percentage of particles less than 5 μm 
was greater indicating that ML001 has a greater percentage of fine particles than the 
SV003. The d90 value for ML001 was greater than for SV003 indicating that the largest 
particles in ML001 had a greater median diameter than those of SV003. This is the 
result of the manufacturing process for each grade of lactose monohydrate. ML001 is 
manufactured by jet milling large lactose monohydrate particles (DFE Pharma 2014a), 
which is a destructive process whereby a large quantity of fine particles is generated. 
SV003 is a sieved grade lactose monohydrate (DFE Pharma 2014b) where the lactose 
particles are passed through a range of different sieves and different fractions of 
powder are isolated with a more narrow particle diameter range than ML001. 
 
 d10 (μm) d50 (μm) d90 (μm) % < 5 μm 
ML001 3.71 ± 0.17 48.11 ± 0.42 153.92 ± 1.89 11.16 
SV003 32.86 ± 1.56 60.28 ± 0.89 91.35 ± 1.81 2.65 
 
Table 3.1 Particle size values of ML001 and SV003 (n=5, mean ± SD) 
 




Scanning electron micrographs of the two grades of lactose monohydrate at 200 times 
magnification are displayed in Figure 3.1. The images clearly show that ML001 has a 
large number of fine particles present and qualitatively the particle diameter range is 
large. Conversely, SV003 contains much fewer fine particles of lactose monohydrate 












3.3.3 Characterisation of rheological properties 
 
Both grades of lactose were characterised using a FT4 Powder Rheometer (Freeman, 
UK) as described in Chapter 2 section 2.2.3. Identical 20 mL volumes of each grade 
were analysed. The values for the BFE, the conditioned bulk density (CBD), the AE at 
8 m/s and the dynamic flow index (DFI) are displayed in Table 3.2. The BFE for SV003 
was considerably higher than for ML001 (300.7 ± 7.5 mJ for SV003 vs 119.7 ± 12.7 mJ 
for ML001) indicating that the energy required to displace the SV003 particles was 
greater than for ML001 when the sample was not aerated. This may be understood in 
terms of the packing of the particles within the split vessel where owing to the 
increased fine particle content there is a greater amount of air within the sample for 
ML001 compared with SV003 and so ML001 takes less energy to displace. This is 
supported by the CBD data which shows that the density of the conditioned SV003 is 
greater than that of the ML001. 
Upon aeration of the sample at 8 m/s, the AE of ML001 is greater than for SV003 (31.0 
± 3.2 mJ for ML001 vs 5.9 ± 1.1 mJ for SV003, approximately five times the difference). 
This is due to the fact that ML001 is a cohesive powder compared with SV003 which is 
relatively free flowing and is a result of ML001 having a larger particle size distribution 
with increased percentage of fines than SV003 where the particle size distribution is 
relatively narrow. 
The difference in the rheological properties was why the two powders were selected for 
the study as one could hypothesise that a relatively free flowing, easily aeratable grade 
of lactose monohydrate such as SV003 might be more susceptible to triboelectrification 
during processes involving powder flow such as blending and filling, than a sticky, 
cohesive grade of lactose monohydrate such as ML001.  
 
 BFE (mJ) ± S.D. CBD (g/mL) ± S.D. AE @ 8m/s ± S.D. DFI ± S.D. 
ML001 119.7 ± 12.7 0.56 ± 0.02 31.0 ± 3.2 5.5 ± 0.6 
SV003 300.7 ± 7.5 0.67 ± 0.01 5.9 ± 1.1 60.9 ± 12.4 
 






Samples of ML001 and SV003 were passed through sieves of different mesh size 
directly into a Faraday pail and the charge/mass ratio of the samples was recorded. 
The results are illustrated in Table 3.3. 
 
 







  -54.99 ± 2.99 
 
     -9.65 ± 1.86 
125   -19.22 ± 5.32      -3.55 ± 0.15 
180   -16.84 ± 2.21      -1.34 ± 0.35 
212     -7.85 ± 0.44      -1.35 ± 0.14 
250     -6.11 ± 0.98      -1.66 ± 0.06 
355     -0.99 ± 0.52      -0.44 ± 0.02 
500     -1.48 ± 0.24      -0.33 ± 0.04 
850     -0.67 ± 0.12      -0.10 ± 0.02 
1000     -1.20 ± 0.38      -0.11 ± 0.02 
 
Table 3.3 Triboelectrification of ML001 and SV003 during sieving (n=3, mean ± SD) 
 
These data show that as the mesh diameter of the sieve decreases, the extent of 
particle triboelectrification increases for both grades of lactose monohydrate. This is 















The extent of particle triboelectrification was greater for ML001 than for SV003 (e.g. 
average charge/mass ratio of ML001 was -54.99 ± 2.99 nC/g vs -9.65 ± 1.86 nC/g for 
SV003 when passed through a mesh size of 90μm). The possible reason for this may 
relate to the free flowing nature of SV003 which requires minimum agitation from the 
stainless steel scraper to be passed through the sieve due to the minimum 
agglomerate formation of the lactose monohydrate powder due to its low cohesive 
nature. Secondly, the d90 for ML001 is greater than for SV003 (153.92 ± 1.89 μm for 
ML001 vs 91.35 ± 1.81 μm for SV003). Therefore, larger particles are present in ML001 
and as such, more particles will come into closer proximity with the sieve mesh 
resulting in a greater quantity of stainless steel – lactose contacts and thus a larger 
negative net charge generated on the powder. In addition, there are more fine particles 
in ML001, resulting in a larger surface area to mass ratio than for SV003 and therefore 
more particle surface area which is available to become tribocharged for ML001 than 
for SV003. 
 
3.3.5 Net charge method development 
 
Net charge measurements of powder samples are notoriously difficult to accomplish 
and are susceptible to a large amount of error due to a variety of factors which are 
sometimes difficult to control (Harper 1967). Therefore, a reliable method to measure 
the net charge on powder samples in situ seems advantageous as the majority of 
methods involving a Faraday pail involve displacement of the powder from its 
surroundings which may lead to additional triboelectrification and hence unreliable, 
unrepeatable measurements which are likely to be operator dependent. The easiest 
way to move DPI formulations into a Faraday pail is by pouring however, as the 
particles slide over the container surface they become tribocharged (Murtomaa et al. 
2002) which will alter the charge on the sample before it is measured.  A number of 
different methods were therefore developed in an attempt to measure the net charge of 
both ML001 and SV003 grades of lactose monohydrate, as received, without any prior 
processing. As the powder had not been processed it was expected that charge values 
recorded should be zero or close to zero. A summary of the data generated for each 
method is displayed in Table 3.4. Twenty measurements were taken per variable of 
differing masses of powder up to values of 2.50 grams. It should be noted that the 
operator wore a conductive wristband connected to earth to prevent unintentional 






Charge/Mass Ratio (nC/g) ± S.D. 
Measurement Method ML001 SV003 
Direct Pour -0.021 ± 0.04 -9.65 ± 1.86 
Modified Spatula -0.393 ± 0.18 -3.55 ± 0.15 
Modified Spatula (Earthed) -0.500 ± 0.16 -1.34 ± 0.35 
Polyethylene Scoop 0.887 ± 1.22 -1.35 ± 0.14 
Polyethylene Scoop (Earthed) 0.783 ± 0.78 -1.66 ± 0.06 
1st Generation Powder Ladle -0.151 ± 0.06 -0.44 ± 0.02 
1st Generation Powder Ladle (Earthed) -0.146 ± 0.07 -0.33 ± 0.04 
2nd Generation Powder Ladle 0.003 ± 0.01 0.005 ± 0.02 
2nd Generation Powder Ladle (Earthed) 0.002 ± 0.01 0.001 ± 0.03 
3rd Generation Powder Ladle -0.004 ± 0.01 0.044 ± 0.03 
3rd Generation Powder Ladle (Earthed) 0.003 ± 0.01 0.013 ± 0.07 
4th Generation Powder Ladle 0.012 ± 0.01 0.007 ± 0.01 
 
Table 3.4 Summary of charge/mass ratios recorded for ML001 and SV003 as received 
using a range of different methods (n=20 ± S.D) 
 
The average values for the charge/mass ratio of the samples are displayed graphically 
in Figures 3.3 to 3.14. Single point measurements are shown as in some cases both 
positive and negative values for the net charge were recorded from the same sample 







3.3.5.1 Direct pouring of lactose monohydrate 
 
The first method employed involved pouring small quantities of lactose directly from 
polythene bags and into the Faraday pail as received. The data is displayed graphically 
in Figure 3.3. 
 
Figure 3.3 Pouring lactose samples straight from polythene bag 
 
The results show that for ML001, the charge density values recorded were relatively 
low (average -0.021 ± 0.04 nC/g) and did not increase greatly with mass. In contrast for 
SV003, the samples recorded exhibited a net negative charge in all case and the 
charge density increased with increased mass, however, the linear correlation was 
poor (R2 = 0.2683). It was observed that for ML001, which is a cohesive powder 
(Emery et al. 2009), once the powder approached the edge of the bag, it fractured 
roughly and detached from itself before falling into the Faraday pail and there was 
minimal sliding across the polythene surface. For SV003 which is a relatively free 
flowing powder (Chen et al. 2012) the majority of particles which fell into the Faraday 
pail had slid across the surface of the polythene and as such had become negatively 
charged. This effect was also observed by Murtomaa et al. who recorded the extent of 
triboelectrification of lactose monohydrate while flowing through a polypropylene pipe 
and into a Faraday pail (Murtomaa et al. 2002). 
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3.3.5.2 Modified stainless steel spatula 
 
The next method developed involved the use of a stainless steel spatula. The leading 
edge of the spatula was bent upwards in an attempt to prevent powder from sliding 
over the metal surface. The spatula was placed into the bag of lactose monohydrate 
and a large heap of powder was removed. The spatula was then placed over the top of 
the Faraday pail and was then gently tapped so that only powder fell from the top of the 
heap into the well. The experiment was performed both A without and B with an 
earthing cable attached to the spatula and the results are displayed in Figure 3.4. 
In all cases the values calculated for the net charge density were negative. For both 
ML001 and SV003 as the mass of powder measured increased, the net charge on the 
sample increased. For ML001 the correlation between charge and mass was 
approximately linear (R2 values 0.802 and 0.767) for the unearthed and earthed 
spatula, respectively, however, for SV003 the correlation was poor (R2 values 0.281 
and 0.071). The opposite trend was observed as for pouring in that when ML001 was 
placed on the spatula, the spatula had to be tilted considerable before any lactose 
monohydrate would fall into the well and the mechanism by which involved a fracture of 
the bulk powder mass which then came into contact with the sides of the spatula. For 
SV003, particles of lactose monohydrate fell from the top of the powder heap more 
freely and hence less came into contact with the metal surface. The operator observed 
that the spatula was not a suitable method for transferring powder to the Faraday pail 
as powder falling into the Faraday pail over the surface of the spatula resulted in net 






Figure 3.4 Using a modified spatula to perform net charge measurements A, without and 
B, with an earthing cable 
 
3.3.5.3 Polyethylene scoop 
 
The next method employed was to use an improvised polyethylene scoop made from a 
polypropylene weighing boat to see if any differences could be observed when using a 





show a high level of variability and so identifying trends in the results is difficult. 
However, it was shown that ML001 was observed to have net positive charge and 
SV003 net negative charge. The high variability in the results may be partly attributed 
to operator error as it was difficult to pour powder into the Faraday pail in a repeatable 
way. Thus this method was deemed to be inappropriate for further development.  
 
Figure 3.5 Using a polyethylene scoop to perform net charge measurements of ML001 
and SV003 
 
3.3.5.4 Development and optimisation of a powder ladle 
From the first two sets of data it became apparent that any powder sliding over a 
surface when being transferred into the Faraday pail had the potential to be 
tribocharged and hence could affect the reliability of the results. As such a novel 
method was envisaged using a bespoke powder ladle. The criteria for the ladle was 
that it must be small enough to fit into the appropriate receptacle such as a 
polyethylene bag or blending vessel and that any powder being transferred to the 
Faraday pail had not been in contact with any surface of the ladle. Heaping powder 
onto the ladle during a scooping process and subsequently tilting the ladle over the 
Faraday pail, such that only particles from the top of the heap could fall into the well 





Figure 3.6 Net charge measurements using the first generation powder ladle A, without 
and B, with an earthing cable 
 
For clarity, only values of the net charge recorded with SV003 for sample masses 
below 1.2 grams are displayed in Figure 3.6 for A, the unearthed ladle and B, the 
earthed ladle. It was observed that for the smaller masses of SV003, the only particles 
that entered the Faraday pail were those from the top of the heap of lactose 
monohydrate as intended. In this instance only positive values for the net charge were 
recorded which are circled in blue in Figure 3.7. Once larger masses were measured, 
particles began to slide over the metal surfaces of the ladle and the net charge 






Figure 3.7 Measurements of SV003 for sample masses less than 1.2 grams with A, the 
unearthed and B, the earthed first generation powder ladle 
 
To prevent any particles sliding over the metal surfaces of the ladle body, the ladle was 
redesigned and an image of the Second Generation Powder Ladle is displayed in 
Figure 3.8. Improvements included using a cylindrical handle rather than a flat one to 









well; narrowing the walls of the ladle body to as thin a diameter as possible (~1 mm) to 
prevent powder from sitting on the top edges and angling the edges of the ladle body 
inwards by 15 degrees to stop powder from falling out of the ladle cavity and into the 
Faraday pail during pouring. 
 
 
Figure 3.8 Second Generation Powder Ladle 
 
 
Results generated with the Second Generation Powder Ladle are displayed in Figure 
3.9. A difference in the data is observed as compared with the First Generation Powder 
Ladle and forms of powder introduction to the Faraday pail. Rather than a propensity 
for the net charge recorded to become increasingly negative with increasing mass of 
powder, the net charge recorded appeared to be independent of the mass of the 
sample and was very close to zero. Additionally, in the case of both the non-earthed 
and earthed data, the average net charge density values calculated were positive in all 
cases (ML001: 0.003 ± 0.01 nC/g and 0.002 ± 0.01 nC/g, respectively; SV003 0.005 ± 





Figure 3.9 Net charge measurements using the A, unearthed and B, earthed second 
generation powder ladle 
 
Despite the improvements in the design, small quantities of particles of powder were 
still observed to be sliding over the metal surfaces, chiefly from the handle and from the 
outer surfaces of the body. 
The design of the ladle was further optimised as shown in Figure 3.10. Shot blasting 





powder within the cavity. The outer surfaces of the body were highly polished to 
prevent powder from sticking prior to the powder transfer process. The shape of the 
handle was also changed from circular to triangular to further prevent powder build up 
on the handle. 
 
Figure 3.10 Third Generation Powder Ladle 
 
The results produced with the Third Generation Powder Ladle are displayed in Figure 
3.11. The results, as expected, were similar with the Second Generation Powder Ladle 
in that the value of the charge recorded fell within a narrow range. The average values 
for the calculated net charge density for ML001 were similar for both the unearthed and 
earthed ladle and very close to zero (-0.004 ± 0.01 nC/g and 0.002 ± 0.01 nC/g, 
respectively). A larger average value for the net charge density for SV003 was 
observed for the unearthed ladle (0.044 ± 0.03 nC/g) vs the earthed ladle (0.013 ± 0.03 
nC/g) and thus earthing the ladle may have contributed to increasing the accuracy of 






Figure 3.11 Net charge measurements using A, the unearthed and B, earthed third 
generation powder ladle 
 
The Third Generation Powder Ladle led to a great reduction of variability in the net 
charge measurements of bulk powder samples, however, some variability was still 
apparent in that measurements for ML001, as received, showed both positive and 
negative values for the net charge density of the powder. Therefore, a Fourth 
Generation Powder Ladle was created by coating the Second Generation Powder 





made. The results are shown in Figure 3.12 and show by coating the ladle in a non-
conductive material that for ML001 negative charge was prevented from being 
transferred from the ladle to the powder sample. This was indicated by the overall net 
charge measurement for the fourth generation ladle being higher than that of the third 
(0.012 nC/g vs 0.002 nC/g). The ladle was not earthed as attaching an earth cable to 
an already insulated surface would not alter the results. 
 
 
Figure 3.12 Net charge measurements using the fourth generation powder ladle 
 
In order to show the disparity in the results generated for the First Generation and the 
Fourth Generation Powder Ladle, the results for both ML001 and SV003 were overlaid 
as shown in Figure 3.13. This figure highlights the obvious difference in measuring the 
net charge on a powder sample when the sample slides over a surface which 
frictionally tribocharges it in the case of the first generation powder ladle, or when the 
particles of powder fall only from the main powder body as in the case of the Third 
Generation Powder Ladle. 
The fourth generation powder ladle method appeared to produce excellent results for 
the net charge measurement of the two grades of lactose monohydrate as received, 
preventing the sample from becoming additionally tribocharged during transfer from the 
bulk sample to the Faraday pail. In general, the values recorded were very small for 
each ladle, in the order of picoCoulombs which was to be expected as the samples had 





Figure 3.13 Comparison of first generation ladle (earthed) with the fourth generation ladle 
for A, ML001 and B, SV003 
 
 
3.3.6 Low shear blending 
 
Having developed a novel method for measuring the net charge on both ML001 and 
SV003 samples as received, the powder ladle method was used to measure the net 





traditional pouring method similar to one used previously (Adi et al. 2010) . Batch sizes 
of 80 grams were placed in 500 cm3 vessels which were placed inside a type T2F 
Turbula blender. It was hypothesised that using the powder ladle post blending would 
be a more accurate measurement method than simply pouring as additional frictional 
triboelectrification of the powder samples would not occur as the powder slid against 
the inner wall of the mixing vessel during the pouring process. To illustrate this 
phenomenon, samples of lactose monohydrate were also poured directly from the 
various mixing vessels prior to blending. This was to illustrate that pouring tribocharges 
the powder samples and thus is expected to render the results of the net charge 
generation post blending inaccurate when using a pouring method. After transferring 
powder samples to the vessels, the vessels were left for one hour prior to testing to 
allow any charge to dissipate. The results are displayed in Table 3.5. 
The results indicated that when the sample was poured out of the container prior to 
blending, as the powder slid over the inner surface of the vessel wall it became 
negatively charged via triboelectrification. The greatest extent of tribocharging occurred 
for the polyethylene container as this container has a greater surface roughness than 





Charge/Mass Ratio (nC/g) ± S.D. 
ML001 SV003 
Direct pour pre blending 
Stainless Steel -0.92 ± 0.16 -0.16 ± 0.02 
Polyethylene -0.86 ± 0.26 -3.72 ± 0.29 
Glass -0.11 ± 0.03 -0.62 ± 0.09 
Direct pour post blending 
Stainless Steel -0.77 ± 0.28 -0.03 ± 0.00 
Polyethylene -0.28 ± 0.05 0.18 ± 0.14 
Glass 0.80 ± 0.19 -0.77 ± 0.28 
Powder ladle post blending 
Stainless Steel 0.00 ± 0.01 0.00 ± 0.00 
Polyethylene 0.05 ± 0.01 0.01 ± 0.02 
Glass 0.00 ± 0.00 0.00 ± 0.00 
 
Table 3.5 Net charge measurements of ML001 and SV003 pre and post blending (n=3, 
mean ± SD) 
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After blending, when samples were poured from the container directly into the Faraday 
pail, in all cases the total net charge either became less negative or positive compared 
with the samples as measured by pouring prior to blending. When the samples were 
measured post blending with the Foruth Generation Powder Ladle (earthed), little or no 
net charge was recorded for all three container materials and for both kinds of lactose 
monohydrate. The results of each low shear blending experiment are displayed 
graphically in Figure 3.14 and show charge to mass ratios of ML001 vs SV003 A, 
poured directly from each container without blending, B, poured from each container 












Figure 3.14 Charge to mass ratios of ML001 vs SV003 A, poured directly from each 
container without blending, B, poured from each container and C measured with the 
fourth generation powder ladle after blending for 20 minutes at 22 RPM. 
 
These data show that by simply pouring the powder out of the container prior to 
blending, the powder became tribocharged. When the fourth generation powder ladle 






3.3.7 Low shear and high shear blending comparison – timed experiments 
 
High shear blending is a method which can be used for manufacturing batches of DPI 
formulations on a large scale (Bridson et al. 2007). Typically, the manufacturing 
method is different to Turbula blending in that rather than rotating the vessel, a 
stainless steel impeller is lowered into the vessel and rotated in a circular direction at a 
much higher specified speed. A comparison was drawn between net charge generation 
on ML001 and SV003 post blending using the Fourth Generation Powder Ladle 
(earthed). 150 gram samples were blended and the net charge was recorded after 
each specific time point. The results are displayed in Table 3.6 and Figure 3.15 and 
show that in the case of low shear blending, very little charge was measured on both 
ML001 and SV003 post blending, regardless of the blending time.  
 
Blending Method Blending Time 
Charge/Mass Ratio (nC/g) ± S.D. 
ML001 SV003 
Low shear (22 RPM) 
1 -0.004 ± 0.002 0.001 ± 0.001 
2 -0.003 ± 0.001 -0.003 ± 0.002 
5 -0.001 ± 0.002 -0.002 ± 0.003 
10 -0.003 ± 0.001 -0.001 ± 0.001 
20 -0.006 ± 0.001 -0.002 ± 0.001 
30 -0.008 ± 0.007 -0.006 ± 0.001 
High shear (500 RPM) 
1 -0.002 ± 0.002 -0.002 ± 0.002 
2 0.003 ± 0.000 0.000 ± 0.000 
5 0.017 ± 0.006 0.001 ± 0.006 
10 0.006 ± 0.005 -0.001 ± 0.002 
20 0.028 ± 0.009 -0.005 ± 0.001 
30 0.047 ± 0.015 -0.003 ± 0.005 
 
Table 3.6 Net charge measurements of ML001 and SV003 post low shear and high shear 





Figure 3.15 Net charge measurements of ML001 and SV003 post A, low shear and B, high 
shear blending. 
In the case of high shear blending at 500 RPM, for SV003, the net charge measured 
was also very close to zero, however, for ML001 the net positive charge appeared to 






After either low shear or high shear blending, minimal charge generation was detected 
with the powder ladle method. Elajnaf et al. performed static charge decay of lactose 
monohydrate compacts at a range of relative humidities (Elajnaf et al. 2007) and 
showed that the charge decay of lactose monohydrate was fast at the humidity range 
of 45 ± 5% RH used for these experiments. Sung et al. used a microwave-based open-
reflection resonator sensor to determine the dielectric properties of microcrystalline 
cellulose, anhydrous lactose and α–lactose monohydrate (Sung et al. 2011). They 
showed that moisture content in lactose as well the crystal structure has an effect on 
the electrical permittivity which in turn will affect the ability of lactose to become 
statically charged. Although the resistivity of lactose monohydrate is high compared 
with a conductor such as stainless steel, it is lower than that of an insulator such as 
polytetrafluoroethylene (PTFE). This theory is supported by the fact that the net charge 
measurements of ML001 and SV003 were larger with an earthing cable attached to the 
ladle than without. As such it is possible that the charge on the lactose monohydrate 
generated after both low and high shear blending dissipated too quickly to be 
measured by the ladle. 
 
3.4 Conclusions 
Experiments have been conducted to assess various techniques of measuring the net 
charge on two pharmaceutical inhalation grades of lactose monohydrate with differing 
rheological properties. Upon sieving through different mesh sizes, ML001, which is a 
milled, cohesive grade of lactose monohydrate with a high percentage of fines, became 
more statically charged than SV003 which is a free-flowing, sieved grade of lactose 
monohydrate with a narrower particle size distribution. SV003 required minimal 
agitation to be passed through each stainless steel sieve and so the net charge build 
up on the lactose monohydrate particles was lower. 
A number of different methodologies were employed to investigate the net charge 
density of ML001 and SV003 grades of lactose monohydrate as received using a 
Faraday pail. It was shown that simply pouring the powder from the polythene bag was 
enough to tribocharge the powder. In addition, any method of powder transfer to the 
Faraday pail which involved particles sliding over a surface was enough to tribocharge 
the sample and thus affects the validity of the results. A powder ladle was designed 
and subsequently optimised so that the only particles which fell into the Faraday pail 
had slid from off the top of the heap of other particles. This appeared to generate 
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accurate, reliable and repeatable results which are notoriously difficult to accomplish in 
the case of bulk powder electrostatic measurements. 
The powder ladle method was then used to measure both ML001 and SV003 after 
blending with a type T2F lower shear Turbula blender and with a Niro Microgral high 
shear blender. The results showed that when samples were measured with the ladle, 
little to no appreciable net charge accumulation on either grade of lactose monohydrate 
was detected, for low shear blending, independent of container material. In the case of 
high shear blending a slight accumulation of positive charge was observed for ML001, 
however, the amount was not appreciable. It is possible that the charge on the sample 
dissipated during the measurement process as a result of humidity in the environment. 
An alternative suggestion is that the surfaces of the blending vessels became coated 
with charged lactose monohydrate particles during blending which may have protected 
additional lactose monohydrate particles from being tribocharged. 
Future experiments could look at the addition of an API to lactose monohydrate to 
determine whether the API particles become significantly more charged than the 
lactose monohydrate particles during sieving and blending procedures. Additionally, 
performing static charge decay experiments on lactose monohydrate and API particles 
would determine whether the rate of charge decay is too fast for accurate 












Chapter 4    The Effect of Relative Humidity on the Static 




DPI formulations are susceptible to being electrostatically charged via the mechanism 
of triboelectrification (Ireland 2010a). This may occur during formulation and processing 
of the lactose-API blends and upon aerosolisation of the formulation within an inhaler 
(Bennett et al. 1999). The extent to which a DPI formulation will become statically 
charged is dependent on the type of the collisions the particles that a DPI formulation 
experiences during blending and filling. These may be governed by a large number of 
variables including the electrical and physico-chemical properties of the API, its target 
dose, the flow behaviour of the coarse carrier, the frequency and energy of the 
collisions with surfaces, the electrical properties of these surfaces and the water vapour 
pressure (relative humidity) of the working environment (Kwok and Chan 2008a). If the 
electrostatic charges generated do not dissipate quickly, problems may occur due to 
weighing errors, increased agglomeration, poor flow, adhesion to container surfaces, 
reduced API recovery, loss of content uniformity and manual handling difficulties 
(Karner and Anne 2011). A fundamental understanding of the role that relative humidity 
plays in the build up and subsequent decay rate of static charge is thus of critical 
importance in the development and processing of DPI formulations. 
The amount of bound surface water to a particle is highly dependent on the 
hydrophilic/hydrophobic properties of the API, but generally increases with increasing 
humidity until a sorption-desorption equilibrium is reached (Lutz and Kindersberger 
2009). Adsorbed water will increase the conductivity and dielectric permittivity of the 
surface of a particle. This, in turn, will decrease the ability of the particle to become 
electrostatically charge and will increase the overall rate of charge decay (Nomura et 
al. 2003). The environmental humidity may also affect the cohesive properties of 
micronized drugs used in inhalation therapy (Young et al. 2004) and of the overall 
performance of a dry powder inhaler (Mackin et al. 1997). Berard et al. demonstrated 
using atomic force microscopy that an increase in environmental RH increased the 
overall adhesive forces of Zanamivir/lactose blends (Berard et al. 2002). Guardiola et 
al. investigated the degree of static charge build up on glass beads within a fluid bed 
drier with the use of an electric probe. They showed that an increase in the relative 
humidity resulted in a decrease in the static charge build up and adhesion of the beads 
to internal surfaces of the drier (Guardiola et al. 1996). Lutz and Kindersberger showed 
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a linear relationship between the surface resistivity and static charge decay times on 
epoxy resin insulators following the application of a positive corona charge for one 
minute (Lutz and Kindersberger 2009). Faster rates of static charge displacement were 
observed as relative humidity levels increased.  Elajnaf et al. demonstrated that over a 
range of RH from 0-86% an increase in RH produced a decrease in both the 
electrostatic charge and adhesion of salbutamol sulphate and ipratropium bromide DPI 
blends during low shear turbula blending (Elajnaf et al. 2006). Chow et al. performed 
static and dynamic charge measurements of lactose carriers and demonstrated a linear 
correlation between static charge build up and the humidity of the environment (Chow 
et al. 2008). Sharma et al. demonstrated that an increase in RH decreased the surface 
resistivity of acrylic polymer powders (Sharma et al. 2003). Grosvenor and Staniforth 
manufactured compacts of selected commonly used pharmaceutical excipients and 
demonstrated that static charge decay rates were dependent on the material’s 
electrical resistivity, with the greater the resistivity, the longer the decay time. They also 
determined that by conditioning the compacts with water the resistivities were reduced, 
resulting in a dramatic reduction in charge decay times (Grosvenor and Staniforth 
1996). 
This study investigates the effect of relative humidity and API concentration on the 
susceptibility of a DPI formulation to become electrostatically charged and the 
subsequent rate of charge decay. The study also seeks to determine the effect of 
vessel container material on the extent of triboelectrification of a DPI formulation during 
low shear turbula blending and its subsequent rate of charge decay. 
 
 
4.2 Materials and methods 
4.2.1 Materials 
 
Micronised fluticasone propionate was supplied by Chemagis Ltd (Bnei Brak, Israel) 
and micronised budesonide supplied by Farmabios (Perugia, Italy). Respitose® ML001 
and Respitose® SV010 grades of lactose were obtained from DFE Pharma (Veghel, 
The Netherlands). Prior to use the samples were stored in a sealed humidity cabinet 
with a saturated salt solution of potassium carbonate (Fisher Bioreagents, NJ, USA) at 
43% relative humidity in an air conditioned room maintained at 20 ± 2⁰C. All solvents 
used were of HPLC grade (Sigma-Aldrich, St. Louis, MO, USA). Ultra pure water was 
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produced by reverse osmosis (MilliQ, Milliipore, Molsheim, France). Ammonium 




4.2.2.1 Dynamic vapour sorption 
 
Dynamic vapour sorption (DVS) is a commonly used technique in the pharmaceutical 
industry for determining the ability of water to adsorb to the surface of an excipient or 
API at a definite relative humidity (Sun 2011). Moisture sorption isotherms can be used 
to quantify the hygroscopicity of a material over a range of relative humidity values. 
Measurements of the percentage change in mass are taken over a range of specified 
humidities, as a nitrogen carrier gas is flowed over the sample. Elajnaf et al. performed 
DVS experiments on lactose, salbutamol sulphate and ipratropium bromide and 
witnessed an increase in the quantity of moisture adsorbed to the sample as relative 
humidity increased (Elajnaf et al. 2007). 
DVS experiments were performed with a DVS-1 instrument (Surface Measurement 
Systems Ltd, London, UK). 100mg of sample was weighed into a sample pan and after 
equilibrium with the environment has been reached; its mass was continually recorded 
during exposure to humidity cycles of 0-90% RH in 10% RH steps at 25°C. The rate of 
change of mass (dm/dt) was plotted as a function of relative humidity and an 
equilibrium mass change of ≤0.0005% was achieved for ten minutes before the 
humidity was changed to the next set point. 
 
4.2.2.2 Manufacture of blends 
 
Micronized budesonide and fluticasone propionate were blended with ML001 and 
SV010 grades of lactose to produce formulations with concentrations of 0.05%, 0.08%, 
0.1%, 0.4%, 1%, 0.8% and 2% w/w, using a low shear method to produce 50g blends. 
Budesonide was formulated with ML001 and fluticasone with SV010. 10% of the 
required lactose was passed through a 250μm mesh sieve (Endicotts Ltd, UK) followed 
by the total required API, followed by another 10% of the required lactose to create a 
sandwich. This sandwich was blended for 10 minutes at 22 RPM using a type T2F 
Turbula Blender (WAB, Switzerland) in a sealed stainless steel vessel of capacity 
250cm3. 50% of the remaining lactose was passed through the sieve, followed by the 
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preblend, followed by the other 50% of the remaining lactose. The formulation was then 
blended at 22 RPM for an additional 20 minutes. Once blending was complete the 
blends were transferred to labelled polythene bags and stored in a sealed humidity 
cabinet with a saturated salt solution of potassium carbonate (Fisher Bioreagents, NJ, 
USA) at 43% relative humidity in an air conditioned room maintained at 20 ± 2⁰C. Each 
blend was left in storage for a minimum of one week to allow any electrostatic charge 
present to dissipate. 
 
4.2.2.3 Assay and content uniformity 
 
Assay and content uniformity analysis was performed to determine the API recovery 
and homogeneity of each blend and was measured using reverse phase high 
performance liquid chromatography (RP-HPLC) using a UV detector (UV-975, Jasco 
Corporation, Japan) at a wavelength of 244nm for budesonide and 235 nm for 
fluticasone. Analysis was performed using an ODS Hypersil Column, 100x4mm 
(Thermo Scientific, Waltham, MA, USA) maintained at 40⁰C using a column oven 
(Jasco CO-965) The mobile phase used contained 45% methanol, 35% acetonitrile and 
20% distilled water (v/v). All solvents were HPLC grade (Fisher Chemical, 
Loughbrough, UK) and distilled water was produced by reverse osmosis (MilliQ, 
(18.2MΩ) Millipore, Molsheim, France). A run time of 5 minutes was used for each 
sample at a flow rate of 1.5 ml/min with an injection volume of 100μl per sample. The 
retention time of budesonide was 2.43 minutes and of fluticasone propionate was 1.95 
minutes. 10 x 50mg samples of each blend were each dissolved in 100mL of mobile 
phase and the API content was calculated by comparison with an externally calibrated 
standard. 
 
4.2.2.4 Charge decay measurements 
 
A Charge Decay Time Analyser (CDTA) (JCI155 v6, Chilworth Technology Ltd. 
Southampton, UK) as shown in Figure 4.1 is an instrument used for determining the 
electrostatic charge decay rates of materials. The system applies a corona discharge to 
the surface of a sample which in turn creates a surface voltage as a result of the 
charge imparted. An electrostatic field meter, used for non-contact measurements of 
the electrostatic charge of an object, records the electrostatic field of the sample as a 
potential difference in Volts. The initial peak surface potential post corona charging (Vs) 
137 
 
is recorded as well as values for the time taken for the surface potential of the sample 
to decay to 10% and 1/e of the initial value.  
 
 
Figure 4.1 Image of the JCI 155v6 Charge Decay Time Analyser (reproduced with 
permission from JCI Chilworth Ltd.) 
8.50 ± 0.01 g samples of the blends were placed into weighing boats and stored at the 
required humidity for a minimum of 24h in a relative humidity cabinet (Safetech 
Climatezone, Hampshire, UK) in order to allow any charge present to dissipate and for 
the level of moisture adhered to the surface of the particles to equilibrate. Samples 
were added to the sample holder of the Charge Decay Time Analyser (CDTA) (JCI155 
v6, Chilworth Technology Ltd. Southampton, UK) and the top of the powder bed was 
smoothed using an earthed metal scraper to produce a homogeneous surface. The 
intensity of the electric field on a charged material is at its maximum at its surface, 
decreasing inversely with the square of the distance from the surface (Bailey 1993). 
Maintaining the distance between the surface of the powder and the field meter is 
therefore necessary and achieved by maintaining a consistent amount of powder in the 
sample holder. Once the sample holder was placed within the CDTA it was further left 






Pretest Voltage (V) ≤ ±5 
Corona Voltage (V) 8000 
Corona Time (s) 0.03 
Analysis Start (s) 0.07 
Plate Speed Slow 
Temperature (°C) 20 
 
Table 4.1 Run settings of the JCI Chilworth CDTA used for electrostatic charge decay 
measurements 
The electrostatic field meter of the CDTA measures the surface potential difference of 
the sample in Volts. The surface potential difference is directly proportional to the 
charge of the material (Chubb 1996). Prior to the commencement of any experiment, 
the pretest voltage, that is the surface potential difference of the sample, was 
determined to be ≤5 V as recommended by JCI Chilworth. In reality, the surface 
potential of all samples prior to testing was ≤0.5 V. A plate is present within the 
equipment which protects the corona charger when the instrument is not in use. When 
the test starts, the plate slides open to expose the powder surface to the corona 
charger. The plate speed was set to “slow” so as not to disturb the powder bed during 
this process. The corona discharge voltage used for all experiments was set to -8000V. 
This was to simulate a powder sample becoming negatively charged when coming into 
contact with metallic surface, such as stainless steel which is commonly used as a 
material for pharmaceutical processing equipment. The maximum voltage which could 
be applied was selected in order provide the maximum differentiation possible between 
each sample in terms of its charge decay characteristics. The corona discharge was 
applied for 0.03 seconds for all samples and the analysis start time, that is, the time at 
which the field meter began taking readings, was 0.07 seconds after the corona 
discharge had stopped. The temperature was controlled within the relative humidity 
cabinet at 20°C for each experiment. In between samples the sample holder was 
washed with soapy water, rinsed thoroughly with methanol and allowed to dry for a 




Once the corona discharge had been applied to the sample, the field meter detected 
and recorded the change in surface potential and plotted it as a function of time as 
shown in Figure 4.2  
 
Figure 4.2 Typical surface potential verses time decay profile generated with the CDTA 
The rate of charge decay is described mathematically by Equation 4.1 which shows 
that the charge follows an exponential relationship with time as has been 
experimentally determined (Chubb 1995). 
 
𝑄 = 𝑄0 𝑒
−1
𝜏  Equation 4.1 
  
Where Q0 is the initial charge, Q is the charge at a set point in time after the charge 
decay has begun and Τ is the charge decay time constant of the material at that 
particular time. 
The initial surface potential difference (Vs) was recorded as well as the time taken for 
the charge to dissipate to 1/e of its initial value (36.8%) and the time taken for the 
charge to dissipate to 10% of its initial value. Each set of blends was tested with the 
CDTA (n=3) at relative humidities of 35%, 55% and 75% RH. ML001 and SV010 
grades of lactose as placebos were also tested for reference. 
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The data which was recorded by the CDTA was stored in a data buffer and results 
were transferred to a PC via a USB memory stick. Subsequent analysis of the data was 
performed using Microsoft Excel. 
 
4.2.2.5 Blending experiments 
 
25 gram samples of the 2% budesonide blend and 2% fluticasone blend were weighed 
directly into either a stainless steel or plastic vessel, approximately 250cm3 in volume. 
The blend was then subjected to low shear blending using a type T2F turbula blender 
(WAB, Nidderau-Heldenbergen, Germany) for 20 minutes at 22 RPM within a 
controlled humidity cabinet at 35% RH. Once blending was complete, the sample was 
poured directly into the sample holder of the CDTA until a flat powder bed was 
achieved and the lid was closed. A charge decay time profile for the material was then 
plotted with no corona discharge applied to the sample. After the measurement was 
taken, the DPI blend was returned for further use and the blending vessel and sample 
holder washed with soapy water and dried with methanol. The 2% w/w API 
formulations were selected for the experiment as these formulations contained the 
highest percentage of API and therefore were predicted to undergo the greatest 
amount of triboelectrification. 
 
 
4.3 Results and discussion 
4.3.1 Dynamic vapour sorption 
 
Dynamic vapour sorption experiments were performed on ML001, SV010, budesonide 
and fluticasone propionate, as shown in Figure 4.3 A-D respectively. This was 
undertaken to ascertain the extent of bound surface water at varying humidity, with 
undetectable amounts of amorphous disorder. Each material was shown to be 
relatively hydrophobic, with total change in mass percentages not greater than 0.3% at 
90% RH for each of the samples. ML001, budesonide and fluticasone produced typical 





Figure 4.3 A, DVS moisture sorption plot of Respitose® ML001 
 






Figure 4.3 C, DVS moisture sorption plot of micronised budesonide 
 
 






This indicated that increases in mass as a result of increases in relative humidity were 
reversible processes for each material. SV010 demonstrated a difference in behaviour 
between cycle 1 and cycle 2, with cycle 1 showing a greater and more variable 
increase in moisture as the RH increased than for cycle two. At the end of cycle 1, it 
was shown that an irreversible increase in moisture level of 0.2% had occurred. The 
reason for this is unclear, however may be due to a physical change in the lactose 
structure. As the SV010 blends which were used for static charge decay experiments 
had been equilibrated at the required humidity for a minimum of 72 hours, far greater 
than the length of the DVS experiment, this effect is not expected to have influenced 
the accuracy of the charge decay measurements. The shape of the second sorption 
cycle was more usual and similar in behaviour to the other samples tested. 
 
4.3.2 Assay and content uniformity analysis 
 
Each blend manufactured was determined to fall within the acceptable pharmacopoeia 
requirement for content uniformity, with an assay value of between 95-110% and 
relative standard deviation of ≤5%. This showed that the manufacturing process was 
efficient at producing homogeneously mixed DPI blends suitable for further 
characterisation. 
 
4.3.3 Effect of loaded dose on the initial surface potential generated on the DPI 
formulations by the CDTA at varying RH 
 
For the budesonide formulations, the initial surface potential increased as a function of 
API concentration for each humidity as shown in Figure 4.4 A. For API concentrations 
above 0.4% w/w a roughly linear correlation was observed between API concentration 
and initial surface potential with R2 values of 0.900, 0.975 and 0.855 for 35%, 55% and 
75% RH respectively as shown in Figure 4.4 B. At 75% RH, the only values recorded 
were for API concentrations of 0.4% w/w and above. Below this drug concentration, the 
initial surface potential was too low to be recorded by the field meter of the CDTA and 







Figure 4.4 Initial surface potential plotted as a function of relative humidity for A, all 
budesonide concentrations and B 0.4% to 2% w/w budesonide 
 
For the fluticasone formulations, the initial surface potential increased as a function of 
API concentration for each humidity as shown in Figure 4.5 A. For API concentrations 





and initial surface potential at 35% and 55% RH with R2 values of 0.997, 0.711 
respectively. At 75% the linear correlation was poor (R2 = 0.221) as shown in Figure 




Figure 4.5 Initial surface potential plotted as a function of loaded dose for A, all 





At 75% RH, the only values recorded were for API concentrations of 0.4% w/w and 
above. Below this concentration, the initial surface potential was too low to be recorded 
by the field meter of the CDTA and result of “no peak found” was recorded. The values 
for the initial voltage at 55% RH for fluticasone concentrations of 0%, 0.02%, 0.05% 
and 0.08% appear to be due to the properties of the lactose, rather than the 
fluticasone. 
The results generated showed similar trends between the budesonide and fluticasone 
formulations. The lowest initial surface potentials recorded were for the lactose carriers 
with the values for ML001 -756.67 ± 112.65V, -89.33 ± 29.17V and 0V and for SV010 -
663.83V ± 112.65V, -1027.30V ± 85.56V and 0V at 35%, 55% and 75% RH 
respectively (although the value for SV010 at 55%RH was determined to be an outlier). 
As the API concentration was increased, the initial surface potential differences 
increased with a linear correlation even though the mass of the sample remained 
constant, with the maximum values reached at an API concentration of 2%. For the 2% 
budesonide blends, the Time to 10% values corresponding to 35%, 55% and 75% RH 
were 26450.11 ± 411.95 seconds, 115.13 ± 11.95 seconds and 7.19 ± 0.24 seconds 
respectively and for fluticasone were 24143.28 ± 1482.08 seconds, 17546.19 ± 2270 
seconds and 225.25 ± 0.59 seconds. This indicated that both budesonide and 
fluticasone are more electrically resistive and prone to becoming statically charged 
than the coarse carrier grades of lactose used to manufacture the formulations. 
 
4.3.4 Effect of relative humidity on the initial surface potential generated on the DPI 
formulations by the CDTA 
 
The initial surface potential for each budesonide concentration, plotted as a function of 
relative humidity is shown in Figure 4.6 A. The results indicated that as relative 
humidity increased the initial surface potential decreased with no values recorded for 
budesonide concentration below 0.4%w/w at 75% RH. For budesonide concentrations 
≥ 0.4%w/w, a linear correlation was observed with R2 values of 0.955, 0.950, 0.991 
and 0.999 for concentrations of 0.4%, 0.8%, 1% and 2% budesonide, respectively, as 




     
Figure 4.6 Initial surface potential plotted as a function of relative humidity for A, all 
budesonide concentrations and B, 0.4%-2% w/w budesonide 
The initial surface potential for each fluticasone concentration, plotted as a function of 
relative humidity is shown in Figure 4.7 A. Excluding the values for the 0%, 0.02%, 
0.05% and 0.08%w/w blends at 55% RH, the results showed that as the relative 
humidity increased the initial surface potential decreased with no values recorded for a 
fluticasone concentration of less than 0.4% at 75% RH. For fluticasone concentrations 





0.997, 0.794 for concentrations of 0.4%, 1% and 2%w/w fluticasone, respectively, as 
shown in Figure 4.7 B. 
 
       
Figure 4.7 Initial surface potential plotted as a function of relative humidity for A, all 
fluticasone concentrations and B, 0.4%-2% w/w fluticasone 
 
These data show that as ambient relative humidity increased, the initial surface 
potential differences of the budesonide and fluticasone samples decreased. For 





corresponding to 35%, 55% and 75% RH were -813.00 ± 56.57 V, -314.27 ± 52.36 V 
and -88.37 ± 13.94 V, respectively, and for the 0.4% blend fluticasone the values were 
-659.77 ± 17.53 V, -274.50 ± 7.73 V and -113.90 ± 18.56 V respectively. For blends < 
0.4% w/w the charge transferred by the corona discharge was so low that no surface 
potential peak could be detected by the electrostatic field meter. This highlights that the 
presence of adhered moisture to the particles’ surfaces decreased the electrical 
surface resistivity, thus reducing the ability of the particles to become charged by the 
corona discharge of the CDTA. 
 
4.3.5 Effect of loaded dose on the static charge decay times of the DPI formulations 
at varying RH 
 
The time taken to get to 10% of the initial surface potential values (Time to 10%) 
increased as a function of budesonide concentration for each humidity as shown in 
Figure 4.8 A. For budesonide concentrations > 0.4% w/w an exponential correlation 
was observed with R2 values of 0.987, 0.969 and 0.998 for 35%, 55% and 75% RH 
respectively as shown in Figure 4.8 B. This indicated the charge decay kinetics 
became dominated by the API behaviour at a critical surface coverage level of 0.4% at 






Figure 4.8 Time to 10% decay values plotted as a function of API concentration for each 
relative humidity for A, all budesonide concentrations and B, 0.1%-2% w/w budesonide 
 
The time taken to reach 1/e of the initial surface potential values (Time to 1/e) 
increased as a function of API concentration for each humidity as shown in Figure 4.9 
A. For API concentrations > 0.4% w/w an exponential correlation was observed with R2 
values of 0.756, 0.976 and 0.989 for 35%, 55% and 75% RH respectively as shown in 
Figure 4.9 B. This again indicated the charge decay kinetics became dominated by the 
API behaviour at a critical surface coverage level of 0.4% at 75% RH and 0.1% at 35 







Figure 4.9 Time to 1/e decay values plotted as a function of budesonide concentration for 




The Time to 10% values increased as a function of fluticasone concentration for each 





exponential correlation was observed with R2 values of 0.997, 0.981 and 0.946 for 
35%, 55% and 75% RH respectively as shown in Figure 4.10 B. 
 
 
Figure 4.10 Time to 10% decay values plotted as a function of API concentration for each 
relative humidity for A, all fluticasone concentrations and B, 0.1%-2% w/w budesonide 
The Time to 1/e values increased as a function of fluticasone concentration for each 





exponential correlation was observed with R2 values of 0.977, 0.982 and 0.968 for 
35%, 55% and 75% RH, respectively, as shown in Figure 4.11 B.  
 
 
Figure 4.11 Time to 1/e decay values plotted as a function of fluticasone concentration 






This indicated the charge decay kinetics became dominated by the API behaviour at a 
critical surface coverage level of 0.4% at 75% RH and 0.1% at 35 and 55% RH as was 
found with the budesonide formulations. 
These data also show that for both budesonide and fluticasone propionate, as the API 
concentration increased, the Time to 1/e and Time to 10% values also increased. 
Above a minimum concentration of 0.1% API an exponential relationship was 
determined for both sets of formulations at 35% and 55% RH. Below this minimum 
concentration, the bulk powder charge decay properties were dominated by the coarse 
carrier, with the API only having a small effect on the overall decay times. Above a 
concentration of 0.1% sufficient API was available such that the reading of surface 
potential by the field meter of the CDTA was dominated by the surface coverage and 
electrostatic behavior of the API particles. Although the initial surface potentials 
increased linearly as a function of API concentration the charge decay times increased 
exponentially highlighting the extent to which the API present governs the overall 
charge decay behavior of a DPI formulation. 
 
4.3.6 Effect of relative humidity on the static charge decay times of the API 
formulations 
 
The Time to 10% values decreased as a function of humidity for each budesonide 
concentration as shown in Figure 4.12 A. For API concentrations above 0.4% w/w an 
exponential correlation was observed with R2 values of 0.867, 0.906, 0.948, and 0.966 






Figure 4.12 A, Time to 10% values as a function of humidity for A, all budesonide 
concentrations and B, 0.4%-2% w/w budesonide 
 
At 35% RH, a change in the order of magnitude was observed in the time to 10% 
values between 0.08% and 1.0% budesonide concentrations. This indicated the 
increased susceptibility of the formulation to become statically charged as this critical 





however, there are marked differences in the time to 10% values for the 2% 
budesonide formulations at all humidities. 
The Time to 1/e values decreased as a function of humidity for each budesonide 
concentration as shown in Figure 4.13 A. For API concentrations above 0.4% w/w an 
exponential correlation was observed with R2 values of 0.885, 0.935, 0.982, and 0.979 
for 0.4%, 0.8%, 1% and 2% w/w formulations, respectively, as shown in Figure 4.13 B. 
As for the time to 10% values, an order of magnitude change was again observed 








Figure 4.13 Time to 1/e decay values as a function of humidity for A, all budesonide 
concentrations and B, 0.4%-2% w/w budesonide 
The Time to 10% values decreased as a function of humidity for each fluticasone 
concentration as shown in Figure 4.14 A. For concentrations above 0.4% w/w an 
exponential correlation was observed with R2 values of 0.869, 0.993, and 0.807 for 








Figure 4.14 Time to 10% decay values as a function of humidity for A, all fluticasone 
concentrations and B, 0.4%-1% w/w fluticasone 
 
The Time to 1/e values decreased as a function of humidity for each fluticasone 
concentration as shown in Figure 4.15 A. For API concentrations above 0.4% w/w an 
exponential correlation was observed with R2 values of 0.864, 0.998, 0.892 for 0.4%, 









Figure 4.15 Time to 1/e decay values as a function of humidity for A, all fluticasone 
concentrations and B, 0.4%-1% w/w fluticasone 
 
These data show that for both sets of formulations, as ambient relative humidity 
increased, the static charge decay rate of the sample following the application of the 
corona discharge decreased, with the slowest charge decay rates observed at 35% RH 
and the quickest at 75% RH. For example, for the 1% budesonide blend, the Time to 
10% values corresponding to 35%, 55% and 75% RH were 8767.67 ± 211.73 seconds, 
35.45 ± 0.14 seconds and 3.44 ± 0.16 seconds respectively and for fluticasone were 
791.50 ± 34.02 seconds, 47.92 ± 0.92 seconds and 5.91 ± 0.36 seconds, respectively. 
These data highlighted an enormous difference in the decay rates between 35% and 
55% RH with charge decay to 10% of the initial value taking less than a minute at 55% 
RH and nearly two and a half hours at 35% RH for the 1% budesonide formulation. 
When the API concentration was increased from 1% to 2 %w/w the Time to 1/e and 
Time to 10% values dramatically increased by an order of magnitude at each relative 
humidity tested highlighting the dominant behaviour of the API on the charging 
propensity and charge decay rate of the sample. 
The presence of humidity in the air should in theory aid the ability of a corona 




conductive path through which the discharge can travel. However, as was 
demonstrated from the DVS results, an increase in relative humidity will increase the 
total amount of water adhered to the surface of the particles. This in turn acts to 
increase the dielectric permittivity and conductivity of the particle surface facilitating 
increased mobility of the charge present. Water droplets in the air surrounding the 
particle will also adsorb and desorb from the particle’s surface at random and during 
this process charge will be transferred from the particle to the water molecules in order 
to reduce the charge saturation on the particle and minimise the energy difference 
between the two species. Both of these effects will result in lower initial surface 
potential difference values post corona charging and more rapid charge decay rates at 
higher humidities. This was highlighted by the fact that for both APIs, no initial surface 
potential difference values were recorded for concentrations of less than 0.4% at 75% 
RH. 
The data generated from these experiments indicates that the overall charging 
propensity and charge decay kinetics became dominated by the API behaviour at a 
critical surface coverage level of 0.1% w/w API at 35 and 55% RH for both sets of 
formulations. At 75% RH this value increased to 0.4% w/w API as the increased level 
of water adsorbed to the particles surfaces decreased the formulations electrical 
resistivities sufficiently to percent corona charging from occurring. 
4.3.7 Blending experiments 
 
The static charge decay times for the 2% w/w budesonide in ML001 formulation are 
displayed in Table 4.2 and the 2% w/w fluticasone formulation in SV010 are displayed 
in Table 4.3. As no corona discharge was applied, the software of the CDTA did not 
record an initial surface potential value, however for both the fluticasone and 
budesonide blends, the blending process resulted in a net negative charge build up for 
both the stainless steel and polypropylene containers. The values for the charge decay 
rates recorded data demonstrated that the blending vessel material had a marked 
effect on the extent of triboelectrification of the blend. The Time to 1/e values of the 
budesonide and fluticasone blends were 16056.8 ± 3254.1s and 1411.8 ± 203.6s for 
the polypropylene container and 156.6 ± 14.9s and 62.0 ± 10.1s for the stainless steel 
container, respectively. These data indicated that the polypropylene vessel imparted 
significantly more negative charge onto the sample than the stainless steel vessel. The 
Time to 10% value for the 2% budesonide formulation with the polypropylene container 
was not recorded by the CDTA as the instrument exceeded the maximum time limit for 






Stainless Steel Polypropylene 
Time10% (s) Time1/e (s) Time10% (s) Time1/e (s) 
35% RH 1894.6 ± 196.2 156.6 ± 14.9 N/A 16056.8 ± 3254.1 
55% RH 406.7 ± 34.5 79.8 ± 21.2 926.3 ± 87.5 387.1 ± 44.6 
75% RH N/A N/A 28.9 ± 13.2 13.2 ± 3.0 
 
Table 4.2 Time to 10% and Time to 1/e values for the 2% budesonide formulation post low 




Stainless Steel Polypropylene 
Time10% (s) Time1/e (s) Time10% (s) Time1/e (s) 
35% RH 339.4 ± 48.6 62.0 ± 10.1 15015.2 ± 2010.2 1411.8 ± 203.6 
55% RH 130.0 ± 25.2 21.5 ± 5.4 926.3 ± 87.5 148.2 ± 15.7 
75% RH N/A N/A 40.1 ± 9.3 7.4 ± 1.9 
 
Table 4.3 Time to 10% and Time to 1/e values for the 2% fluticasone formulation post low 
shear turbula blending (n=3, mean ± SD) 
 
Humidity also affected the extent of triboelectrification; at 75% RH the surface potential 
difference of the sample post blending was too low for the software to detect. The trend 
observed was that as the humidity increased the charge decay times decreased with, 
for example, the Time to 1/e values for the 2% w/w fluticasone formulation being 
1411.8 ± 203.6s, 148.2 ± 15.7 and 7.4 ± 1.9 s at 35%, 55% and 75% RH, respectively. 
A plot of the Time to 1/e values post blending in the polypropylene vessel for each 
formulation as a function of humidity is displayed in Figure 4.16. These data 
demonstrated an exponential relationship between Time to 1/e and humidity as was 
observed during the previous charge decay experiments with R2 values of 0.999 and 





Figure 4.16 Time to 1/e values plotted as a function of RH for the 2% w/w budesonide and 
fluticasone formulations post low shear turbula blending at 22 RPM in a polypropylene 
container 
It was observed that the static charge decay rates of the 2% w/w budesonide 
formulation were significantly greater in all cases than for the fluticasone formulations 








The JCI Chilworth 155v6 Charge Decay Time Analyser is a useful tool for ranking the 
electrostatic charging propensity of powder blends and assessing the rate of charge 
decay as a function of time. If the corona discharge is kept at a constant value, the 
initial potential difference generated on the powder surface will give an idea of the 
susceptibility of a powder to pick up static charge, with the greater the initial value, the 
greater the expected charging propensity. In addition, the charge decay rate as 
quantified by the Time to 10% and Time to 1/e values will indicate how long a powder 
will remain statically charged for after it has undergone a tribocharging event. Lactose 
monohydrate has a simple carbohydrate structure, is semiconducting in nature and for 
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Respitose® SV010 and ML001 it was shown that the charge decay rates were very 
rapid after the samples had become charged by the corona discharge. As such it is 
believed that the greater influence in determining the extent to which a DPI formulation 
remains charged after triboelectrification is the API which is normally more electrically 
resistive in nature. The initial surface potential of the DPI formulations increased 
linearly as a function of API concentration, however, an exponential correlation was 
observed between the API concentration and charge decay rate for blends above 0.4% 
w/w API. This has important implications as the use of this type of measurement would 
provide formulators with an understanding of exactly how long they would need to 
leave a DPI formulation to equilibrate for after a processing step to allow any charge 
present to dissipate. 
 
The effect of environmental relative humidity was investigated and it was found that 
humidity had a dramatic effect on the initial surface potential difference values and 
respective charge decay rates. For the 0.8% budesonide formulation, equivalent to a 
200μg commercial dose, the charge decay rate (Time to 10%) was in the order of 
seconds at 75% RH, minutes at 55% RH and several hours at 35% RH. The lactose 
and API samples were analysed using DVS and showed only minimal increases in 
mass as a function of humidity. Nevertheless, as humidity increases the amount of 
water adhered to the particles’ surfaces will also increase, decreasing the electrical 
resistivity which in turn decreased the initial surface potential differences and increases 
the charge decay rates. The environmental relative humidity will dramatically affect the 
extent to which a DPI formulation may become tribocharged during a processing step 
and also highlights that humidity control is vital when performing electrostatic 
measurements in order to ensure repeatable and reliable results. It was also found that 
the minimum level of API required to influence a DPI formulation’s bulk electrostatic 
properties could be determined experimentally as long as humidity control was 
maintained. 
The blending experiments performed illustrate the highly dependent nature of 
triboelectrification with relative humidity. Often in pharmaceutical company 
manufacturing environments humidity control is not employed as it is not a regulatory 
requirement. Therefore the extent to which triboelectrification may occur is variable and 
this could lead to handling and processing issues as well as variable formulation 
performance. The effect of container material was also shown to have a dramatic effect 
on the extent of triboelectrification, with the polypropylene vessel tribocharging the 
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blends to a much greater extent than the stainless steel vessel resulting in vast 
increases in the charge decay times. 
Future work could look to expand on the investigations described in this chapter by 
using the CDTA to determine whether the effect of variables such as particle size, 
morphology, chemical structure, surface area and surface energy have a role in 
contributing to the electrostatic charge decay properties of a DPI blend. A control set of 
formulations should be produced such as either fluticasone propionate in ML001 or 
budesonide in SV010 so that a direct comparison can be made between the two sets of 
charge decay data generated for this experiment. In addition, as it is believed that APIs 
are the prime suspects in cases of static charge related processing issues, 
unformulated APIs could be tested under controlled humidity conditions to characterise 
their electrostatic properties. If a new API target is developed then measurements 
could be taken and compared with historical data to indicate the risk of the API being 
particularly susceptible to becoming tribocharged. By controlling factors such as the 
surface area through API particle processing, the risk of triboelectrification could be 


















Chapter 5   Measuring the bipolar charge distribution of 





It is well known that upon aerosolisation of either a DPI pMDI formulation both excipient 
and drug particles present in the formulation are highly susceptible to becoming 
electrostatically charged via the mechanism of triboelectrification (Bennett et al. 1999, 
Watanabe et al. 2007). Pressurised metered dose inhalers (pMDIs) typically consist of 
a canister containing a solution or suspension of solid active pharmaceutical ingredient 
(API) drug particles within a pressurised propellant (for example HFA 134a) sometimes 
in the presence of other excipients such as surfactants. The canister is incorporated 
with a metering chamber and valve which allows the correct dose of API to be 
delivered with each actuation of the inhaler. Prior to actuation, the API particles are in 
contact with the walls of the metering chamber, the valve, valve seals, spring and stem 
(James et al. 2009). Upon actuation, the API particles become aerosolised and enter a 
highly kinetically energetic state, undergoing numerous collisions with each other and 
with the components of the inhaler. During these collisions electron transfer may occur 
to or from the API particles via the mechanism of triboelectrification causing the 
creation of highly charged species (Kwetkus 1998). Due to the multi-component nature 
of the system, the precise mechanisms remain relatively poorly understood, although it 
has been hypothesised that charge transfer occurs as a result of differences in the 
electrical properties of the materials involved. The canister and spring are metal 
whereas the valve, valve seals, stem are insulators. The API particles which are 
electrically resistive may come into contact with each surface and charge transfer may 
occur at each point of contact. The amount of charge transferred between the API 
particles and the various device components depends on the difference between the 
effective work functions of the two materials coming into contact, which is a measure of 
how much energy is required to remove an electron from the Fermi level of the material 
to the vacuum energy level. Charge transfer ceases when the Fermi levels of the two 





Researchers have discussed the effects of electrostatic charge build up on aerosol 
particles on the efficiency of deep lung airway deposition and consequent therapeutic 
effect. Wilson theorised that aerosol particles with the same polarity will mutually repel 
and thus expand, enhancing deposition within an enclosed environment (Wilson 1947). 
Melandri et al. performed an in vivo study in humans which showed that increasing 
electrostatic charge (either positive or negative) increased the deposition of aerosol 
particles in deep lung (Melandri et al. 1983). More recently, Bailey et al. developed a 
mathematical model to describe charged particle deposition in the lung in relation to 
complimentary clinical studies showing that particle size, charge and breathing 
conditions are key to targeting specific regions of the lung for drug delivery (Bailey 
1997). Further to this work, several authors have looked at the effect of electrostatic 
charge on spacer devices in combination with pMDIs, where interactions between 
electrostatic charge of the aerosol particles and the inner spacer walls has been shown 
to have a marked effect on the performance. For example, Kenyon et al. showed that in 
an in vivo study with a glucocorticosteroid pMDI, gamma scintagraphy images 
indicated the presence of static charge on the walls of the spacer reduced the in vivo 
deposition of the therapeutic dose (Kenyon et al. 1998). Glover and Chan (2004) used 
the electrical low pressure impactor (ELPI) to measure the net charge of both 
Flixotide™ and Ventolin™ pMDIs (Glover and Chan 2004a). For Flixotide™, they found 
that at higher particle cut off diameter, an overall net negative charge was recorded. At 
lower particle cut off diameter, an overall net positive charge was recorded. When 
plotted against the mass of deposition of the FP particles, at the lower cut off 
diameters, almost no FP was deposited, but a large net positive charge was recorded. 
This may be due to the presence of water which forms ice crystals during the actuation 
of the pMDI. With Kwok, they expanded their study to include Intal, Tilade and QVAR™ 
pMDIs together with Flixotide™ and Ventolin™ (Kwok et al. 2005). 
Various attempts have been made to accurately quantify the charge build up on 
aerosol particles in proportion to their mass and surface area. The first widely available 
commercial method developed was the ELPI (electrical low pressure impactor) in which 
an Andersen cascade type impactor was modified such that the impaction plates are 
electrically isolated and connected to electrometers allowing for simultaneous net 
charge measurements and mass quantifications to be performed (Marjamaki et al. 
2000). The idea was taken further with the development of the Electrical Next 
Generation Impactor (eNGI) (Hoe et al. 2009c) in which the impaction cups of a 
conventional NGI are connected to an electrometer in a similar way as the ELPI and 
the net charge to mass ratios of aerosol particles are determined. These two systems 
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also allow the mass of the aerosol particles to be quantified but both do not take into 
account the bipolar nature of the aerosol particles and only provide a measurement of 
the net of the negative and positive charges. Alternatively, by using the principals of 
electrostatic precipitation, systems such as those developed by O’Leary et al. and 
Kulon et al. (Kulon and Balachandran 2001, O'Leary et al. 2008) allow the bipolar 
charge ratios of aerosol particles to be measured. However, these systems are not 
ideally suitable for performing accurate quantification of the deposited aerosol particles 
and as such do not provide the complete picture in terms of measurement of bipolar 
charge to mass ratios. Ali et al. utilised an electrical single particle aerodynamic 
relaxation time (ESPART) analyser to determine electrodynamic effects of some 
sample DPI and pMDI formulations (Ali et al. 2009a). Although the system provides 
measurements of bipolar charge to mass ratio, only single particle measurements may 
be recorded and not the entire deposited aerosol dose per shot.  
To further the understanding of pMDI inhalation aerosol electrostatics, the author 
presents a novel apparatus for performing bipolar charge measurements and 
quantifications of aerosol particles – the Bipolar Next Generation Impactor (bp-NGI) 
which has been successfully used to characterise the bipolar charge to mass 
distributions of Flixotide™ 250, Serevent™ 25 and Seretide™ 250 pMDIs. 
The bp-NGI as described in the materials and methods section consists of a modified 
Next Generation Impactor which is an industry standard aerosol particle size classifier 
used to determine the in vitro performance of inhalable drug products (Marple et al. 
2003b). An electrostatic precipitation system is connected to a preselected stage of the 
NGI to allow measurement of the charge to mass ratio of the aerosol particles from the 
selected stage and below. As opposed to conventional net charge measurement 
systems, which measure the sum of the positive and negative charges present (which 
cancel) (Saini et al. 2008), the system is able to accurately separate the aerosol 









5.2 Materials and methods 
5.2.1 Materials 
 
Flixotide™ 250, Serevent™ 25, Seretide™ 250/25 Evohalers are suspension based 
pressurised metered dose inhaler (pMDI) formulations delivering 250µg of fluticasone 
propionate (FP), 25µg salmeterol xinafaote (SX) and a combination of 250µg FP and 
25µg SX per actuation, respectively. These formulations contained the drug(s) 
suspended in HFA134a propellant and were manufactured by GlaxoSmithKline (Ware, 
UK). Commercial samples of the pMDIs were supplied by AAH Pharmaceuticals Ltd. 
(Coventry, UK). Fluticasone propionate was supplied by Chemagis Ltd (Bnei Brak, 
Israel) and salmeterol xinafoate supplied by Neutech Laboratories (Hyderabad, India). 
All solvents used were of HPLC grade (Sigma-Aldrich, St. Louis, MO, USA). Ultra pure 
water was produced by reverse osmosis (MilliQ, Millipore, Molsheim, France). 




5.2.2.1 Particle size 
 
Particle size measurements were conducted using a Helos laser diffraction unit in 
conjunction with Windox 5 software, both from Sympatec GmbH (Clausthal-Zellerfield, 
Germany). The particle size distributions of the drugs were measured using the R3 lens 
and the cuvette wet dispersion system. Prior to each measurement, a background 
reading of the dispersant, cyclohexane and 0.1% lecithin was recorded. Each pMDI 
was actuated into the cuvette, and more dispersant was added. The cuvette was then 
sonicated for five minutes in five, one minute intervals in order to produce an optical 
concentration of between 5 and 10%. The stir speed using the magnetic flea was set to 
1500 RPM. Five repeat measurements of five seconds duration were recorded for each 
sample. 
 
5.2.2.2 Experimental setup of the bp-NGI 
 
A schematic representation of the bp-NGI for measuring bipolar charge distributions of 
pMDI particles is shown in Figure 5.1 incorporating two electrostatic precipitators for 
the collection of charged aerosols below a well-defined cut-off diameter of an NGI 
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stage. The precipitation section can be attached to the majority of the stages of an NGI 
(stage 2 through to stage 7) allowing charge to mass ratios of aerosol particles from the 
selected stage and all the stages below to be determined. 
 
 
Figure 5.1 Experimental set up of bp-NGI 
In this study, the electrostatic precipitators were attached to stage 2 of the NGI, with a 
cut-off diameter of 6.40µm at a flow rate of 30 L/min. The flow rate was controlled by a 
TPK (Copley Instruments, Nottingham, UK) attached to a vacuum pump which was 
connected to the base of the electrostatic precipitators. Below the collection cup of 
stage 2, the aerosol dose is bifurcated into the two precipitators with an airflow rate of 
15 L/min through each section. Each section contains an earthed outer tube, to create 
a Faraday shield, a precipitation tube, a filter holder and a high voltage electrode, 
which is centrally positioned within the precipitation tube. 
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The bp-NGI was designed to maintain laminar flow through the precipitators. The 
critical dimensions of the two electrostatic precipitators were designed to maximise the 
collection efficiency (Kprecip) of the electrically mobile aerosol particles by adapting a 
methodology used by Kulon et al. (Kulon et al. 2001). The collection efficiency was 
determined using Equation 4.2. 
 





𝑣𝑜 ln(𝑟2 𝑟1⁄ )
 × 100                  Equation 4.2 
Where 𝑍𝑝 is the electrical mobility of the charged aerosol particle, V is the voltage on 
the central electrode, L is the length of the electrode, 𝑣𝑜 is the airflow rate, 𝑟1 is the 
radius of the electrode and 𝑟2 is the radius of the precipitation tube. 
The theoretical collection efficiencies of the bp-NGI at ±3.0 kV are shown in Figure 5.2 
for aerosol particles exhibiting 100, 200 and 300 electrons of charge at the cut-off 
diameters of the NGI stages at 30 L/min. The graph shows that particles with a 
diameter of 6.40μm and below will be reasonably efficiently collected at ±3.0 kV, with a 
near maximum collection efficiency occurring when a particle gains a negative or 
positive charge equivalent to 200 electrons per particle. 
 
Figure 5.2 Theoretical collections efficiencies (K(precip) (%)) for the bp-NGI as a function of 




5.2.2.3 Methodology for performing bipolar charge to mass ratio measurements of 
pMDI drug particles using the bp-NGI 
 
Opposite polarity high DC voltage sources (Spellman, CZE1000R, West Sussex, UK) 
were applied to the electrically insulated copper electrodes, centrally located in the 
respective precipitators. During operation, the electric field created by the negative 
electrode repels the negatively charged aerosol particles onto the negative precipitation 
tube, while the positively charged aerosol particles are attracted onto the electrode. 
Conversely, negatively charged aerosol particles in the oppositely charged precipitator 
are deposited onto the positive electrode while the positively charge aerosols are 
repelled onto the positive precipitation tube. Aerosol particles with low electrical 
mobility, which cannot be precipitated onto either the electrodes or the precipitation 
tubes are collected onto 0.45μm glass fibre filters (Whatman, Fisher Scientific, UK), 
housed at the base of each precipitation tube. The system is modular, such that each 
section of the apparatus can be isolated and separately washed down for drug 
quantification via HPLC. The amount of drug collected on the negative precipitation 
tube and positive electrode indicates the quantity of drug particles that have sufficient 
negative electrical mobility to be precipitated within the two precipitators. The quantity 
of drug collected on the positive precipitation tube and negative electrode indicates the 
quantity of drug particles that are positively charged. The mass of drug collected from 
the respective filters represent the amount of aerosol dose which has insufficient 
positive or negative electrical mobility to be precipitated. 
The precipitation tubes are connected via BNC adapters to a Keithley Instruments 6521 
multi-input scanner card (Keithley Instruments, Reading, UK) connected to a Keithley 
6517B electrometer for charge measurements. During each actuation of the inhaler 
device into the bp-NGI, the current versus time profiles during aerosol deposition onto 
the two precipitation tubes are recorded and subsequently integrated to measure the 
positive and negative charge collected per shot. The cumulative amount of positive and 
negative charge for a well-defined number of shots is also measured. These values are 
divided by the total mass of drug collected within the positive and negative precipitation 
tubes to determine the net charge to mass ratio of the negatively and positively 
charged aerosols.  During the experiments, the operator is connected to earth via a 
wrist band and the outer tubes surrounding the electrostatic precipitators are earthed to 
shield the precipitation tubes from stray external fields. 
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A total of five shots of Flixotide™ 250, Seretide™ 250 and Serevent™ 25 were each 
fired through the bp-NGI. The mass of the negatively, positively and neutrally charged 
particles was quantified via HPLC to calculate the bipolar charge to mass distribution 
within the bp-NGI. The experiments were performed in triplicate for statistical 
robustness. The temperature range for all experiments was 20°C ± 1 and the humidity 
range was 40% ± 2. The flow rate through the bp-NGI was set to 30 L/min with 15 
L/min being pulled through each precipitator as a result of the bifurcation. The voltage 
applied to the negative electrode was -3.0 kV and the positive electrode was +3.0 kV. 
 
 
5.2.2.4 HPLC Analysis 
 
Determination of the mass distribution of fluticasone propionate (FP) and salmeterol 
xinafoate (SX) within the bp-NGI was adapted from a previously published HPLC 
method (Murnane et al. 2006). The HPLC system consisted of a pump (Jasco PU-980, 
Jasco Corp., Japan) coupled to an autosampler (Jasco AS-950) and UV detector 
(Jasco UV-975) set at 228nm for simultaneous determination of both APIs. Separation 
was performed using a BDS Hypersil Column, 250x4mm (Thermo Scientific, Waltham, 
MA, USA) maintained at 40⁰C using a column oven (Jasco CO-965). The mobile phase 
was a mixture of methanol–0.6% (w/v) aqueous ammonium acetate solution (75:25%, 
v/v), filtered through a 0.45μm nylon membrane (Whatman International Ltd., 
Maidstone, UK) and degassed. The retention time for salmeterol was 4.4 minutes and 
for fluticasone propionate was 5.4 minutes. Quantification was carried out by an 
external standard method and linearity was checked between 0.5 and 50 μg/mL for 
each individual API.  
 
5.2.2.5 Statistical analysis 
 
Linear regression analysis was used for the assessment of HPLC calibration. Statistical 
analysis between different populations was carried out using one-way analysis of 
variance. Comparison of the mean values was performed by Tukey’s pair-wise 
comparison. All statistical analyses were performed using GraphPad Prism software 
(GraphPad Software Inc, California, USA). Error bars in graphical representations of 




5.3 Results and discussion 
5.3.1 Particle size 
 
The log density distributions of the particle sizes of A, Flixotide™ 250, B, Serevent™ 
25 and C, Seretide™ 250 are displayed in Figure 5.3. The average (n=5) of the 10% 
undersize (d10), 50% undersize (d50) and 90% undersize (d90) values were recorded as 
well as the percentage of particles with diameter less than 5 μm and these data are 








Figure 5.3 Log density distributions of the particle size of A, Flixotide™ 250, B, 
Serevent™ 25 and C, Seretide™ 250. 
 
 
    d10 (μm)      d50 (μm) d90 (μm) % < 5 μm 
Flixotide™ 250 0.72 ± 0.01 1.73 ± 0.01 3.70 ± 0.01 94.68 ± 0.09 
Serevent™ 25 0.72 ± 0.00 1.79 ± 0.02 4.04 ± 0.03 93.06 ± 0.20 
Seretide™ 250 0.74 ± 0.00 1.78 ± 0.02 3.55 ± 0.01 96.98 ± 0.04 
 
Table 5.1 Average (n=5, mean ± S.D.) of the 10% undersize (d10), 50% undersize (d50) and 
90% undersize (d90) values and % < 5 μm of each pMDI 
 
The results show that each pMDI contained micronized API particles with all three 
exhibiting a percentage less than 5 μm of greater than 93%. This ensures that the 
majority of API particles in each pMDI have the required diameter in order to reach the 
bronchioles in the lung which are the desired therapeutic target area. The electrostatic 
precipitation sections of the bp-NGI were connected to stage 2 of the NGI with a 
particle cut off diameter of 6.40μm. Therefore the majority of the FPF was expected to 
enter the electrostatic precipitation sections of the bp-NGI. 
The bipolar charge nature of aerosol particles from commercial Flixotide™ 250, 
Serevent™ 25 and Seretide™ 250 pressurised metered dose inhalers were measured 




electrostatic precipitators and the bipolar charge measurements of the APIs were 
measured at 0 V and ±3 kV. These measurements were used to calculate the charge 
to mass ratio of both the negatively and positively charge aerosols for each inhaler. 
 
5.3.2 Bipolar Charge to Mass Ratio Determination of Flixotide™ 250 
 
The mass deposition profile of FP from a commercial Flixotide™ 250 pMDI on the 
various sections of a bp-NGI at 0 V and ±3 kV are shown in Figures 5.4 A and B, 
respectively, and summarised in Table 5.2. These data are expressed in terms of the 
mean quantity of drug deposited on each of the precipitation tubes, electrodes and 
filters and the relative percentage of the total amount of drug entering each 
precipitation section. When no voltage is applied to the central electrodes of the bp-
NGI, over 95% of the particles were recovered from the filters. The minimal deposition 
of FP on the electrodes and precipitation tubes at 0V suggested that a laminar flow was 
maintained within each section. At 0V, there was no significant difference (p > 0.05) in 
the quantities of FP entering each precipitation section of the bp-NGI (150.0 ± 10.7 μg 







Figure 5.4 Percentage mass of FP particles deposited within the within the bp-NGI from 5 































































































































































Table 5.2 Mass and Percentage mass of FP particles deposited within the bp-NGI from 5 
shots of Flixotide™ 250 (n=3, mean ± SD) at A, 0 Volts and B ±3000 Volts 
 
Upon applying -3 kV and +3 kV to the central electrodes of the two precipitators, similar 
quantities of FP were recovered although only a relatively small percentage of the dose 




negative and positive filters at ± 3.0 kV was 13.0 ± 1.2% and 11.6 ± 1.6%, respectively.  
For the positive precipitator section (+3.0 kV), 64.7 ± 1.4% of the mass collected was 
recovered on the central electrode, with 23.8 ± 1.7% of the aerosols precipitating on 
the positive precipitation tube. For the negative precipitator section (-3.0 kV), 25.0 ± 
3.2% of the mass was collected on the central electrode, with 62.0 ± 2.3% on the 
negative precipitation tube.  The mass ratios of the negatively to positively charged 
particles on the positive and negative sections of the bp-NGI were an average of 2.6:1. 
These data suggest that FP particles undergo sufficient triboelectrification upon 
aerosolisation to be electrostatically precipitated and that the FP aerosols exhibit a 
bipolar charge distribution with the greater amount of sub 6.40 μm particles being 
negatively charged.   
The charge measurements from the precipitation tubes of the two sections (labelled 
negative and positive) at 0V are shown in Figure 5.5 A and the corresponding charge 
measurements from the precipitated particles on the outer tube of the negatively and 






Figure 5.5 Charge measurements of FP particles deposited within the bp-NGI from 5 
shots of Flixotide™ 250 (n=3, mean ± SD) at A, 0 Volts and B ±3000 Volts 
 
Measuring in current versus time mode at 0V, each precipitation section measures the 
overall net charge of the small fraction of the aerosol dose that was collected on the 
tube surface for each actuation. Both sections exhibited a net positive charge (average 
+0.04 ± 0.003 nC), which is in agreement with the research findings of Peart et al., that 
showed unlike the majority of marketed pMDI products, GSK’s US FP pMDI product 
(Flovent®) consistently produced a net positively charged aerosol cloud for the fine 
particle dose (Peart et al. 2003). Conversely, Hoe et al., who used an electrical Next 
Generation Impactor (eNGI) to measure the net charge of Flixotide™ and Seretide™ 
on individual stages at three different flow rates, found that the net charge to mass 
ratios for particles of FP and Salmeterol were slightly negative and close to zero pC/μg 
(Hoe 2009). Kwok et al. used a Faraday Well and also the ELPI to measure the net 
charge to mass ratios of a range of pMDIs including Flixotide [4]. For Flixotide, the 
overall net charge of the entire dose as measured with the Faraday well was found to 
be positive whereas on the ELPI stages, the FP particles were found to have net 
charges which were predominantly negative. 
Upon applying a -3.0 kV and +3.0 kV DC voltage to the respective negative and 




was recorded as -0.36 ± 0.01 nC, and the mean charge of the positively charged FP 
particles per shot was +0.43 ± 0.01 nC. The polarity of the mean net charge of the fine 
particle cloud per shot was electropositive and calculated to be +0.07 ± 0.01 nC. The 
net charge data for the aerosol dose below ≤ 6.4 μm at both 0 V and ± 3.0 kV are in 
good agreement with previous findings. 
The bipolar charge to mass (Q/m) ratios of Flixotide™ 250 are shown in Figure 5.6. 
The charge to mass ratios of the negatively and positively charged particles was -18.0 
± 2.8 pC/μg and +68.8 ± 5.6 pC/μg respectively. These data indicate that although 
there were fewer positively charged particles, their charge per unit mass was 
significantly larger in magnitude than the negatively charged particles. The net charge 
to mass ratio is not a sum of the negative and positive charge to mass ratios as the 
quantity of negatively and positively charged particles is different. Instead, the net 
charge to mass ratio is calculated by dividing the total net charge as sum of the 
average negative and positive charges per shot by the total mass of the negatively and 
positively charged particles collected on each precipitation tube combined per shot. 
The overall net charge to mass ratio was much lower in magnitude (-0.9 ± 7.2 pC/μg) 
than the bipolar charge to mass ratios, and provides less detail of the electrostatic 
behaviour of the aerosol cloud emitted by the pMDI. 
 
Figure 5.6 Bipolar charge to mass ratios of FP particles from 5 shots of Flixotide™ 250 




5.3.3 Bipolar Charge to Mass Ratio Determination of Serevent™ 25 
 
The mass deposition profile of SX from a commercial Serevent™ 25 pMDI on the 
various sections of a bp-NGI at 0 V and ±3.0 kV are shown in Figures 5.7 A and 5.7 B, 
respectively and the data tabulated in Table 5.3.  At 0 V, over 88% of the particles were 
collected on the filters, with no significant differences in the quantities entering each 




Figure 5.7 Percentage mass of SX particles deposited within the within the bp-NGI from 5 




























































































































































Table 5.3 Mass and Percentage mass of SX particles deposited within the bp-NGI from 5 
shots of Serevent™ 25 (n=3, mean ± SD) at A, 0 Volts and B ±3000 Volts 
 
Applying a ±3.0 kV potential to the central electrodes significantly reduced the 
deposition of SX on the filters (p > 0.05). The percentage of low electrical mobility 
particles recovered from the filters dropped to below 14%. For both precipitators, there 
was a significantly greater recovery of positively charged SX particles than negatively 
charged SX particles. The mass ratio of positively charged to negatively charged 
particles in both precipitators was approximately 3:1. These findings are in contrast to 
the Flixotide™ 250 data, which showed the opposite trend.      
The charge measurements from the outer precipitation tubes for the charged 
salmeterol particles for five consecutive shots at 0 V and ±3.0 kV is shown in Figures 
5.8 A and 5.8 B, respectively. With no voltage applied, measurements indicated that 
the net charge of SX particles were low and slightly electropositive for both 





Figure 5.8 Charge measurements of SX particles deposited within the bp-NGI from 5 
shots of Serevent™ 25 (n=3, mean ± SD) at A, 0 Volts and B ±3000 Volts. 
Upon applying a -3.0 kV and +3.0 kV DC voltage to the respective negative and 
positive electrodes, there was no significant differences in the mean charge per shot of 





The charge to mass ratios of the negatively and positively charged particles as shown 
in Figure 5.9 were -106.2 ± 23.4 pC/μg and +43.7 ± 3.3 pC/μg, respectively. These 
data indicate that while there were fewer negatively charged particles, their charge was 
significantly larger in magnitude than the positively charged particles which is in 
reverse to the trend observed for FP in Flixotide. The overall net charge to mass ratio 




Figure 5.9 Bipolar charge to mass ratios of SX particles from 5 shots of Serevent™ 25 
(n=3, mean ± SD) 
 
5.3.4 Bipolar Charge to Mass Ratio Determination of Seretide™ 250 
 
The mass deposition profile of FP and salmeterol from a commercial Seretide™ 250 
pMDI on the various sections of a bp-NGI at 0 V and ±3 kV are shown in Figures 5.10 
A-D respectively, and summarised in Tables 5.4 and 5.5. 
These data show that at 0V, as shown in the other formulations, the majority of the FP 
and SX particles are collected on the filters, with over 85% of the recovered dose in 
both precipitators. Upon applying a high voltage (±3.0 kV), similar quantities of FP and 
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SX were recovered from each precipitation section of the bp-NGI, indicating efficient 
bifurcation of the fine particle cloud within the system. The mass ratio of negatively to 
positively charged particles of precipitated FP is 2.6:1 which is similar to that obtained 




Figure 5.10 Percentage mass of FP particles deposited within the within the bp-NGI from 
5 shots of Seretide™ 250 at A, 0 Volts and B ±3000 Volts and percentage mass of SX 






































































































































































Table 5.4 Mass and Percentage mass of FP particles deposited within the bp-NGI from 5 































































































































































Table 5.5 Mass and Percentage mass of SX particles deposited within the bp-NGI from 5 





The mass ratio of negatively to positively charged of precipitated SX particles is 1.7:1. 
This is opposite to the trend in the Serevent data set, which indicated the mass ratio of 
negatively to positively charged SX particles to be 0.6:1. These data suggest that the 
presence of a relatively high dose of FP compared to SX may have a significant impact 
on the mass deposition profile of SX within an electrostatic precipitator. The different 
deposition profile of SX particles may suggest that SX may form agglomerates with FP 
and therefore altering its response to an electric field. Agglomerate formation of FP and 
SX has previously been reported for Seretide pMDI formulation by (GSK) Raman 
spectroscopy. As was seen in Flixotide and Seretide, the FP particles show a greater 
propensity to become more negatively charged than positive, thus in Seretide, there is 
the potential to form aggregates between negatively charged FP particles and 
positively charged salmeterol particles via Coulombic attractive forces. The presence of 
FP-SX agglomerates in Seretide has recently been confirmed by Rogueda et al. who 
tested the in vitro performance of Seretide with an Andersen Cascade Impactor (ACI) 
and subsequently used Raman Spectroscopy and AFM imaging to map the distribution 
of FP and SX on the impaction plates (Rogueda et al. 2011).  If, for example, an 
aggregate is formed with one salmeterol particle of +1 arbitrary charge unit and two FP 
particles with -1 arbitrary charge units or one salmeterol particle of +1 arbitrary charge 
units and one FP particle of -2 arbitrary charge units, the overall net charge of the 
aggregate will be -1 arbitrary charge units and so the whole aggregate, including the 
positively charge salmeterol particle will be deposited onto the negative precipitation 
tube. The formation of a large number of these kinds of aggregates will result in the 
salmeterol particles appearing to be negatively charged when it is in fact the overall 
negative charge of the FP-salmeterol aggregates which may cause the behaviour 
observed. 
The charge measurements of FP and SX per shot recorded at 0V and ±3.0kV are 
shown in Figures 5.11 A and 5.11 B respectively. At 0V, the net charge measurement 
in each precipitation was low and positive. At ±3.0 kV, the average charge measured 
per shot for the negative and positive precipitators were 0.37 ± 0.006 nC and +0.47 ± 
0.010 nC, respectively, with an average net charge per shot of +0.10 ± 0.010 nC. 
These results are similar to that observed for Flixotide™, with the fine particle dose 
being overall electropositive in nature indicating that the overall bipolar charge to mass 
values of Seretide™ are dominated by the FP particles which are in large excess with a 






Figure 5.11 Charge measurements of FP and SX particles deposited within the bp-NGI 
from 5 shots of Seretide™ 250 (n=3, mean ± SD) at A, 0 Volts and B ±3000 Volts. 
The bipolar charge to mass ratios of Seretide™ 250 are shown in Figure 5.12. The 
charge to mass ratios of the negatively and positively charged particles were -11.5 ± 
0.5 pC/μg and +42.8 ± 4.6 pC/μg respectively. These data indicate that although there 
were more negatively charged particles, the charge per unit mass was larger for the 





Flixotide™. The overall net charge to mass ratio was again much lower in magnitude 
(+2.6 ± 0.4pC/μg) than the bipolar charge to mass ratios. These findings suggest that 




Figure 5.12 Bipolar charge to mass ratios of FP and SX particles from 5 shots of 
Seretide™ 250 (n=3, mean ± SD). 
 
A summary of the percentage mass distributions recorded by the negative precipitation 
section of the bp-NGI of the various drug particles from each pMDI are shown in Table 
5.6. For FP, the results for Flixotide 250™ and Seretide 250™ are very similar showing 
62.0 ± 2.3% and 61.2 ± 4.5% for the percentage of negatively charged particles, 25.0 ± 
3.2% and 24.8 ± 2.7% for the positively charged particles and 13.0 ± 1.2% and 14.1 ± 
1.98% for the uncharged particles respectively. This indicates that the presence of 
salmeterol in Seretide has little effect on the electrostatic properties of FP within a 
pMDI. For salmeterol, the results for Seretide 250™ and Serevent 25™ are very 
different. Values of 52.8 ± 2.7% and 20.1 ± 2.3% for the percentage of negatively 
charged particles, 30.1 ± 2.2% and 65.7 ± 6.9% for the positively charged particles and 
17.2 ± 2.9% and 14.2 ± 1.0% for the uncharged particles were recorded respectively. In 
the mono dose Serevent 25™, the Salmeterol particles show a propensity to become 
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more positively charged than negatively charged however, in Seretide 250™ the 
reverse trend is observed.  
 







































Table 5.6 Summary of the mass deposition of negatively, positively and uncharged 
particles from each pMDI (n=3, mean ± SD) 
 
A summary of the average negative, positive and net charge per shot of drug particles 
from each pMDI at ±3 kV is shown in Table 5.7. These data show that the values for 
the charge recorded for Flixotide™ 250 and Seretide™ 250 were very similar (-0.36 ± 
0.01 nC and -0.37 ± 0.01 nC for the negatively charged particles, +0.43 ± 0.01 nC and 
+0.47 ± 0.010 nC for the positively charged particles and 0.07 ± 0.01 nC and +0.10 ± 
0.01 nC for the net charge of the particles). This shows that the addition of the small 
dose of salmeterol in Seretide does not overly affect the values of the charge 
measurements recorded, presumably as the dose of salmeterol is only 10% of that of 
the dose of FP. The values for the charge recorded for Serevent ™ 25 are, however, 
appreciable (-0.22 ± 0.01 nC for the negatively charged particles, +0.21 ± 0.01 nC for 
the positively charged particles and -0.003 ± 0.004 nC for the net charge of the 
particles). The absence of FP in Serevent™ 25 results in different charging 
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This study demonstrates that more negatively charged particles were produced than 
positively charged from both Flixotide™ and Seretide™ in terms of mass deposited, 
although the charge to mass ratios of the positively charged particles were larger in 
magnitude than the negatively charged. In the case of Serevent, the SX particles 
showed a propensity to become more positively charged than negatively charged, 
however, the charge to mass ratios of the negatively charged particles were 
significantly larger in magnitude. The difference in behaviour between the SX particles 
in Serevent™ and Seretide™ may be attributed to the presence of FP-SX aggregates 
in Seretide™ which are not present in Serevent™. The results of the study illustrate 
that the bp-NGI is an effective tool to quantify the bipolar charge to mass ratios of 
respirable aerosol particles produced by the three commercially available pMDIs.  
Comparisons with data generated by Kwok et al. with the ELPI indicated that the 
positive charge values recorded may have been contributed to by the presence of ice 
crystals exiting the inhaler as the pMDI propellant evaporated (Kwok et al. 2008). A 
control experiment is suggested to characterise a propellant only pMDI formulation; 
values for the propellant bipolar charge could be subtracted from the overall bipolar 
charge in order to determine the contribution of the API to the charge values. 
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Unfortunately placebo pMDI canisters of Flixotide™, Serevent™ and Seretide™ are 
not commercially available and could not be analysed for this study.  
Further studies suggested include measuring the bipolar charge distributions of other 
pMDI formulations such as QVAR® and Ventolin® with the bp-NGI and comparing the 
bipolar charge to mass ratio values recorded with net charge to mass ratio values 
published in the literature. Other variables such as flow rate, dosage strength, humidity 
and the type and colour of the polymer used to disperse a pMDI could also be 
investigated as well as the addition of a spacer device. The bipolar charge of only the 
combined fine particle fraction from the bp-NGI from stages 2 and below of the NGI 
were collected, additional experiments could also be performed to connect the 
electrostatic precipitation system to the other stages in order to build up a more 
accurate picture of the relationship between aerosol particle charge and aerodynamic 




















Chapter 6    The effect of relative humidity on the electrostatic 




DPI blends are manufactured using a number of steps which may induce electrostatic 
charge on the formulation including sieving and blending (Engers et al. 2006). It has 
been suggested that the static charge decay time of active pharmaceutical ingredients 
(APIs) in a DPI formulation may be long (Carter et al. 1998, Sharma et al. 2003), 
particularly when then initial charge generated on the particles is very large and that 
electrostatic charges introduced to the API particles during formulation may lead to 
changes in product performance (Elajnaf et al. 2007). The effect of storage relative 
humidity (RH) is also important as increased RH may result in lower initial quantities of 
charge building up on the DPI particles and also increase charge decay rate times 
(Kwok and Chan 2008b). However, if the humidity is too high, an adverse effect on 
performance may be observed with a drop in fine particle fraction and fine particle dose 
(Maggi et al. 1999, Voss and Finlay 2002). Young et al. showed a decrease in 
performance of a salbutamol sulphate DPI formulation at relative humidities above 60% 
(Young et al. 2007). The storage conditions may also affect the moisture content, 
crystallinity, polymorphism and chemical degradation of the API (Hickey and Martonen 
1993). Due to these complex factors, it is expected that both the manufacturing 
process and the storage conditions will affect the physical and chemical stability of the 
formulation (Telko and Hickey 2005) and also its electrostatic properties. As processes 
used during formulation of a DPI blend may generate electrostatic charge on the API 
particles, it would be useful to measure the initial bipolar charge on the aerosol 
particles generated by a DPI and at subsequent time points post blending to determine 
if indeed charge is present on the particles and whether this charge relaxes over time.    
 
 
This study is designed to determine the electrostatic properties and formulation 
performance of a laboratory scale, low shear, DPI blend of budesonide with 
Respitose® ML001, an inhalation grade lactose. Testing was performed with the bp-
NGI and with the conventional NGI in order to determine both the extent of 
triboelectrification of the respirable dose aerosol particles and the formulation 
performance as a function of storage relative humidity. Measurements of the dynamic 
charge of the device and capsule and net charge of the capsule were also performed 
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using the flow through Faraday pail as used by previous researchers (Murtomaa et al. 
2004, Chow et al. 2008, Karner and Urbanetz 2013) and Faraday pail respectively 
using experimental set up as described in Chapter 2. By recording the device, capsule 
and aerosol particle charge simultaneously a more complete picture of the nature of 
electrostatic charge build up during aerosolisation of a DPI formulation may be 
determined. 
 




Micronised budesonide and Aerolizer® devices were supplied by Novartis Pharma AG 
(Basel, Switzerland). Respitose® ML001 lactose was obtained from DFE Pharma 
Excipients (Veghel, The Netherlands). Size 3 HPMC capsules were sourced from 
Qualicaps (Madrid, Spain). Samples were stored in sealed humidity cabinets with a 
saturated salt solution of potassium carbonate at 43% RH (Fisher Bioreagents, NJ, 
USA) in an air conditioned room maintained at 20 ± 2 ⁰C. All solvents used were of 
HPLC grade (Sigma-Aldrich, St. Louis, MO, USA). Ultra-pure water was produced by 




6.2.2.1 Particle size 
 
Particle size measurements of ML001 were measured dispersed dry at a pressure of 2 
bars using a Sympatec Helos laser diffraction system with an R4 lens in conjunction 
with a RodosT4 disperser and a Vibri feeder controlled by WINDOX software 
(Sympatec Gmbh, Germany). Particle size measurements of micronised budesonide 
were measured dispersed wet using the cuvette dispersion system with 0.1% lecithin in 
cyclohexane as the dispersant. A small aliquot of budesonide was suspended in the 
dispersant, the suspension sonicated for five minutes at one minute intervals before 
five repeat measurements were recorded at an optical concentration of between 5 and 
10%. The values recorded for the d10, d50 and d90 were averaged as well as the 




6.2.2.2 Scanning electron microscopy 
 
Scanning electron microscopy (SEM) images of the lactose and budesonide samples 
were performed on a JEOL JSM-6480LV scanning electron microscope (JEOL, Tokyo, 
Japan). Samples were mounted on sticky carbon tabs and coated with an Edwards 
sputter coater S150B (Edwards, Israel) for 5 minutes prior to analysis. An acceleration 
voltage of 10 kilovolts was used for the imaging. 
 
 
6.2.2.3 Preparation of the budesonide DPI formulation 
 
The budesonide DPI formulation was prepared using a small scale laboratory method 
to make a total batch size of 80 grams. 10% of the required lactose was passed 
through a 250 μm mesh sieve, followed by the budesonide, followed by another 10% of 
the lactose in order to break up any large agglomerates. This sandwich was then 
preblended in a grade 316 stainless steel vessel using a WAB type T2F turbula blender 
(WAB, Nidderau-Heldenbergen, Germany) at 22 RPM for 20 minutes. Half of the 
remaining lactose required was passed through the 250 μm mesh sieve, followed by 
the preblend, followed by the remaining lactose. The formulation was then blended for 
a further 20 minutes at 22 RPM. Size three HPMC capsules were hand filled with the 
formulation using a five place analytical balance to obtain a capsule fill weight of 25 ± 
0.1 mg. Capsules were transferred to a sealed storage cabinet maintained at 43% RH 
with a saturated solution of potassium carbonate and were stored at this humidity for a 
minimum of 72 hours prior to testing. 
 
 
6.2.2.4 In vitro aerodynamic performance determination 
 
The in vitro performance of the formulation was determined using the Next Generation 
Impactor (NGI) (Copley Scientific, Nottingham, UK). The Aerolizer® device was used 
for aerosolising the formulation into the NGI equipped with a pre-separator. The flow 
rate of air was set to 90 L/min for 2.7 seconds as controlled by a TPK critical flow 
controller (also Copley Scientific). A total of five capsules were used per test. The 
diluent used for recovery of the API was a degassed mixture of MeOH : Acetonitrile : 
Water 55:35:20 (v/v/v). The limit of detection for budesonide was determined to be 0.01 
μg/mL and the response was linear between concentrations of 0.01 and 50 μg/mL. The 
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NGI was kept within the relative humidity cabinet throughout the testing and the relative 
humidity was maintained at 55%. 
 
 
6.2.2.5 Bipolar charge to mass ratio measurements 
 
The bipolar charge to mass ratios of the formulation were determined using the bipolar 
Next Generation Impactor (bp-NGI). The Aerolizer® device was used for aerosolising 
the formulation into the bp-NGI equipped with a pre-separator. The flow rate of air was 
set to 90 L/min for 2.7 seconds as controlled by a TPK critical flow controller (Copley 
Scientific, Nottingham, UK). The diluents used for the recovery of lactose and the API 
was a mixture of ACN and deionised H2O (75:25% v/v). A total of five capsules were 
used for each test and testing for each condition was performed in triplicate. The Next 
Generator Impactor section of the bp-NGI was retained inside the Climatezone relative 
humidity cabinet to ensure humidity control of the environment was maintained. The 
voltage applied to the negative electrode was -3000V and the positive electrode was 
+3000V. The flow rate of the NGI was set to 90 L/min with 45 L/min pulled through 
each precipitator as a result of the bifurcation. Laminar flow was maintained through 
the system with a Reynold’s number of 1413 through each precipitator. 
 
6.2.2.6 HPLC analysis of budesonide 
 
Determination of the mass distribution of budesonide from the NGI and bp-NGI was 
determined using reverse phase high performance liquid chromatography (RP-HPLC). 
The HPLC system consisted of a pump (Jasco PU-980, Jasco Corp., Japan) coupled to 
an autosampler (Jasco AS-950). A UV detector (Jasco UV-975) set at 260 nm was 
used for the determination of budesonide. Separation was performed using an ODS 
Hypersil Column, 200x4mm (Thermo Scientific, Waltham, MA, USA) maintained at 
40⁰C and the retention time for budesonide was 2.0 minutes. The mobile phase was a 
degassed mixture of MeOH : Acetonitrile : Water 55:35:20 (v/v/v). The retention time 
for budesonide was 4.1 minutes. Quantification was carried out by an external standard 
method and linearity was checked between 0.5 and 50 μg/mL. The limit of detection for 
budesonide was determined to be 0.01 μg/mL and the response was linear between 




6.2.2.7 HPLC analysis of lactose 
 
Lactose does not possess a UV active chromophore and so an evaporative light 
scattering detector (ELS 1000, Polymer Labs, Church Stretton, Shropshire, UK) was 
employed. Separation was performed using an APS-2 Hypersil Column, 100x3mm 
(Thermo Scientific, Waltham, MA, USA) maintained at 30⁰C and the retention time for 
lactose was 1.37 minutes. The mobile phase consisted of 75 : 25 acetonitrile to 
deionised water and the injection volume was 100 µl. The nebuliser temperature of the 
ELS detector was set to 60⁰C and the evaporation temperature to 110⁰C. The flow rate 
was 1.0 ml/min and the gas flow rate was set to 1.5. Quantification was carried out by 
an external standard method and linearity was checked between 0.5 and 50 μg/mL. 
The plot of peak area against concentration was found to follow a quadratic function as 
has been observed previously with similar evaporative light scattering experiments 
(Kaufmann et al. 2001). 
 
6.2.2.8 Dynamic charge measurement of the Aerolizer® device 
 
The change in dynamic charge of the capsule and device during aerosolisation of the 
formulation from a capsule was determined using the Flow Through Faraday Pail using 
the method described in Chapter 2. Dynamic charge measurements were performed in 
combination with bipolar charge measurements of the aerosol particles using the bp-
NGI. 
 
6.2.2.9 Net charge measurements of the capsules 
 
Immediately post aerosolisation of the formulation from a capsule, the empty capsule 
was dropped from the device into a Faraday pail. The net charge value was then 
recorded. 
 
6.2.2.10 Testing regimen 
 
Dynamic charge measurements of the device and capsule, bipolar charge 
measurements of the formulation and net charge measurements of the capsules were 
performed using the experimental set up as shown in Figure 6.1. This experimental set 
up allowed for simultaneous measurements of device, capsule and aerosol particle 
charge, all at a controlled relative humidity. The formulation was tested at relative 
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humidities of 35, 55 and 75% with a working hypothesis that the higher the relative 
humidity, the lower the electrostatic charge generated as well as the faster the charge 
decay rate. Based on work by Nemeth et al. and Mountain et al. who looked at the 
effect of relative humidity on the electrostatic properties of polymers, it was 
hypothesised that for the Aerolizer® device, which is made of a plastic polymer 
material, acrylonitrile butadiene styrene (ABS) an increase in % RH would result in a 
decrease in the surface potential and charge decay rate and therefore lower dynamic 
charge measurements using the flow through Faraday pail (Mountain et al. 2001, 
Nemeth et al. 2003). 
 
6.2.2.11 Statistical analysis 
 
Data was subjected to statistical analysis using Minitab statistical software version 16 
(Minitab Ltd., Coventry, UK). One way ANOVA analyses were performed with Tukey’s 
post-test to determine a 95% confidence interval defined as p < 0.05. 
 
 





6.3 Results and discussion 
6.3.1 Particle size 
 
The particle size distributions of ML001 and budesonide are displayed in Table 6.1 and 
the particle size distribution of budesonide is shown in Figure 6.2. The average (n=5) of 
the 10% undersize (d10), 50% undersize (d50) and 90% undersize (d90) values were 
recorded as well as the percentage of particles with diameter less than 5 μm.  
 
d10 (μm) d50 (μm) d90 (μm) % < 5 μm 
Budesonide 0.9 ± 0.0 2.1 ± 0.0 4.0 ± 0.0 94.4 ± 0.1 
ML001 3.7 ± 0.2 48.1 ± 0.4 153.9 ± 1.9 11.2 ± 0.3 
 
Table 6.1 Particle size values of budesonide and ML001 (n=5, mean ± SD) 
 
 
Figure 6.2 Particle size log density distribution of micronised budesonide 
 
The results show that as ML001 is a milled carrier grade of lactose it has a much larger 
particle size distribution than budesonide. Budesonide was processed via micronisation 
and the average percentage of particles with diameter of less than 5 μm was 94.43 ± 
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0.07%, to ensure that upon aerosolisation and subsequent inhalation the particles are 
able to reach the deep lung in order to produce the desired therapeutic effect. 
6.3.2 Scanning electron microscopy 
 
Scanning electron micrographs of A, ML001 and B, budesonide are displayed in Figure 
6.3. The image for ML001 at 200x magnification shows the relative large particles of 
the course carrier. The image for budesonide at a magnification of 15000x shows the 











6.3.3 Assay and content uniformity 
 
After the blend was manufactured, 10 samples of 25mg of the formulation were 
dissolved in 100 mL of mobile phase. HPLC analysis was performed and the drug 
content was found to be 96.55 ± 1.89 % which is within the 85 - 115% USP criteria for 
content uniformity (USP 2011). The CV was 2.04% indicating that the blend was a 
homogenous mixture. 
 
6.3.4 In vitro performance of the formulation at 55% RH 
 
The in vitro performance of the budesonide formulation at 55% RH is shown in Figure 
6.4 and Table 6.2. This is experiment was performed as a control to allow comparison 
with data generated with the bp-NGI. The distribution of budesonide throughout the 
stages of the NGI shows an in vitro performance distribution with a maximum 
deposition on stage 2 with a cut off diameter of 6.48µm at a flow rate of 90 Lmin-1. 
 






RD (µg) ± S.D. FPF (ED) (%) ± S.D. ISM (% of RD) ± S.D. MMAD (μm) ± S.D. 
1020.2 ± 40.1 33.4 ± 0.3 34.3 ± 0.9 3.5 ± 0.1 
 
Table 6.2 In vitro performance of the budesonide formulation (n=3, mean ± SD) 
 
These data show that the formulation performed efficiently at a relative humidity of 
55%, with a fine particle fraction of the emitted dose of 33.4 ± 0.3 % and an MMAD of 
3.5 ± 0.1 μm. 
 
 
6.3.5 Comparison of the performance between the NGI and the bp-NGI and the effect 
of humidity on the formulation performance. 
 
A potential concern highlighted during the design of the bp-NGI was whether the 
modifications to the system would affect the in vitro performance of formulations tested.  
Although the flow rate was maintained at the desired level, the incorporation of the 
bifurcator and electrostatic precipitation sections resulted in a large addition to the total 
interior volume, which could result in a difference in the air pressure of the system 
during simulated inhalation air flow. Consequently, the in vitro performance of the 
budesonide formulation was compared with the conventional NGI and the bp-NGI in 
order to ensure the performance of the two instruments was comparable. This was 
achieved by comparing the results from the capsules, device, mouthpiece and throat, 
preseparator and the impactor stage masses from stages 2 and below. The formulation 
performance results at the three different humidities tested with the bp-NGI were also 











Testing Condition RD (µg) ± S.D. ISM (% of RD) ± S.D. 
   
NGI 55% RH 1020.2 ± 40.1 34.3 ± 0.9 
bp-NGI 35% RH 944.5 ± 59.1 29.6 ± 3.6 
bp-NGI 55% RH 1001.5 ± 60.5 31.5 ± 3.5 
bp-NGI 75% RH 997.9 ± 49.4 37.2 ± 2.7 
 
Table 6.3 Comparison of the in vitro performance of the budesonide formulation with the 
NGI and the bp-NGI (n=3, mean ± SD) 
 
 
Figure 6.5 Comparison of the in vitro performance of the budesonide formulation with the 
NGI and the bp-NGI. *- significantly different from the ISM determined with the bp-NGI at 
35% RH (n=3, mean ± SD) 
 
The results were analysed using Minitab version 16 statistical analysis software for 
each relative humidity condition and no significant difference (p >0.05) was observed 
between the values of ISM (equivalent to the total deposition from stage 2 and below), 
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for the NGI and bp-NGI, indicating that the formulation performance was comparable 
between the two pieces of equipment. 
 
The effect of humidity on the formulation performance was determined with the bp-NGI 
at relative humidities of 35, 55 and 75% RH within the humidity cabinet. This was 
achieved by comparing the ISM as a percentage of the recovered dose for each 
humidity tested. Statistical analysis for data in Table 6.3 indicated that there was no 
significant difference between the values for 35% and 55% and 55% and 75% relative 
humidity respectively. However a statistical difference (p <0.05) was observed between 
the values at 35% and 75% RH (29.6 ± 3.6% and 37.2 ± 2.7% respectively). This 
indicated that as the relative humidity increased, formulation performance increased, 
with increased deposition occurring on stages two and below. This is in agreement with 
findings by Young et al. (2007) who showed that the fine particle dose and fine particle 
fraction of the emitted dose of a salbutamol DPI formulation increased with increasing 
humidity in the range of 0 – 60% RH (Young et al. 2007). 
 
6.3.6 Bipolar charge to mass ratios of the formulation as a function of humidity 
 
6.3.6.1 35% RH 
 
The mass distribution of budesonide generated within the bp-NGI at 35% RH is shown 
in Figure 6.6 and Table 6.4. An asymmetric mass distribution was produced which was 
not consistent with the symmetrical mass distributions observed with the pMDI aerosols 
in Chapter 5. At low values of charge, the electrical mobility of the particles is lower and 
as such it is harder for them to be precipitated. Under ideal conditions, the collection 
efficiency of the electrodes and precipitation tubes should be identical. However, when 
the flow is not completely uniform, the collection efficiencies of the central electrodes 
may be lower than that of the precipitation tubes because the electrodes have a 
smaller surface area. Although the computational fluid dynamic analysis performed 
indicated that the flow was laminar, the velocity contour diagram showed that the 
electrodes created some slight turbulence in the precipitation tubes, with the airflow 
velocity increased around the electrode and slower closer to the precipitation tube. 
Since an increase in velocity will result in a decrease in precipitation efficiency, this 
may have resulted in a reduction in collection efficiency of the electrodes and hence 









 Precipitation Section   Precipitation Section 
 Negative Positive   Negative Positive 
Mass Tube  
(μg) ± S.D. 
37.0 ± 0.4 24.6 ± 3.4 
 Percentage Tube  
(%) ± S.D. 
65.5 ± 0.7 42.5 ± 5.9 
Mass Electrode 
(μg) ± S.D. 
10.2 ± 0.6 17.3 ± 3.1 
 Percentage Electrode 
(%) ± S.D. 
18.1 ± 1.0 29.8 ± 5.4 
Mass Filter  
(μg) ± S.D. 
9.3 ± 0.1 16.0 ± 2.8 
 Percentage Filter  
(%) ± S.D. 
16.5 ± 0.1 27.7 ± 4.9 
Total  
(μg) ± S.D. 
56.5 ± 1.0 57.9 ± 9.3 
 Total  
(%) ± S.D. 
100.0 ± 1.8 100.0 ± 16.1 
 
Table 6.4 Masses and percentages of budesonide particles deposited within the bp-NGI 
at 35% RH (n=3, mean ± SD) 
 
The results show that budesonide exhibited a propensity to become more negatively 
charged than positively charged, with the ratio of negative to positive particles being 
1.54 : 1 as determined from the percentage of budesonide particles deposited on the 
precipitation tubes. The total masses of API particles collected were 56.5 ± 1.0 and 
57.9 ± 9.6 for the negative and positive precipitation sections respectively, which were 




The mass distribution of lactose generated within the bp-NGI at 35% RH is shown in 
Figure 6.7 and Table 6.5. Again an asymmetric mass distribution was produced 
indicating that the charge of the lactose particles entering the precipitation sections was 
low, resulting in reduced deposition onto the central high voltage electrodes. 
 
 
Figure 6.7 Percentages of lactose particles deposited within the bp-NGI at 35% RH 
 
 Precipitation Section   Precipitation Section 
 Negative Positive   Negative Positive 
Mass Tube  
(μg) ± S.D. 
1473.4 ± 173.0 1389.9 ± 38.5 
 Percentage Tube  
(%) ± S.D. 
66.5 ± 7.8 62.7 ± 1.7 
Mass Electrode 
(μg) ± S.D. 
354.9 ± 40.3 360.9 ± 107.3 
 Percentage Electrode 
(%) ± S.D. 
16.0 ± 1.8 16.4 ± 4.8 
Mass Filter  
(μg) ± S.D. 
386.4 ± 82.5 461.5 ± 85.4 
 Percentage Filter  
(%) ± S.D. 
17.5 ± 3.7 20.8 ± 3.9 
Total  
(μg) ± S.D. 
2214.7 ± 295.7 2215.3 ± 231.2 
 Total  
(%) ± S.D. 
100.0 ± 13.4 100.0 ± 10.4 
 
Table 6.5 Masses and percentages of lactose particles deposited within the bp-NGI at 
35% RH (n=3, mean ± SD) 
 
The results show that for lactose, the ratio of negatively charged : positively charged 
particles was 1 : 0.9 as determined from the mass of particles deposited on the 
precipitation tubes. The masses of lactose particles collected were 2214.7 ± 295.7 and 
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2215.3 ± 231.2 for the negative and positive precipitation sections respectively, which 
were much larger than the quantities of API particles collected. This demonstrated that 
ML001 has a significant quantity of fine particles generated from the milling process 
used to manufacture it (Steckel et al. 2006). 
 
The charge measurements of the < 6.48 μm particles from each shot of the formulation 
which entered the precipitation sections at 35% RH are shown Figure 6.8. The negative 
charge values were fairly consistent with an average value of -0.31 ± 0.10 nC. The 
positive charge values were lower in magnitude with an average value of +0.21 ± 0.13 
nC. This resulted in the net charge measurements (as calculated from the sum of the 
negative and positive values) being overall negative in nature with an average value of 
-0.09 ± 0.26 nC.  
 
Figure 6.8 Charge measurements of five successive shots of the budesonide formulation 
at 35% RH 
 
The bipolar charge measurements of the < 6.48 μm budesonide and lactose particles 
at 35% RH are shown in Figure 6.9. The results show that the average charge to mass 
ratio of the positively charged particles (+0.77 ± 0.20 pC/μg) was lower in magnitude 
than the negatively charged particles (-1.03 ± 0.31 pC/μg). The overall net charge to 
mass ratio of the particles was -0.16 ± 0.45 pC/μg highlighting the greater charge 




Figure 6.9 Bipolar charge to mass ratios of the budesonide and lactose particles 
collected within the bp-NGI at 35% RH 
 
 
6.3.6.2 55% RH 
 
The mass distribution of budesonide generated within the bp-NGI at 55% RH is shown 
in Figure 6.10 and Table 6.6. The mass distribution within the precipitation sections 
was similar to 35% RH, with the budesonide particles showing a greater propensity to 
become negatively charged than positively charged with the ratio of positive : negative 
particles being 1.10 : 1, as determined from the percentages collected on the 
precipitation tubes of the electrostatic precipitation sections. The total masses of API 
particles collected were 63.9 ± 5.2 and 69.4 ± 4.5 for the negative and positive 
precipitation sections respectively, again demonstrating efficient bifurcation of the 
airflow and an increase in the total amount of budesonide which entered the 





Figure 6.10 Percentages of budesonide particles deposited within the bp-NGI at 55% RH 
storage 
 
 Precipitation Section   Precipitation Section 
 Negative Positive   Negative Positive 
Mass Tube  
(μg) ± S.D. 
48.2 ± 5.3 33.2 ± 0.4 
 Percentage Tube  
(%) ± S.D. 
68.5 ± 7.6 48.4 ± 0.6 
Mass Electrode 
(μg) ± S.D. 
10.4 ± 0.9 21.0 ± 0.7 
 Percentage Electrode 
(%) ± S.D. 
14.8 ± 1.3 30.6 ± 1.0 
Mass Filter  
(μg) ± S.D. 
11.8 ± 0.2 14.4 ± 2.8 
 Percentage Filter  
(%) ± S.D. 
16.8 ± 0.3 21.0 ± 4.1 
Total  
(μg) ± S.D. 
70.3 ± 6.5 68.6 ± 3.9 
 Total  
(%) ± S.D. 
100.0 ± 9.2 100.0 ± 5.7 
 
Table 6.6 Masses and percentages of budesonide particles deposited within the bp-NGI 
at 55% RH (n=3, mean ± SD) 
 
The mass distribution of lactose generated within the bp-NGI at 55% RH is shown in 
Figure 6.11 and Table 6.7. The distribution was similar to 35% RH with less lactose 
collected on the electrodes than the precipitation tubes. The lactose particles showed a 
slight propensity to become negatively charged rather than positively charged with a 
ratio of 1.1 : 1 negative : positive particles recorded from the precipitation tubes. The 
mass of lactose collected in each precipitation section was again high with 1945.6 ± 
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Figure 6.11 Percentages of lactose particles deposited within the bp-NGI at 55% RH 
 
 Precipitation Section   Precipitation Section 
 Negative Positive   Negative Positive 
Mass Tube 
(μg) ± S.D. 
1197.3 ± 41.1 1087.7 ± 33.1 
 Percentage Tube 
(%) ± S.D. 
61.5 ± 2.1 58.2 ± 1.8 
Mass Electrode 
(μg) ± S.D. 
344.4 ± 24.1 424.8 ± 41.9 
 Percentage Electrode 
(%) ± S.D. 
17.7 ± 1.2 22.7 ± 2.2 
Mass Filter 
(μg) ± S.D. 
403.9 ± 5.2 357.1 ± 13.9 
 Percentage Filter 
(%) ± S.D. 
20.8 ± 0.3 19.1 ± 0.7 
Total 
(μg) ± S.D. 
1945.6 ± 70.4 1869.6 ± 88.9 
 Total 
(%) ± S.D. 
100.0 ± 3.6 100.0 ± 4.8 
 
Table 6.7 Masses and percentages of lactose particles deposited within the bp-NGI at 
55% RH (n=3, mean ± SD) 
 
The charge measurements of the < 6.48 μm particles from each shot of the formulation 
which entered the precipitation sections at 55% RH are shown Figure 6.12. The 
average negative and positive charge values were slightly lower than those at 35% RH 
with averages values of -0.27 ± 0.03 nC and +0.24 ± 0.06 nC respectively. The overall 





Figure 6.12 Charge measurements of five successive shots of the budesonide 
formulation at 55% RH 
 
The bipolar charge measurements of the < 6.48 μm budesonide and lactose particles 
at 55% RH are shown in Figure 6.13. The results show a reduction in the average 
charge to mass ratio of the positively charged particles from +3.18 ± 0.25 pC/μg to 
+2.08 ± 0.25 pC/μg which was a direct consequence of the lower positive charge value 
recorded at this condition. The charge to mass ratio of the negatively charged particles 
also showed a slight reduction in magnitude from -1.54 ± 0.29 pC/μg to -1.22 ± 0.44 
pC/μg although this was not significantly different. The lower positive charge values 
also resulted in a reduction in the overall net charge to mass ratio of the particles which 




Figure 6.13 Bipolar charge to mass ratios of the budesonide and lactose particles 
collected within the bp-NGI at 55% RH 
 
 
6.3.6.3 75% RH 
 
The mass distribution of budesonide generated within the bp-NGI at 75% RH is shown 
in Figure 6.14 and Table 6.8. The mass distribution within the precipitation sections 
was similar to 35% RH and 55% RH, with the budesonide particles showing a greater 
propensity to become negatively charged than positively charged with the ratio of 
positive : negative particles being 1.25 : 1. The total masses of API particles collected 
were 71.4 ± 5.3 and 83.7 ± 5.6 for the negative and positive precipitation sections 
respectively, again demonstrating efficient bifurcation of the airflow and showing an 
increase in the total amount of API entering the precipitation sections compared with 





Figure 6.14 Percentages of budesonide particles deposited within the bp-NGI at 75% RH 
 
 
 Precipitation Section   Precipitation Section 
 Negative Positive   Negative Positive 
Mass Tube  
(μg) ± S.D. 
39.4 ± 2.8 36.9 ± 2.9 
 Percentage Tube  
(%) ± S.D. 
55.2 ± 3.9 44.1 ± 3.5 
Mass Electrode 
(μg) ± S.D. 
17.6 ± 2.4 26.4 ± 0.1 
 Percentage Electrode 
(%) ± S.D. 
24.7 ± 3.4 31.6 ± 0.2 
Mass Filter  
(μg) ± S.D. 
14.4 ± 0.1 20.3 ± 2.5 
 Percentage Filter  
(%) ± S.D. 
20.1 ± 0.2 24.3 ± 3.0 
Total  
(μg) ± S.D. 
71.4 ± 5.3 83.7 ± 5.6 
 Total  
(%) ± S.D. 
100.0 ± 7.4 100.0 ± 6.7 
 
Table 6.8 Masses and percentages of budesonide particles deposited within the bp-NGI 
at 75% RH (n=3, mean ± SD) 
  
The mass distribution of lactose generated within the bp-NGI at 75% RH is shown in 
Figure 6.15 and Table 6.9. The distribution was similar to 35% and 55% RH with less 
lactose collected on the electrodes than the precipitation tubes. The bipolar charge 
distribution of the lactose also showed a slight propensity for more negatively charged 
particles to be formed with a ratio of 1.05 : 1 negative : positive particles recorded from 
the precipitation tubes. The mass of lactose collected in each precipitation section was 
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again high with 2219.3 ± 114.2 μg and 2344.9 ± 47.8 μg collected in the negative and 
positive sections respectively. 
 
Figure 6.15 Percentages of lactose particles deposited within the bp-NGI at 75% RH 
 
 
 Precipitation Section   Precipitation Section 
 Negative Positive   Negative Positive 
Mass Tube 
(μg) ± S.D. 
1467.3 ± 77.9 1399.0 ± 25.6 
 Percentage Tube 
(%) ± S.D. 
66.1 ± 3.5 59.7 ± 1.0 
Mass Electrode 
(μg) ± S.D. 
383.07 ± 19.7 434.8 ± 7.1 
 Percentage Electrode 
(%) ± S.D. 
17.3 ± 0.9 18.5 ± 0.3 
Mass Filter 
(μg) ± S.D. 
368.9 ± 16.5 511.2 ± 15.2 
 Percentage Filter 
(%) ± S.D. 
16.6 ± 0.7 21.8 ± 0.7 
Total 
(μg) ± S.D. 
2219.3 ± 114.2 2344.9 ± 47.8 
 Total 
(%) ± S.D. 
100.0 ± 5.2 100.0 ± 2.0 
 
Table 6.9 Masses and percentages of lactose particles deposited within the bp-NGI at 
75% RH (n=3, mean ± SD) 
 
The charge measurements of the < 6.48 μm particles from each shot of the formulation 
which entered the precipitation sections at 75% RH are shown Figure 6.16. The 
negative and positive charge values were both lower than at 35% and 55% RH with 
average values of -0.15 ± 0.04 nC. and +0.16 ± 0.07 nC respectively. The average 
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overall net charge per shot was +0.04 ± 0.11 nC which was positive in nature rather 
than negative as was seen at 35% and 55% RH. 
Figure 6.16 Charge measurements of five successive shots of the budesonide 
formulation at 75% RH 
 
The bipolar charge measurements of the < 6.48 μm budesonide and lactose particles 
at 75% RH are shown in Figure 6.17. The results showed the average charge to mass 
ratio of the negatively charged and positively charged particles was of -0.50 ± 0.16 
pC/μg and +0.64 ± 0.42 pC/μg, respectively. These values were significantly lower than 
the values at 35% and 55% RH. There was also a switch in the overall net charge to 
mass ratio of the particles to positive rather than negative as seen for 35% and 55% 






Figure 6.17 Bipolar charge to mass ratios of the budesonide and lactose particles 
collected within the bp-NGI at 75% RH 
 
6.3.7 Comparison of charge and charge to mass ratios recorded at each humidity  
 
A plot of average negative, positive and net charge per shot for each humidity tested is 
shown in Figure 6.18 and a plot of the corresponding charge to mass ratios is shown in 
Figure 6.19. The results show that the bipolar charge values recorded decreased in 
magnitude as a function of relative humidity. The average negative charge per shot 
decreased from -0.31 ± 0.10 nC at 35% RH to -0.15 ± 0.04 nC at 75% RH and the 
average positive charge per shot decreased from +0.21 ± 0.05 nC at 35% RH to +0.16 
± 0.07 nC at 75% RH. This was as a result of the increase in humidity, resulting in a 
decrease on the initial triboelectric charge generation on the particles within the inhaler, 
and a faster rate of charge decay of the particles as they travelled through the bp-NGI 
before being collected onto the precipitation tubes. Interestingly, the overall net charge 
started off being negative at 35% RH at +0.16 ± 0.07 nC and became positive at 75% 
RH at +0.16 ± 0.07 nC. The bipolar charge to mass ratios were more variable, but the 
values at 75% RH were lower than at 35% RH (p < 0.05) with the negative value falling 
from -1.03 ± 0.31 pC/μg to -0.50 ± 0.16 pC/μg and the positive value falling from +0.77 








Figure 6.19 Average negative, positive and net charge to mass ratio vs relative humidity 
 
As was seen with the charge values the net charge to mass ratio also switched from a 
negative value at 35% RH, -0.16 ± 0.45 pC/μg to a positive value at 75% RH, +0.06 ± 
0.09 pC/μg. The switch from the negative values for net charge and charge to mass 
ratio at 35% RH to positive values at 75% RH may have been due to the lactose, which 
exhibited a slight propensity to become negatively charged, experiencing a faster 
charge decay rate than the API and hence increasing the overall positive charge of the 
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system. The magnitude of the bipolar charge to mass ratios recorded were overall less 
than 2 pC/μg which were significantly lower than the charge values recorded for the 
pMDIs previously tested (range 20-90 pC/μg). This shows that overall the frictional 
charging of the API and lactose particles was very low and based on the performance 
results recorded, triboelectrification of the budesonide formulation DPI particles may 
not have significantly affected the inhaler in vitro performance. 
 
6.3.8 Dynamic Charge Measurements of the Aerolizer® Device 
 
The dynamic charge measurements of the Aerolizer device together with the 
formulation and capsule upon aerosolisation of a shot are plotted against relative 
humidity for each shot successive shot in Figure 6.20 and are plotted against shot 
number for each humidity in Figure 6.21. 
 
 
Figure 6.20 Dynamic charge of the Aerolizer® device plotted against relative humidity for 





Figure 6.21 Dynamic charge of the Aerolizer® device plotted against shot number for 
each relative humidity 
 
The results in Figure 6.20 show that a linear relationship was recorded for each 
successive shot number when plotted against relative humidity. This may be due to 
increased water adhesion to the particle surfaces resulting in a greater magnitude of 
net charge recorded. However, by the time the aerosol particles had entered the 
precipitation sections of the bp-NGI, the charge had mostly dissipated. The results in 
Figure 6.21 show the dynamic net charge recorded when plotted against shot number, 
with the dynamic charge becoming more negative as a function of each successive 
shot. This indicates that the charge build up on the device was increasing as each shot 
was fired but by a progressively smaller amount each time. This may be due to the 
device becoming saturated with charge as each shot was fired and the relationship was 
maintained as during the course of the experiment as the charge was only dissipating 
very slowly. The Ax2 + Bx + C relationship observed indicates that the charge build up 
on the device may be a function of its internal surface area. 
 
6.3.9 Net charge measurements of the capsules 
 
The net charge measurements of the capsules as plotted against shot number for each 
humidity are shown in Figure 6.22. The results show that the capsule charge increase 
was positive in nature and the average values were independent of shot number which 
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was in agreement with the charge measurements recorded with the bp-NGI. The 
standard deviations were quite large which may be due to variability in the way the 
capsule was tapped out of the device and into the Faraday pail.  
The average net charge per capsule for each of set of five capsules is plotted against 
relative humidity in Figure 6.23 and shows a linear relationship between net capsule 
charge post aerosolisation (R2=0.998) within the device and humidity which is in 
agreement with the dynamic charge measurements plotted in Figure 6.20. As relative 
humidity increased, the net capsule charge decreased which may be due to the 
increased humidity dissipating the charge, or that the device itself was becoming less 
negatively charged as humidity decreased. 
 
Figure 6.22 Average net capsule charge plotted against shot number for each relative 
humidity tested 
 





This study describes a novel, comprehensive methodology for performing electrostatic 
characterisation of the respirable particles emitted from a DPI device as well as the 
build-up of static charge on the capsules and device as a function of shot number 
 
The effect of relative humidity on the electrostatic properties of a budesonide DPI 
formulation, including the bipolar charge to mass ratios of the respirable dose, the 
dynamic charge of the Aerolizer® device and the net charge of the capsules, as well as 
the in vitro performance was determined. The bipolar charge to mass ratios of the 
aerosol particles were much lower than previously seen with pMDI formulations and the 
presence of charge did not appear to significantly affect the in vitro performance. 
However, a linear correlation was observed between the bipolar charge measurements 
recorded of the aerosol particles and the relative humidity, with an increase in RH 
resulting in a decrease in the aerosol particle charge. This may have an effect on the in 
vivo performance as the presence of electrostatic charge on aerosol particles is 
expected to increase the amount deposited into the lung.  
 
The amount of net negative charge on the Aerolizer® device increased as a function of 
relative humidity, suggesting that the presence of adhered moisture to the particles’ 
surfaces may have increased the frictional contact with the internal surfaces of the 
device. Conversely an increase in relative humidity decreased the overall amount of 
bipolar charge recorded on the aerosol particles, which could be due to an increased 
charge decay rate while the particles were travelling from the inhaler to the electrostatic 
precipitation sections of the bp-NGI. Faraday pail measurements showed that HPMC 
capsules became net positively charged and that the quantity of charge decreased 
linearly as a function of humidity, but was independent of the shot number. 
 
Further suggested work would be to investigate the effect of a range of other variables 
such as flow rate, type of device and aerosolisation mechanism, capsule material, type 
of API and coarse carrier grade of lactose on the dynamic device charge, the capsule 
charge and the bipolar charge to mass ratios of the therapeutic aerosol particles. The 
electrostatic precipitation sections could also be connected to the other stages of the 
NGI in order to produce a measurement of the bipolar charge distribution for each 








Electrostatic charge is a commonly occurring phenomena which is experienced by all 
solid materials, particularly in the case of free flowing particulate systems which 
possess large surface are to mass ratios. In order to treat respiratory illnesses, 
therapeutic drug particles must be delivered to the lung and the most efficient way of 
achieving this is through inhaled therapies. The nature of the human respiratory tract 
requires that airborne particles must be in the region of 5μm or less in diameter to 
ensure that deposition will occur in the bronchi and bronchioles and not impact in the 
mouth, throat and upper airways. This poses a challenge for pharmaceutical scientists 
as the production and delivery of such particles requires a high level of process 
understanding. Inhaled API particles are normally electrically resistive in nature which 
results in a high probability that they will become triboelectrically charged during 
micronisation to the required size, formulation with excipients and packaged for use 
with inhalation devices. The presence of charge on bulk powders may lead to problems 
including weighing errors, agglomeration, adhesion to surfaces and poor flow. In 
addition during the processes of de-aglommeration and fluidisation, the particles will 
undergo numerous collisions with themselves and with the internal surfaces of the 
inhaler resulting in further triboelectrification. This may affect the formulation 
performance and subsequent in vivo deposition. A further consideration is that 
traditional net charge measurements with instruments such as the Faraday pail do not 
take into account the bipolar nature of the charge present, only recording a sum of the 
combined negative and positive charges. 
 
7.2 General Conclusions 
 
Experiments were conducted to assess various techniques of measuring the net 
charge on two pharmaceutical inhalation grades of lactose with differing rheological 
properties. During sieving, ML001, a cohesive grade of lactose was shown to 
experience greater triboelectrification than SV003 which is free flowing. This showed 
that the process of breaking up lactose agglomerates in ML001 resulted in greater 
contact time and frictional forces with the metallic sieve which in turn lead to a greater 
amount of net negative charge being transferred to the particles. 
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The net charge of unprocessed lactose samples was recorded with a Faraday pail 
using a variety of different methods to transfer and dispense the material. It was shown 
that free flowing SV003 was more prone to frictional triboelectrification than ML001 
during transport and that using a metallic instrument imparted negative charge to the 
sample. The development of a bespoke powder ladle prevented triboelectrification 
during dispensing, allowing for the intrinsic net charge of both grades of lactose to be 
recorded. 
Post low shear and high shear turbula blending, at 50% RH, very little net charge was 
recorded when the powder ladle was used to transfer the lactose samples to the 
Faraday pail. This implies that at the environmental conditions of the experiment the 
charge decay rate was too fast to allow meaningful measurements from being 
performed. 
Static charge decay measurements of DPI blends were performed using a Charge 
Decay Time Analyser which artificially charged the sample with a corona discharge and 
then measured the subsequent rate of charge decay. Results showed that the charging 
propensity of a DPI blend followed a linear correlation with API concentration, but 
charge decay rates followed an exponential correlation above a critical API 
concentration of 0.4% w/w. The charge decay rates for the placebos were extremely 
fast and it may thus be concluded that for commercial DPI formulations, where the API 
loading may reach values of up to 2% w/w, the electrostatic behaviour will be 
dominated by the API. 
The effect of humidity on charge decay kinetics of DPI blends was also investigated. 
DVS experiments indicated that at increased environmental RH, the quantity of water 
adsorbed to the particles’ surface increased. This lead to a decrease in the electrical 
resistivity and a concomitant reduction in the charging propensity and the charge decay 
rates. Charge decay rates followed an exponential decrease with increased humidity 
and with higher concentration API blends, charge decay times were hours at 35% RH, 
minutes at 55% and seconds at 75% RH. Humidity control of the environment should 
thus be controlled during to ensure repeatability and reliability of the steps required to 
formulate and process DPI blends. 
The bipolar Next Generation Impactor (bp-NGI) was designed, constructed and 
assessed as a tool for measuring the bipolar charge to mass ratios of aerosol particles 
exiting inhaler devices. Assessment of commercially available pMDIs of Flixotide™, 
Serevent™ and the combination product Seretide™ suggested that fluticasone 
propionate showed a propensity to become more negatively charged than positively 
223 
 
charged whereas the reverse was shown for salmeterol xinafoate in Serevent. In the 
combination product the bipolar charge to mass ratio distribution of salmeterol 
xinafoate switched, with more particles exhibiting negative charge which has been 
suggested to have been caused by the formation of salmeterol-fluticasone aggregates. 
Data was in agreement with literature findings, however, when fluticasone pMDIs were 
tested with the ELPI, positive charge was found to be recorded at the lower stages of 
the impactor despite the fact that little API was present. This may possibly be due to 
positively charged propellant or ice crystals which are not possible to quantify 
accurately due to rapid evaporation. 
 
The bipolar Next Generation Impactor was subsequently used to assess the bipolar 
charge to mass ratios of a budesonide DPI formulation at a range of controlled 
humidities. Fine particle budesonide showed a slight preference to become negatively 
charged over positively charged whereas for ML001 the distribution was 50:50. Much 
lower values for the bipolar charge to mass measurements were recorded than for the 
pMDI suspensions with a result that a decreased quantity of material was precipitated 
onto the central electrodes. A linear correlation was observed between an increase in 
the relative humidity of the environment and a decrease in the overall amount of bipolar 
charge present on the fine particle fraction. Although the in vitro deposition was not 
significantly affected this may have implications for the in vivo performance, where the 
presence of charge on aerosol particles has been shown to increase the overall 
deposition in the lung. 
Dynamic charge measurements of the Aerolizer® device were performed and it was 
shown that as successive shots were fired through the inhaler, the device became 
increasingly net negatively charged. However, the amount of charge imparted to the 
device decreased with each successive shot, indicating that a saturation limit was 
being approached. An increase in humidity of the environment caused an increase in 
the total amount of negative charged transferred from the formulation to the device, 
possibly as a result of increased frictional triboelectrifaction as a result of increased 
bound water. The HPMC capsules used in the study became net positively charged 
during the aerosolisation process, the magnitude by which was independent of the shot 
number fired. A linear correlation was observed between a reduction in the capsule 
charge with relative humidity, possibly due to an increased charge decay rate of the 
capsule, or an electrostatic interaction with the device which increased in overall net 
negative charge under the same conditions.  
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7.3 Future work 
 
Novel methodologies were developed for performing both static and dynamic charge 
measurements of DPI and pMDI formulations, however, investigations performed 
during the course of this project were only able to investigate a limited number of 
variables. The powder ladle developed in Chapter 3 could be used to assess the static 
charge build up DPI formulations during low shear and high shear blending to 
determine the effect of variables such as API type and concentration, coarse carrier 
grade of lactose, blend physico-chemical properties and environmental RH. It could 
also be employed as a tool for sampling DPI formulations at various points during large 
scale manufacturing processes to monitor electrostatic charge levels and the 
information used to determine the length of hold times. 
 
The Charge Decay Time Analyser could be introduced as a science of scale tool for 
performing routine electrostatic characterisation of all powder pharmaceutical 
excipients and APIs. Values for the initial surface potential and charge decay times 
could be compared with physico-properties such as surface area, morphology, surface 
energy, water content, crystallinity, polymorphism and surface chemistry to determine 
the influence of each variable on the susceptibility of the material to become 
tribocharged. The effects of varying the magnitude, polarity and application time of the 
corona discharge to the material could also be investigated. 
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